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The overall aim of this thesis was to improve the knowledge of the public health 
burden of personality disorders in South East London, specifically as this relates to 
the health and mortality of individuals with personality disorders. An additional aim 
was to enhance the knowledge of the psychiatric service use of people with 
personality disorders in South East London. 
 
This thesis addresses the above aims by focusing on four specific objectives. Each 
objective formed the basis of a discrete study. 
1. To establish the life expectancy and all-cause mortality among secondary 
care patients with personality disorder 
2. To establish the clinical predictors of all-cause and cause-specific mortality 
among secondary care patients with personality disorder 
3. To establish the impact of co-morbid personality disorder on the service use 
of people with severe mental illness within secondary mental healthcare. 
4. To use the SAPAS in order to examine the association between personality 
disorder screen status and general health in a local community sample 
 
The thesis opens with an introduction chapter, Chapter 1, covering the relevant 
background literature – definition, classification and assessment of personality 
disorder. The current literature on epidemiology of personality disorder, in particular 
on health, mortality, costs and service use of people with personality disorder, is 
further expounded. Next, the chapter outlines the aims and objectives of the thesis, 
the sources of data used and my contribution to the work. In Chapters 2, 3, 4 and 5, 
the four studies, corresponding to the four defined objectives, are presented in the 
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form of published manuscripts. Chapter 6, the final chapter, presents a discussion of 
the findings, methodological considerations, implications for clinical practice and 
future research, and conclusions. The References section at the end of the thesis 
includes all bibliographic references from the Introduction (Chapter 1) and the 




Personality disorder is prevalent in the community and in clinical populations; it is 
among the most challenging of mental disorders, both to diagnose and to treat. 
Despite the rapid expansion of epidemiological research in personality disorders in 
recent years, substantial gaps remain in our knowledge of the public health burden of 
personality disorders.  
 
This thesis aims to address this gap, by investigating the health, mortality 
experience, and service use of people with personality disorder. Four separate studies 
were carried out, using two discrete sources of data– one a large psychiatric case 
register, the other a community survey in South East London.  
 
People with personality disorder in secondary mental health care experienced a 
significant reduction in life expectancy, compared to the general population; a 
subgroup of young people bore the highest risk. The majority of early deaths were 
from natural causes. Physical illness, substance and alcohol use, and functional 
impairment were significant clinical predictors of mortality. Amongst patients with 
severe mental illness, co-morbid personality disorder was independently associated 
with higher inpatient service use, and greater likelihood of involuntary 
hospitalization. 
 
In the community, individuals at high risk of personality disorder were significantly 
more likely to be unemployed, have poorer health-related behaviours, multiple 
longstanding illnesses, and common mental disorders. However, personality 
dysfunction was independently associated with poor general health, over and above 
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these factors. This applied to clinically significant levels of personality dysfunction 
as well as sub-threshold personality dysfunction. 
 
In conclusion, the findings give evidence of the burden of personality disorder in 
clinical and community populations. They underscore the importance of routinely 
assessing personality status in individuals presenting to general health services and 
mental health services. Moreover, clinicians and services should pay greater 
attention to the areas of physical health, drug and alcohol use, and functional 
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1.1 Comparison of classification of personality disorder in ICD-10 and DSM-5 
1.4 Assessment methods for all personality disorders  




Personality disorders are among the most challenging of all mental disorders, both to 
diagnose, and to treat and manage. The past two decades have seen some 
considerable changes in the field. Since the publication of the third edition of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-III), epidemiological 
research in this area has rapidly expanded, alongside increasing attention on how 
psychiatric care succeeds or fails in helping these patients. Yet, little is currently 
known about the general health and mortality experiences of people with personality 
disorders and the impact of these issues on local services. As a trainee psychiatrist, I 
was interested in resolving some of the lack of knowledge about these matters in my 
local catchment area population. 
 
1.1 Definition of Personality Disorder 
There are two current operational definitions of personality disorder.   
The International Classification of Mental and Behavioural Disorders (ICD-10) [1] 
defines personality disorder as:   
‘a severe disturbance in the characterological constitution and behavioural 
tendencies of the individual, usually involving several areas of the personality, and 
nearly always associated with considerable personal and social disruption’.  
 
ICD-10 also stipulates that  
‘Personality disorder tends to appear in late childhood or adolescence and 
continues to be manifest into adulthood.’ 
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The fourth edition of the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-IV-TR) [2] was replaced in May 2013 by the fifth edition of the Diagnostic 
and Statistical Manual of Mental Disorders (DSM-5) [3].  
 
In contrast to DSM-IV-TR, which employed a multi-axial system and located 
personality disorders on a separate axis (Axis II) to all other mental disorders, DSM-
5 has shifted to a single axis system. Thus, personality disorders are once again 
placed within the same axis as all other mental disorders . This change reflected a 
number of doubts about the validity of the distinction between the Axis II and Axis I 
disorders, and the apparently burdensome nature of  a multiaxial classification 
system. 
 
DSM-5 defines personality disorder as: 
‘an enduring pattern of inner experience and behaviour that deviates markedly from 
the expectations of the individual’s culture, is pervasive and inflexible, has onset in 
adolescence or early adulthood, is stable over time, and leads to distress or 
impairment’. 
 
The diagnostic criteria for personality disorders in DSM-5 (found in “Section II: 
Diagnostic Criteria and Codes” of DSM-5) have not changed from those in DSM-IV, 
and the classification of personality disorders retain the DSM-IV categorical 
approach with the same three ‘clusters’ and 10 personality disorders as in DSM-IV 
(see below). Thus the following outline of DSM-5 classification is essentially 
identical to DSM-IV. However, an alternative approach to the diagnosis of 
personality disorders, a hybrid dimensional-categorical methodology, was developed 
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for DSM-5 for further study and is presented as “Alternative DSM-5 Model for 
Personality Disorders”, under Section III of DSM-5. This approach will be further 
described in the next section.  
 
Like DSM-IV, DSM-5 recognizes three ‘clusters’ of personality disorder: 
• Cluster A (the ‘odd or eccentric’ types): paranoid, schizoid and schizotypal 
personality disorder 
• Cluster B (the ‘dramatic, emotional or erratic’ types): histrionic, narcissistic, 
antisocial and borderline personality disorders 
• Cluster C (the ‘anxious and fearful’ types): obsessive-compulsive, avoidant 
and dependent.  
Table 1.1 lists the specific personality disorders, as classified by ICD-10 and DSM-
5. Of the 10 specific personality disorders in DSM-5, eight have a specific 
correspondence in ICD-10.  For three of these eight categories, there are differences 
in nomenclature between the two systems; ICD-10 uses the term ‘anankastic’ instead 
of the DSM-5 ‘obsessive-compulsive’, ‘dissocial’ instead of ‘antisocial’, and 
‘anxious/avoidant’ instead of ‘avoidant’. DSM-5 classifies borderline personality 
disorder as a specific category, whilst ICD-10 includes it as a subcategory of 
emotionally unstable personality disorder.  One category of personality disorder, 
narcissistic personality disorder, has no equivalent in ICD-10.  Finally, schizotypal 
personality disorder, which is classified under DSM-5 personality disorders, has no 
counterpart under ICD-10 personality disorders, but is considered to be equivalent to 
ICD-10’s schizotypal disorder which is classified under “Schizophrenia, schizotypal 
and delusional disorders”.     
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Table 1.1 Comparison of classification of personality disorder in ICD-10 and DSM-5 (continued overleaf) 
ICD-10 personality disorders DSM-5 personality disorders DSM-5 clusters 
F60.0  
Paranoid Personality Disorder 
301.0  
Paranoid Personality Disorder 
Cluster A 
F60.1  
Schizoid Personality Disorder 
301.2  
Schizoid Personality Disorder 
No equivalent 301.22  
Schizotypal Personality Disorder 
F60.2  
Dissocial Personality Disorder 
301.7  
Antisocial Personality Disorder 
Cluster B 
F60.3  
Emotionally Unstable Personality Disorder 
(with F60.30 impulsive type and 
 F60.31 borderline type) 
301.83  
Borderline Personality Disorder 
F60.4  
Histrionic Personality Disorder 
301.50  
Histrionic Personality Disorder 
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No equivalent 301.81  
Narcissistic Personality Disorder 
F60.5  
Anankastic Personality Disorder 
301.4  








Anxious [avoidant] Personality Disorder 
301.82  
Avoidant Personality Disorder 
F60.7  
Dependent Personality Disorder 
301.6  
Dependent Personality Disorder 
F60.8  
Other specific Personality Disorders 301.9 
Personality Disorder Not Otherwise Specified 
 
F60.9  




1.2 Alternative DSM-5 model for personality disorders: a hybrid 
dimensional-categorical model 
The alternative DSM-5 model aims to address certain shortcomings of the current 
approach to personality disorder classification. In the current approach, patients 
typically meet criteria for more than one of 10 specific personality disorders. It is 
also common for patients to be assigned a diagnosis of other specified or unspecified 
personality disorder, if they do not have patterns of symptoms that correspond with 
one and only one personality disorder. 
In the alternative DSM-5 model, personality disorders are characterized by: 
• impairments in personality functioning;  and  
• pathological personality traits.  
This model retains six specific personality disorder types: antisocial, avoidant, 
borderline, narcissistic, obsessive-compulsive, and schizotypal. A diagnosis of 
personality disorder—trait specified (Personality Disorder-TS) can be made when a 
personality disorder is considered present but the criteria for a specific disorder are 
not met.  
 
1.2.1 General Diagnostic Criteria for Personality disorder (Alternative DSM-5 
model) 
A. Moderate or greater impairment of personality (self/interpersonal) 
functioning. 
B. One or more pathological personality traits. 
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C. The impairments in personality functioning and the individual’s personality 
trait expression are relatively inflexible and pervasive across a broad range of 
personal and social situations. 
D. The impairments in personality functioning and the individual’s personality 
trait expression are relatively stable across time, with onsets that can be 
traced back to at least adolescence or early adulthood. 
E. The impairments in personality functioning and the individual’s personality 
trait expression are not better explained by another mental disorder. 
F. The impairments in personality functioning and the individual’s personality 
trait expression are not solely attributable to the physiological effects of a 
substance or another medical condition (e.g. severe head trauma). 
G. The impairments in personality functioning and the individual’s personality 
trait expression are not better understood as normal for an individual’s 
developmental stage or sociocultural environment. 
 
Early results from field trials show good test-retest reliability of borderline 
personality disorder diagnosis using this personality trait-defined diagnostic criteria 
[4]. 
 
1.3 Future classification of personality disorders in ICD-11 
The publication of the ICD-11 reclassification of mental and behavioural disorders, 
including personality disorder, is expected in 2015. The details of the proposed 
changes to classification have already been published [5, 6] with the key changes 
being: 
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• Primary classification into four or five levels of personality pathology based 
on a single dimension of severity including mild, moderate and severe 
personality disorder.  
• Identification of subthreshold level of personality difficulty, coded separately 
(under Z-codes) and not as a disorder.  
• Secondary classification of likely five domains of personality disturbance: 
asocial/schizoid, dyssocial/antisocial, obsessional/anankastic, 
anxious/dependent, and emotionally unstable. 
• Monothetic instead of polythetic criteria necessary for inclusion 
• Simple diagnostic formulation with persistent interpersonal dysfunction at its 
core 
The proposed classification places the severity of personality disturbance at the 
centre of classification. The dimensional approach is clinically intuitive and allows 
practitioners who have scarce time for detailed assessment to express a diagnosis at 
the level of severity only. The possibility of classifying subthreshold personality 
dysfunction is also potentially useful, and holds the potential advantage of 
destigmatizing personality difficulties. However, the loss of certain categories of 
personality disorders, particularly borderline and antisocial personality disorders 
(which both have a strong epidemiological evidence base), is problematic. Field 
testing is needed to show its reliability as a diagnostic system.  Such substantial 
changes in classification may make it challenging for clinicians, researchers and 
policy makers, to track the prevalence of personality disorder over time, or to 
compare older studies with more recent studies in the field. On the other hand, 
having a system that encourages more consistent and acceptable diagnoses may lead 
to more high quality studies in the future. 
21 
 
Ultimately, to date, researchers and clinicians have failed to come up with a 
harmonised approach to the classification of personality disorder, which incorporates 
the thinking of both the World Health Organisation (i.e. ICD) and the American 
Psychiatric Association (i.e. DSM). Such a goal may be overly ambitious. Yet until 
international consensus on the classification of personality disorders is achieved, 
progress in this field is likely to move at a slower pace compared to other areas of 
medicine.     
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1.4 Assessment of personality disorder  
Prior to DSM-III, published in 1980, assessment for personality disorder in 
psychiatric patients was frequently overlooked.  Even when considered, personality 
disorder diagnosis was mostly based on clinical interview, which has face validity 
but crucially lacked reliability [7]. The presence of more acute and fluctuating 
psychiatric illness, or physical illness, can contaminate the assessment of the 
relatively more stable personality traits [8]. The lack of reliable case detection 
hindered progress in the field of clinical epidemiology in personality disorder, and 
recognition of this problem partially informed the rationale for creating a separate 
Axis – Axis II – in DSM-III for personality disorders.  This approach was 
specifically designed to encourage consideration of personality in all clinical 
assessments, and to stimulate development in the field of personality disorder 
research. DSM-III also heralded the first appearance of clearly defined operational 
criteria for categories of personality disorder. 
 
The publication of DSM-III stimulated the development of a number of structured 
assessments of personality disorders (see Table 1.4). In general, these assessments 
considerably improve the reliability of personality disorder diagnoses. The majority 
of the tabulated measures show satisfactory inter-rater reliability, at least when the 
instruments are used by their developers.  In a review of 15 reliability studies, 
Zimmerman [8] found that the unweighted mean κ coefficient of inter-rater 
reliability was 0.75 for any personality disorder (range: 0.62 for paranoid personality 
disorder to 0.77 for antisocial personality disorder).  In contrast, test-retest reliability 
coefficients for personality disorder measures are generally lower.  The length of 
follow-up interval seems to affect reliability, although the effect appears to vary by 
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personality disorder category, with antisocial personality disorder being the most 
robust category.  Zimmerman (1994) reported an unweighted mean κ for test-retest 
reliability of 0.56 for any personality disorder in the aforementioned review of 
reliability studies (range: 0.11 for schizotypal to 0.84 for antisocial).  A subsequent 
review of four further test-retest reliability studies [9] reported reliabilities consistent 
with Zimmerman’s review.   
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Table 1.4  Assessment methods for all personality disorders (continued overleaf) 
Instrument Authors Method No. of items 
Personality Assessment Schedule 
(PAS) 
Tyrer et al 
(1979) [10] 
Semi-structured interview with informant(s) using ICD-9 
criteria (ICD-10 and DSM-IV version now available) 
24 
Millon Clinical 
Multiaxial Inventory (MCMI-II) 
Millon (1987) 
[11]   
Self-report by patient using DSM-III-R criteria (DSM-IV-
TR version now available) 
175 
Structured Interview for DSM-III 
Personality Disorders (SIDP) 
Pfohl et al 
(1983) [12]  
Semi-structured interview with patient or informant(s) 
using DSM-III criteria (DSM-IV version now available) 
160 




Semistructured interview with patient using DSM-III-R 





Hyler & Rieder 
(1987) [14]  
Self-report by patient or informant(s) using DSM-III-R 
criteria 
152 




Self-report by patient using DSM-III-R criteria (DSM-IV 






Self-report by patient 100 
Structured Clinical Interview for 
DSM-III-R Personality Disorders 
(SCID-II) 
Spitzer et al 
(1987) [17] 
Semi-structured interview with patient using DSM-III-R 




Instrument Authors Method No. of items 
Standardised Assessment of 
Personality (SAP) 
Pilgrim & Mann 
(1990) [18]  
Semi-structured interview with informant(s) using ICD-10 
& DSM-III-R criteria 
N/A 
International Personality Disorder 
Examination (IPDE) 
Loranger et al 
(1994) [19] 
Semi-structured interview with patient using ICD-10 & 
DSM-III-R criteria 
157 
Assessment of DSM-IV Personality 
Disorders Questionnaire (ADP-IV) 
Schotte et al 
(1998) [20] 
Self-report by patient using a 7-point trait scale and a 3 
point distress scale 
94 
Iowa Personality Disorder Screen 
(IPDS) 
Langbehn et al 
(1999) [21]  
Brief self-report screening questionnaire designed for use 







Q-sort method of personality assessment designed for use 
by a clinician/observer 
200 
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1.4.1 Personality disorder screening in clinical practice and epidemiology 
The structured clinical interview is regarded as the most robust method of assessing 
personality disorder. However, structured interviews are usually time-consuming, 
thus are mostly impractical for busy clinical settings, such as GP surgeries and 
community psychiatric teams. Ironically these are the very settings where the 
possible presence of personality disorder needs to be considered routinely and 
detected early. This is because personality disorder significantly affects the 
management and outcome of associated health problems, both psychiatric [23, 24] as 
well as concurrent medical illness [25].  
 
Brief screening tools [21, 26] offer a pragmatic solution, allowing consideration of 
personality disorder to be easily incorporated into a standard clinical assessment. 
Individuals identified at screening to have likely personality disorder can proceed to 
have this confirmed or rejected by a fuller diagnostic assessment. Germans et al [27] 
studied the characteristics and performance of eight different personality disorder 
screening instruments in predicting personality disorder against SCID-II as “gold 
standard”, in three random samples of psychiatric outpatients. The Standardized 
Assessment of Personality-Abbreviated Scale (SAPAS) showed the best 
performance, with respect to percentage correctly classified (81%) and test-retest 




1.5 Epidemiology of Personality Disorder 
This section reviews the current literature on the epidemiology of personality 
disorder. The following areas will be covered: 
1. Prevalence in the general population and in clinical populations. 
2. Socio-demographic correlates of personality disorder. 
3. Natural history of personality disorder. 
4. The health of people with personality disorder. 
5. The mortality risk of people with personality disorder. 
6. The economic cost and health service use of people with personality disorder. 
 
1.5.1 Prevalence 
Various community surveys have found a prevalence of personality disorder of 
approximately 6-10%. The figure is higher in psychiatric settings, yet without 
routine structured evaluation it is often under-diagnosed clinically. Diagnostic 
thresholds and methodological factors also explain the variation in estimates that 
have been obtained.  
 
1.5.1.1 General population / Community  
In Samuels’ 2011 large review of community surveys of personality disorders 
published since 2000, the prevalence of personality disorder was estimated at 6-10% 
[28]. Cluster C personality disorder was more prevalent than clusters A and B. This 
is generally consistent with findings from earlier studies [29, 30].  The author noted 
that the ICD-10 estimates of any personality disorder were about half that of 
estimates based on DSM-IIIR or DSM-IV, and that this difference was most 
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pronounced for histrionic, dissocial (antisocial), and anxious/avoidant disorders.  
The author of the review ascribed this difference to varying diagnostic thresholds, i.e 
the generally greater proportion of criteria required by the ICD-10 for the diagnosis 
of a personality disorder compared to DSM-IV. Support for this explanation is also 
found in a re-analysis of data from the US National Epidemiological Survey on 
Alcohol and Related Conditions (NESARC) study [31].  
 
From a wider perspective, in the largest global survey of DSM-IV personality 
disorder to date (and as part of the World Health Organization World Mental Health 
(WMH) Surveys, carried out across 13 countries, including low- and middle-income 
as well as developed countries), Huang and others found prevalence estimates of 
personality disorder ranging from 2.4% to 7.9%, with a mean prevalence of 6.1% 
[32].  
 
1.5.1.2 Clinical populations 
The prevalence of personality disorder is higher in clinical populations, and varies 
according to the nature of the clinical setting. Among UK primary care attenders, 
about a quarter meet criteria for personality disorder [33]. In secondary mental health 
care settings, the figure is even higher. A recent review of clinical epidemiological 
studies, covering inpatient and outpatient psychiatric settings, found that 
approximately half of the patients in these settings have a personality disorder [34]. 
A study of across four urban UK community mental health teams estimated the 
prevalence of personality disorder to be as high as 40% [35]; these high prevalence 
estimates in clinical settings have been replicated in a large number of cross-
sectional surveys conducted in many other parts of the world.  
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1.5.2 Sociodemographic Correlates 
Age and gender associations of personality disorder across the abovementioned 
epidemiological studies show some inconsistencies as well as commonalities. In the 
UK, any personality disorder and also Cluster B personality disorders appear to 
occur more frequently among men and younger age groups, but there are no clear 
age or gender differences in relation to the prevalence of Clusters A and C [36]. One 
of the largest US surveys of personality disorder, the US National Epidemiologic 
Survey on Alcohol and Related Conditions (NESARC), found that any personality 
disorder, schizoid, antisocial and narcissistic personality disorders were more 
common in men, whilst paranoid, schizotypal, borderline, histrionic, and all cluster 
C personality disorders were more common among women [31, 37]. Contradicting 
these findings, a large Norwegian survey found no gender influence on the 
prevalence of ‘unspecific personality disorder’ [38]. In the aforementioned global 
survey of personality disorder by Huang et al, any personality disorder, clusters A 
and C personality disorder appeared to be more common among men, and cluster B 
was equally prevalent among men and women; the prevalence of any personality 
disorder was inversely related to age, and more specifically clusters A and B, but not 
C [32].  In a large Australian National Survey, persons with personality disorder 
were more likely to be younger, and male; impulsive personality disorder and 
anankastic personality disorder were more prevalent among men, anxious 
personality disorder and dependent personality disorder were more prevalent among 
women, and other categories were equally prevalent in both sexes [39].  
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Although perhaps axiomatic, surveys repeatedly show that compared to people 
without personality disorder, individuals with a personality disorder are more likely 
to report experiencing social problems such as marital difficulties and 
unemployment [36, 40, 41].  They are more likely to be unmarried, to be living 
alone, and less likely to own their accommodation [36, 38, 39, 41, 42]. Compared to 
those without personality disorder, they are significantly more likely to be 
functioning at a lower level, an association which appears to be independent of the 
effects of depressed mood [43].  They are also more likely to report a previous 
history of alcohol and drug problems and to report experiencing a greater number of 
life events. 
 
In terms of education, analyses of associations by personality disorder cluster have 
seen mixed results, where clusters A and B have been variously associated with 
lesser, and cluster C has been associated with higher, education attainment [37, 38] 
 
1.5.3  Natural history of personality disorder  
Longitudinal studies provide key data about the course and natural history of a 
disorder. In the area of personality disorder, three key longitudinal studies have 
yielded important information on the course and development of personality 
disorder, and these are summarised below. 
 
The Children in the Community (CIC) Study [44] provided knowledge into 
childhood risk factors for and the development of personality disorder in adolescence 
and early adulthood. The study tracked the developmental trajectories of about 800 
youths in New York state, with repeated measures over 20 years. In terms of change 
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and stability of personality disorder symptoms, the authors found that the prevalence 
of personality disorder symptoms or disorders was highest in early adolescence with 
a decline between adolescence and adulthood [45]; some of this decline was 
attributed to normal developmental declines in impulsivity, attention seeking, and 
dependency. About one-fifth of the sample had an overall increase in personality 
disorder symptoms over the follow-up period. Over time, youths at the extreme end 
of personality disorder problems showed increasing deviance relative to their peers. 
Key early risk factors included family characteristics (socioeconomic status, parental 
conflict, parental illness or death), parenting style and the quality of early parent-
child relationships [44, 46]. Comorbidity with Axis I disorders was generally an 
indicator of greater longer-term impairment and poor prognosis. 
 
The Collaborative Longitudinal Personality Disorders Study (CLPS) [47] is a 
prospective, repeated measures study, which originally set out to test the stability of 
personality disorders in a treatment-seeking adult population. The original study 
sample included treatment-seeking patients with schizotypal, borderline, avoidant, 
and obsessive-compulsive personality disorder, as well as those with major 
depression and no personality disorder. The study found that remission (defined as at 
least 12 consecutive months of fulfilling no more than two baseline personality 
disorder criteria) among patients with personality disorder was common and was 
observed in more than half of all patients with personality disorder within the first 
two years of follow-up. Temporal stability of personality disturbance was much 




Regarding comorbidity with Axis-I disorders, the course of personality disorder was 
relatively independent of changes in the course of Axis I disorders, with the 
exception of borderline personality disorder and major depression and post-traumatic 
stress disorder (PTSD), and avoidant personality disorder and social phobia. Of note, 
impairment of social functioning was found to be more enduring than 
psychopathology in individuals with personality disorder [48]. Over a 10-year 
course, patients with borderline personality disorder had high rates of remission 
(85%), but severe and persistent impairment in social functioning [49]. 
 
The McLean Study of Adult Development (MSAD) [50] is a prospective study of 
the course and outcome of borderline personality disorder. The study originally 
recruited 378 patients with borderline personality disorder along with 72 patients 
with other Axis II disorders, excluding borderline personality disorder. All patients 
were recruited at their index psychiatric admission, and all patients were repeatedly 
followed-up at 2-yearly intervals over two decades. Over time, remission was 
defined as no longer meeting criteria for borderline personality disorder (on Revised 
Diagnostic Interview for Borderlines and DSM-III-R) or another personality disorder 
(DSM-III-R) for a period of two years or more (or one follow-up period). Recovery 
was defined as a Global Assessment of Functioning score of 61 or higher – when 
operationalized, this is broadly equivalent to an individual being in remission from 
his or her primary personality disorder (Axis II) diagnosis, having at least one 
emotionally sustaining relationship with a close friend or life partner/spouse, and 
being able to work or go to school consistently, competently, and on a full-time 
basis. Using these definitions, at 16-year follow-up, high rates of remission were 
seen in both borderline personality disorder participants and Axis II comparison 
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participants (range for borderline participants: 78%–99%; range for Axis II 
comparison participants: 97%-99%), but rates of recovery were lower in the 
borderline group (40%–60% compared with 75%–85%).  However, symptomatic 
recurrence and loss of recovery occurred more rapidly and at substantially higher 
rates among borderline patients than Axis II comparison subjects (recurrence: 10%–
36% compared with 4%–7%; loss of recovery: 20%– 44% compared with 9%–28%). 
 
Taken together, the findings from both the CLPS and MSAD studies show that 
whilst symptomatic remission is common in the longitudinal course of personality 
disorder, sustained improvement in social functioning is harder to attain, especially 
in those with borderline personality disorder. Indeed enduring impairment in social 
functioning appears to be a defining characteristic of all personality disorders.  
Beyond the immediate impact on the ability to work and sustain relationships, little 
is known about the longer-term impact of this impairment on an individual’s health 
and their use of services.  One recent study provides an insight and in a large 
community sample found an incremental association between severity of personality 
disturbance and the extent of social difficulties including contacts with the criminal 
justice system, economic inactivity, more Axis I pathology and greater service 
contact [51]. 
 
1.5.4  The health of people with personality disorder  
A literature search was conducted using MEDLINE, Pubmed, and Google Scholar in 
order to identify previously published studies examining the association between 
personality disorder and physical and mental health.  The following search terms 
were used ‘Personality disorder’, ‘health’, ‘physical health’, ‘medical illness’, ‘co-
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morbid’, ‘comorbidity’ and the search limited to English-language articles, up until 
August 2013.  The literature search was supplemented by a hand search of references 
cited in relevant review articles. For studies concerning mental health and 
personality disorder, studies were included if they examined personality pathology or 
personality disorder, and prevalence, comorbidity or outcome in a major mental 
illness (depression, bipolar disorder, psychosis). For studies concerning physical or 
general health, studies were included if they examined personality pathology or 
personality disorder, and a medical condition or a measure of physical or general 
health, functioning, or well-being. 
 
1.5.4.1  Comorbidity with other mental disorders 
There is a growing interest and literature on the influence of co-morbid personality 
disorder on the outcome of Axis I disorders. Samuels’ 2011 review [28] of 
community studies found strong unconfounded associations between personality 
disorders and a wide range of other mental disorders, including anxiety disorders, 
affective disorders, substance use disorders and psychosis. Consistently, studies have 
found that among the three DSM clusters, axis I co-morbidity occurs more 
frequently among individuals from the cluster B personality disorder subgroup.  
 
The best studied association has been between depressive disorders and personality 
disorder status [23]. The question of influence of personality disorder on outcome in 
depressed patients has been the subject of a review by Mulder [52], and a more 
recent meta-analysis by  Newton-Howes et al [53]. Whilst Mulder’s review showed 
that the best designed studies show little or no difference in outcome between 
depressed patients with and without personality disorder, the meta-analysis of 34 
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studies by Newton-Howes et al concluded that personality disorder has a significant 
association with poorer outcome in depression (pooled odds ratio 2.18; 95% 
confidence interval 1.70-2.80). A recent community study by Skodol et al [54] 
investigated the role of personality disorders on the 3-year course of major 
depression and found that borderline personality disorder robustly predicted 
persistence of major depression, whilst other specific personality disorders did not.  
 
Personality disorder is also prevalent among patients with severe mental illness 
(SMI) [55]. Among patients with psychosis, co-morbid personality disorder is 
associated with increased risk of violence [56], and suicidal behaviour [57]. 
Regarding Bipolar disorder, a review by Fan and Hassell [58] concluded that bipolar 
patients with personality psychopathology have poorer response to medications and 
a more turbulent course of illness. The literature on the impact of co-morbid 
personality disorder on the course of schizophrenia is more limited, with mixed 
findings [59, 60]. Notwithstanding, from a service utilisation perspective, studies of 
cohorts of patients with SMI have found that those with co-morbid personality 
disorder tend to spend greater periods of time in hospital [61, 62]. 
 
1.5.4.2  Comorbidity with physical illness 
Comparatively little attention has been paid to investigating physical health and 
physical morbidity in individuals with personality disorders. This marks an area of 
relative neglect from a research perspective.  For instance, a large body of empirical 
research has now established depression as a risk factor for cardiovascular disease, 
and is motivating the health profession to address this seriously [63]. In severe 
mental illness, studies providing evidence of poor general health, increased 
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cardiovascular risk and risk of diabetes, and increased cancer mortality, all underline 
the need for effective physical health care as a priority action in this population [64]. 
A focus and awareness of physical health issues in the field of personality disorder 
research and clinical practice is however still in its infancy. Very few studies have 
considered this association alongside a comprehensive range of potential 
confounding factors. Moreover, the possible impact of response bias as an 
explanation for the association between personality disorder and poor health has not 
been fully explored. 
 
Two review articles have addressed the relationship of personality disorder and 
physical illness.  Frankenburg’s 2006 review on personality disorder and medical 
comorbidity [25] found that in general, those with personality disorders do not feel 
as ‘fit’ as others do. The review found that those with active (as opposed to remitted) 
borderline personality disorder, personality disorder that is comorbid to axis I 
disorders, and antisocial personality disorder, were all likely to have more medical 
problems. Furthermore, personality disorders can complicate the course of chronic 
medical illnesses, through more disordered health behaviours and/or greater 
difficulty complying with treatment. The use of multiple psychotropic medications is 
not uncommon amongst patients with personality disorder, and this in itself can be 
associated with health risks (e.g weight gain and diabetes with atypical antipsychotic 
agents). 
 
The aforementioned 2011 review of community studies by Samuels [28] also found 
personality disorder to be associated with medical service use, and medical 
37 
morbidity and mortality, especially related to cardiovascular disease. The key 
reviewed studies and other recent studies are detailed below. 
 
Data on the association between personality disorder and poor physical health has 
emerged from cross-sectional surveys and also longitudinal studies.   
 
1.5.4.3  Cross-sectional surveys examining the association between health 
and personality disorders 
In the National Epidemiologic Survey on Alcohol and Related Conditions 
(NESARC), a US population-based survey of over 40,000 adults aged 18 and over, 
personality disorder was significantly associated with current alcohol use disorder 
and current drug use disorder (16.4% had a current alcohol use disorder and 6.5% 
had a current drug use disorder) [65] A further substudy of the NESARC population 
detected a specific association between antisocial personality disorder and substance 
use disorders [66]. Associations with alcohol and substance use problems are not in 
themselves direct indicators of poor health, although they are linked with health 
problems.  Hence personality disorder may be linked with poor health through 
alcohol and substance use. 
 
In the Australian National Mental Health and Well-Being Survey, a survey of 10,641 
people randomly sampled from the general population [67], the presence of 
personality disorder was robustly and independently associated with having one or 
more days out of role functioning in the past 4 weeks (OR = 6.3), even after 
adjusting for the effects of Axis I and physical co-morbidity. The severity of 
disability increased with the number of personality disorders present. Moreover, 
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each specific personality disorder was strongly associated with one or more 
measures of disability [67, 68]. The key limitation of the study however was the lack 
of accounting for important health-related confounding factors such as smoking, 
alcohol and substance use, exercise, and obesity. 
 
Moran et al [69] conducted the first study of the association between personality 
disorder and cardiovascular disease, using a national household survey of over 8000 
adults living in England, Wales and Scotland. Those individuals screening positively 
for the presence of personality disorder were more likely to experience a stroke or 
ischaemic heart disease, even after adjusting for key cardiovascular risk factors 
(hypertension, diabetes, smoking and alcohol use). The impact of concurrent 
depression or other mental disorders, however, was not accounted for in this study.  
 
El-Gabalawy et al [70] used data from the NESARC to study the association 
between borderline personality disorder and physical health conditions in the 
community. After adjusting for sociodemographic variables, common Axis I mental 
disorders, and nonborderline personality disorders, borderline personality disorder 
was significantly associated with a number of medical conditions, including 
arteriosclerosis or hypertension, hepatic disease, cardiovascular disease, 
gastrointestinal disease, arthritis, venereal disease, and "any assessed medical 
condition". This study used a large, population-based sample, but the findings are 
limited to borderline personality disorder alone, and confounding by health 
behaviours was not accounted for. 
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Powers and Oltmanns studied personality disorder and physical health in an 
epidemiologically-based sample of 608 middle-aged (55-64 years) adults in St. Louis 
(in Missouri, USA), and found that disordered personality was significantly 
predictive of worse physical functioning, role limitations, fatigue and pain at both 
baseline and 6-months, even when current health problems, the presence of 
depression, and health behaviours (i.e., smoking, drinking, exercise) were controlled 
for [71]. Nonetheless, these findings have limited generalizability to the general 
adult-age population. 
 
An association between personality and health may be explained by differential 
reporting of poor health among those with certain personality features.  Goodwin and 
Engstom examined this possibility in a representative adult community sample of 
over 3000 individuals; some support for this hypothesis was found, in that 
personality factors (as measured by the Midlife Development Inventory Personality 
Scales (MIDI), based on the ‘big five’ factor model) were found to predict 
perception of health, in both the presence and absence of medical conditions [72]. A 
limitation is that common mental disorders were classified with all other medical 
conditions (as the outcome variable) and thus the possible link between personality, 
anxiety or depression, and general health was not examined. 
 
1.5.4.4  Longitudinal studies examining the association between health and 
personality disorders 
Further insights into the association between personality disorder and poor physical 
health have emerged from longitudinal studies of people with personality disorders. 
In the Collaborative Longitudinal Personality Disorders Study (CLPS), co-morbid 
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personality disorder in the context of current depression was associated with greater 
impairment in terms of role limitations due to emotional problems, social 
functioning and a lower perception of general health [73]. The presence or absence 
of chronic medical illnesses, and health-related lifestyle factors were not assessed. In 
the McLean study (MSAD), nonremission of borderline personality disorder 
(compared to remitted borderline personality disorder) was associated with a 
heightened risk of reporting functional syndromes (i.e. chronic fatigue, fibromyalgia, 
or temporomandibular joint syndrome) and chronic medical conditions (i.e. obesity, 
osteoarthritis, diabetes, hypertension, back pain, urinary incontinence). In addition, 
nonremitted borderline patients were more likely to report poor health-related 
lifestyle choices (regular smoking and alcohol drinking, and lack of exercise) and 
regular use of pain medication or sleep medication [74]. It should however be noted 
that both the CLPS and MSAD studies were carried out in clinical, help-seeking 
samples of patients with specific categories of personality disorder, thus limiting 
generalizability to the general population.  
 
1.5.5  The mortality of people with personality disorder 
Given the impact of personality disorder on health, the mortality of people with 
personality disorder warrants greater attention than it has hitherto been given. 
Consistent with the other indicators of the public health impact of personality 
disorder, the condition appears to be associated with a substantial burden of 
mortality. However, methodological issues in the existing literature limit its utility 
and generalizability to present day populations. Moreover, nothing is currently 




A list of psychiatric mortality studies including personality disorder was compiled 
through MEDLINE, Pubmed and Google Scholar literature searches.  ‘Personality 
disorder’, ‘psychiatric’, ‘mental disorder’, ‘mortality’, ‘death’, and ‘life expectancy’ 
were entered as search terms and the search limited to English-language articles. The 
literature search was supplemented by a hand search of references cited in relevant 
review articles. This section reviews the findings from these studies, with a 
particular focus on mortality in personality disorder. 
 
In general terms, mental disorder per se is an established risk factor for increased 
mortality [75-77]. People with mental disorders die prematurely for a variety of 
reasons, including poor physical health [78, 79], adverse physiological consequences 
of long-term psychotropic medication, unhealthy lifestyle, as well as increased death 
rates as a result of suicide, accidents and homicide [80, 81]. The risk of increased 
mortality has been shown to vary according to type of mental disorder, with 
substance use disorders conferring a particularly high risk of early death [75, 80, 82, 
83].   
 
A number of studies have previously reported the existence of an association 
between personality disorder and raised mortality, from both natural and unnatural 
causes [80, 83-90]. Harris and Barraclough’s 1998 review of mortality in mental 
disorder [75] identified two papers with data on personality disorder, from Iowa in 
the US and from Israel respectively [86, 90]. The combined sample size of 
personality disorder patients was around 1800, in which the risk of death from all 
causes was 1.8 times that expected in the reference population (Standardized 
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Mortality Ratio (SMR) =184). SMR for unnatural deaths was 371 (accounting for 
52% of excess deaths), and SMR for natural deaths was147 (48% of excess deaths). 
Both studies used inpatient samples and ICD-9 / pre-DSM-III Personality Disorder 
diagnoses, and therefore the generalizability of these findings to present day clinical 
populations is questionable.  
 
Further studies reporting on the association between personality disorder and 
mortality, that have been published since 1990 are summarised in Table 1.5.5. 
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Table 1.5.5 Mortality of personality disorder from published studies (continued overleaf) 
Author Location 




Mortality of patients with personality 
disorder 
Black et al 
(1985)  
[91] 
Iowa, US All inpatients of university 
psychiatric hospital admitted in 
1972-81. N= 900 patients with 




Excessive unnatural deaths (males SMR 4.55, 
female SMR 17.81), but not natural deaths. 
All cause male SMR 1.17, female 1.52 
Zilber et al 
(1989) [86] 
Israel All hospitalized psychiatric 
patients in Israel in 1978. ICD-
9 Personality Disorder patients 
made up 4700 person-years, 
with 35 observed deaths over 




Overall SMR 2.66, males 2.75, females 2.46. 
Age-specific SMRs: 20-39y: 6.89, 40-59y: 
2.20, 60-69y: 0.63, 70+: 1.11 
Cause specific SMRs: 
Natural cause 3.15 (p<0.01) 
Suicide 2.58 (not significant) 
Other unnatural 1.16 
Baxter 
(1996) [88] 
Salford, UK Individuals on psychiatric case 
register between 1969-1975. 
778 patients with ICD-9 
Personality Disorder diagnosis. 
Up to 18 years 
observation 
period 
Overall SMR 2.07 (p<0.0001)  
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Author Location 











People receiving mental health 
services (in-, out- and day 
patients) in 1980-95. Total 
n=4400. Unknown number of 






Mortality rate ratio: male 2.14 (95% CI 1.68-
2.73); female 2.25 (1.71-2.94) 




Denmark Psychiatric case register 
inpatients in 1973-93. Total 
n=257,720. ICD-8 Personality 
Disorder females 205211 





Suicide: female SMR1568 (95% CI 1471-
1672), male SMR1198 (1128-1272). 
Homicide: female SMR 782 (95% CI 499-
1226), male SMR 536 (311-922) 
Accidents:  female SMR 465 (95% CI 404-
535), male SMR 406 (361-455) 
Natural deaths: female SMR 177 (95%CI 
170-185), male SMR 187 (179-196) 
Elevated SMRs for all specific natural causes 








Mortality of patients with personality 
disorder 
Hannerz et al 
(2001) [92] 
Sweden Swedish psychiatric inpatients 
1978-82. N=2229 ICD-8 
Personality Disorder patients. 
5-year study 
period  
Both men and women have reduced life 
expectancy at all ages. At age 40, life 
expectancy is 12 years less for patients with 
personality disorder. 




Mentally ill patients in 
psychiatric care or primary care 
across Nova Scotia 1995-2000. 
Total n=221048. Unknown 
number of ICD-9 Personality 
Disorder patients.  
5-year study 
period 
Mortality rate ratios:  
Overall: males 2.04 (95% CI 1.27-2.79), 
females 2.08 (1.10-3.04) 
Psychiatric care: males 2.28 (95% CI 1.29-
3.25), females 2.17 (0.49-3.80) 
Primary care: males 1.13 (95% CI 0.34-1.90), 







Individuals with long-term 
mental disorder (6 months or 
more) requiring psychiatric 
care or social service support in 
1997. Diagnosis specific SMRs 




Deaths by external causes: male SMR 20.5 
(95%CI 11.9-32.8), female SMR 29.1 (15.5-
49.8) 
Suicide mortality: male SMR 37.6 (21.5-
61.0), female SMR 41.7 (20.8-74.7) 
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Author Location 




Mortality of patients with personality 
disorder 
only. Total n=7740. Unknown 







All psychiatric patients in 
community-based mental 
healthcare system over 1982-
2001. ICD-10 Personality 
Disorder patients made up 3627 
person years  
20-year study 
period 
Overall SMR 2.74 (95% CI 2.0-3.7) 
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All studies displayed in the Table found raised mortality in patients with a diagnosis 
of personality disorder, with all-cause SMRs ranging from 1.2 to 2.8. Across the 
studies, the risk of premature all-cause mortality appears to afflict men and women 
with personality disorder equally.  However, women with personality disorder have 
consistently higher mortality risks for unnatural deaths compared to men with 
personality disorder. Regarding natural cause deaths, differing findings emerge from 
the three studies providing such data. Black et al [90] found no increased risk of 
natural deaths in personality disorder, whereas Zilber et al [86] reported an overall 
natural death SMR of 3.15; Hiroeh [83] found an increased risk of natural deaths in 
both men and women with personality disorder. 
 
The aforementioned studies have some key limitations. Most studies carried out pre-
2000 suffer from two factors that limit the generalizability to present day clinical 
personality disorder populations – a) use of ICD-8 or ICD-9 Personality Disorder 
diagnoses, and b) exclusive use of inpatient samples. ICD-10 Personality Disorder 
classification has major differences with previous ICD versions and it is difficult to 
know whether findings based on ICD-8 or ICD-9 diagnostic data are applicable to 
present day samples. The sole use of inpatient samples, in all but three of the studies, 
means likely selection bias towards more severely unwell patients and thus a 
probable overestimation of overall mortality risk in personality disorder. One study 
suffered a sizeable loss to follow-up of 11% of personality disorder patients [88], 
which may lead to under-estimation of overall mortality, given that loss to follow-up 
may be due to more severe or complex psychopathology, physical illness, or 
unrecorded mortality. Only one study reported on life expectancy [92] – a key public 
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health metric – but again ICD-8 diagnoses were used and the relevance of the 
findings to the present day is unclear.   
 
Moreover, beyond the knowledge that people with personality disorder are at 
increased risk of premature mortality, little is known about the clinical predictors of 
mortality amongst this group. Follow-up studies in personality disorder have almost 
exclusively examined deaths from suicide, particularly within borderline personality 
disorder [94, 95]; among this group, depression, substance use disorder and 
antisocial personality disorder (or traits) are associated with higher risk of completed 
suicide. However, despite the increasing recognition of medical comorbidity in 
personality disorder [25, 28], and of the role of natural causes underlying excess 
mortality in all people with mental disorders [96-98], no previous study has 
investigated deaths from natural causes among people with personality disorder. 
 
1.5.6  The economic cost and health service use of people with personality 
disorder  
It is important to chart patterns of health service use and the associated economic 
costs, in order to inform decision-making both about future resource allocation and 
also the design and delivery of health services. Given the physical and psychiatric 
impact of personality disorder, one might anticipate high levels of service utilisation 
and associated economic burden. Indeed, the current literature suggests that, both at 
a population level and at the level of clinical services, the burden of personality 
disorder may be as high as that of Axis I disorders. However, it remains unclear 
whether this association is predominately confounded or mediated by co-morbid 
Axis I disorders. In addition, the factors underlying an association between co-
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morbid personality disorder and increased service use in patients with severe mental 
illness are not well understood.  
 
A literature search for into this area was conducted using MEDLINE, Pubmed and 
Google Scholar.  ‘Personality disorder’, ‘service use/utilization’, ‘treatment 
use/utilization’, ‘cost’, ‘impact’, and ‘burden’, were entered as search terms and the 
search limited to English-language articles. The literature search was supplemented 
by a hand search of references cited in relevant review articles. Studies were 
included if they examined personality disorder or comorbid personality disorder in 
an Axis I condition, and its association with any aspect of health care use. 
 
Considering the economic burden firstly at a macro-level, a major report 
commissioned by the King’s Fund on National Health Service (NHS) mental health 
spending in England examined the current and future cost of a number of mental 
disorders, including personality disorder, at a population level [99]. The estimated 
number of people with personality disorders in 2007 was 2.47 million, with total 
service costs estimated to be £704 million. The inclusion of lost employment costs, 
which is thought to account for over 90% of total costs, brings this figure up to £7.9 
billion. By 2026, this figure is estimated to be £12.3 billion. This is similar to 
projected costs of depression and anxiety disorders, and considerably higher than 
that of schizophrenic disorders and bipolar disorder. 
 
Micro-level economic data is more sparse, although a few studies have shed light on 




Both the Australian and British national surveys of psychiatric morbidity reported 
data pertaining to the economic impact of personality disorder. In the Australian 
national survey [67], personality disorder was a predictor of visits to GPs, 
psychiatrists and psychologists, over and above other mental disorders and physical 
conditions. Regarding GP visits, personality disorder was a predictor of 
consultations for mental but not physical health problems. A further analysis 
examining individual subtypes of personality disorder [68] found that borderline 
personality disorder predicted mental health consultations with GPs; whereas people 
with paranoid, histrionic and dependent personality disorder were least likely to seek 
mental health consultations with psychiatrists. Overall, having more than one 
personality disorder was associated with increased odds of consulting a psychologist 
or psychiatrist, with the exception of comorbid personality disorder in borderline 
personality disorder, which reduced the likelihood of consultations.  In Coid et al’s 
national study of the prevalence of personality disorder, personality disorder was not 
independently associated with healthcare service use over and above demographic 
and Axis I disorders [36]; however, cluster C personality disorder was associated 
with counselling and psychotropic medication prescription.  
 
Powers and Oltmanns’ epidemiologically based study (mentioned in section 1.5.4.3) 
found that personality disorder features, specifically features of borderline 
personality disorder, were predictive of greater healthcare utilization and 
prescription medication use—an association which did not extend to clusters A and 
C personality disorders [71]. The generalizability of these findings is limited by the 
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fact that the study population was restricted to a middle-aged sample. 
 
A handful of studies in primary care have found that personality-disordered primary 
care patients make more visits to hospital and receive more referrals to secondary 
care [100-102].  However, some of these only examined the effect of borderline 
personality disorder in selected non-random samples of patients [100, 101], and 
suffered from low response.  Therefore, selection and response bias cannot be ruled 
out as explanations for the findings from these studies.   Moran and colleagues 
studied the impact of all categories of personality disorder in a cohort of 374 
consecutive primary care attenders, and found that personality disorder in general 
was independently associated with frequent attendance to general practice and fewer 
referrals to secondary care [103]. Yet in a subsequent economic analysis of service 
costs, personality disorder was not independently associated with increased costs; the 
increased costs were explained by an interaction between personality disorder and 
common mental disorders [104].  
 
Turning to studies derived from secondary/hospital settings, Bender and others 
retrospectively examined the treatment histories of 664 treatment-seeking patients in 
four personality disorder groups -- schizotypal, borderline, avoidant, and obsessive-
compulsive -- and in a comparison group of patients with major depressive disorder, 
who were recruited as part of the Collaborative Longitudinal Personality Disorders 
Study (CLPS) [105]. They found that patients with personality disorder had more 
extensive histories of psychiatric outpatient, inpatient, and psychopharmacologic 
treatment than patients with major depressive disorder and no personality disorder. 
Specifically, patients with borderline personality disorder used most treatments in 
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greater amounts compared to depressed patients or patients with other personality 
disorders. A further, prospective study of treatment patterns in the same cohort 
essentially confirmed these findings [106]. Over a three-year follow-up period, 
patients with borderline personality disorder were significantly more likely than 
those with major depressive disorder and no personality disorder, to have used more 
mental health treatment resources of various types, including individual therapy, 
emergency department visits, hospitalizations, and number of days hospitalized. The 
obsessive-compulsive personality disorder group was significantly more likely than 
those with major depressive disorder and no personality disorder to have received 
individual therapy, but less likely to have visited an emergency department; the 
avoidant personality disorder group was more likely to have received individual 
treatment; the schizotypal personality disorder group was more likely to receive 
psychiatric medications [106]. These differences were not explained by the presence 
of potential confounders including co-morbid psychiatric problems, or socio-
demographic factors. 
 
A Dutch study of 1740 patients with personality disorder under mental healthcare 
institutes examined the cost incurred to medical services and from lost productivity 
at work in the 12 months prior to treatment [107]. Within medical costs, those due to 
inpatient healthcare (e.g. admissions into general or psychiatric hospital) made up 
the largest proportion of costs (33.1%), followed by outpatient mental healthcare 
(26%). Taking mental health services alone, the proportion of patients using 
outpatient services was 45.2%, with only 2.3% receiving inpatient care. Costs from 
lost productivity were also substantial, with 47.6 days per patient per year lost 
because of absence from or inefficiency at work. The authors note that the total 
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economic burden of personality disorders “seems considerably higher than the 
burden of patients seeking mental health treatment for other mental disorders, such 
as depression and generalized anxiety disorder, and comparable to that in 
schizophrenia”. 
 
Another area that is relatively under-explored is the impact of comorbid personality 
disorder on service use in people with other severe mental disorders.  This is an 
important population to study because people with severe mental illness (SMI) are 
among the heaviest consumers of mental health services.  From a service 
perspective, studies of cohorts of patients with SMI have found that those with co-
morbid personality disorder spend more time in hospital [61, 62], and that 
personality disorder is associated with greater unmet need among psychiatric 
inpatients [108]. Co-occurring personality pathology may also contribute to elevated 
mental health service use, including use of psychotropic drugs, among young adults 
in the community [109], and it may affect different types of service use (i.e. 
inpatient, outpatient, and emergency) differentially [110].  However, the full impact 
of co-morbid personality disorder on community and hospital-based service 
utilization by patients with SMI has not been described. Moreover, the factors 
underlying an association between co-morbid personality disorder and increased 




1.6  Summary and remaining areas of uncertainty in the background 
literature 
Personality disorder is prevalent in the general population (around 5% of British 
population) and highly prevalent in clinical populations. The use of standardized, 
semi-structured instruments is usually necessary to diagnose personality disorder, 
although brief screening tools are proving to be a quick, easy and effective way of 
identifying individuals at risk of the diagnosis. 
 
In the community, individuals with personality disorder generally experience more 
social problems, and function at a lower level, compared to those without personality 
disorder. Longitudinal studies show that whilst symptomatic remission is common in 
personality disorder, sustained improvement in social functioning is hard to attain, 
especially in those with borderline personality disorder.  
 
The reviewed literature indicates that personality disorder is strongly associated with 
increased psychiatric morbidity, increased mortality and greater health service use. 
However, the background literature is weak in the following areas: 
1. The association between personality disorder and general physical health has 
been little researched. Most studies on this subject are limited by their reliance on 
clinical, help-seeking, or age-specific samples; their focus on subtypes of personality 
disorder, or their focus on discrete medical conditions as outcomes. Relatively little 
is known about the relationship between personality disorder and general health in 
community populations.  
2. Previous mortality and life expectancy studies involving people with 
personality disorder have limited generalizability to present day clinical populations, 
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due to their use of out-dated personality disorder classifications, exclusive use of 
inpatient samples, or substantial loss to follow-up. No previous research has 
investigated specific clinical predictors of early natural and unnatural mortality in 
individuals with personality disorder.  
3. Although the literature indicates that the burden of personality disorder on 
clinical services is as high as that of Axis I disorders, it remains unclear whether the 
association between personality disorder and service utilization is predominately 
confounded or mediated by co-morbid Axis I disorders. Co-morbid personality 
disorder in severe mental illness (SMI) has been linked to increased psychiatric bed 
use, [61, 62], but the full impact of co-morbid personality disorder on community 
and hospital-based service utilization by patients with SMI has not been described. 
Moreover, the factors underlying an association between co-morbid personality 









1.7  Aims and objectives 
1.7.1 Overall aim 
The overall aim of the work described in this thesis was to improve the knowledge 
about the public health burden of personality disorders in South East London, 
specifically as this relates to the general health and mortality of individuals with 
personality disorders. An additional aim was to enhance knowledge about the 
psychiatric service use of people with personality disorders in South East London.  
 
1.7.2 Specific objectives 
The above aims were addressed by focusing on four specific objectives:  
1. To establish the life expectancy and all-cause mortality among secondary 
mental healthcare patients with personality disorder 
2. To establish the clinical predictors of all-cause and cause-specific mortality 
among secondary mental healthcare patients with personality disorder 
3. To establish the impact of co-morbid personality disorder on the service use 
of people with severe mental illness within secondary mental healthcare. 
4. To examine the association between personality disorder status and general 
health in a local representative community sample 
Each objective forms the basis of a discrete study; the four studies are presented in 




1.7.3 Delivering the objectives 
1.7.3.1 Establishing the life expectancy and all-cause mortality among 
secondary mental healthcare patients with personality disorder 
The objective of this study was to examine the life expectancy and relative mortality 
in people with personality disorder within secondary mental healthcare. This was 
achieved using a large psychiatric case register in southeast London, UK. Mortality 
data were obtained through national mortality tracing procedures. Standardised 
mortality ratios (SMRs) and life expectancies at birth were calculated, using general 
population mortality statistics as the comparator. This work is presented in the form 
of a published manuscript in Chapter 2. 
 
1.7.3.2 Establishing the clinical predictors of all-cause and cause-specific 
mortality among secondary mental healthcare patients with 
personality disorder 
The objective of this study was to delineate these risk factors, using a large cohort of 
patients identified with personality disorder in the electronic case records of a large 
secondary mental healthcare provider, linked to national mortality tracing. The effect 
of a number of pre-specified clinical variables on all-cause, natural cause and 
unnatural cause mortality was modeled using Cox regression. This work is presented 
in the form of a published manuscript in Chapter 3. 
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1.7.3.3 Establishing the impact of co-morbid personality disorder on the 
service use of people with severe mental illness within secondary 
mental healthcare 
This research objective was to examine the impact of co-morbid personality 
disorder, on inpatient and community-based service use and risk of involuntary 
hospitalization, amongst patients with severe mental illness. A study was undertaken 
using a cohort composed of individuals from three mutually exclusive diagnostic 
groups – (1) severe mental illness (SMI); (2) personality disorder; and (3) SMI with 
comorbid personality disorder – identified in the case records of a large secondary 
mental healthcare provider. Multivariable logistic regression was used to model the 
association of diagnosis category on service use outcomes, adjusting for a range of 
possible explanatory variables.  This work is presented in the form of a published 
manuscript in Chapter 4. 
 
1.7.3.4 Examining the association between personality disorder and 
general health in the community 
This research objective was to examine the association between personality disorder 
and general health, using a cross-sectional psychiatric and physical morbidity survey 
of a representative community sample in South East London, UK. Multivariable 
logistic regression was used to model the association between personality disorder 
screen status (as per the Standardized Assessment of Personality-Abbreviate Scale 
(SAPAS)) and general self-reported health, adjusting for a wide range of potential 
explanatory variables.  This work is presented in the form of a published manuscript 
in Chapter 5. 
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1.8 Sources of data 
The studies in this thesis draw their data from two sources. The clinical cohort 
studies all made use of an electronic case register, the Clinical Record Interactive 
Search (CRIS) system, of the South London and Maudsley NHS Foundation Trust. 
The community study, of personality disorder and general health, was a secondary 
analysis using data from the South East London Community Health (SELCOH) 
study. 
 
1.8.1 Clinical Record Interactive Search (CRIS) system 
The South London and Maudsley NHS Foundation Trust (SLAM) is a secondary 
mental healthcare provider that serves an aggregate population of 1.2 million people 
living in four London boroughs (Lambeth, Southwark, Lewisham and Croydon).   
 
The electronic clinical records system of SLAM, named Patient Journey System 
(PJS), is an integrated electronic clinical record used across all Trust services. It is a 
comprehensive record of all clinical information recorded throughout patients' 
journeys through Trust services, and includes demographic and contact information, 
details of referrals and transfers between services, including all community-based 
and inpatient services. The record is used and maintained by multi-disciplinary 
professionals (doctors, nurses, therapists, psychologists, etc) and consists of both 
structured data (such as dates, gender, integers and pick-list data in structured forms) 
and unstructured free text (including written assessments, progress notes and 




The Clinical Record Interactive Search (CRIS) system was developed in 2008, to 
allow searching and retrieval of anonymised (or de-identified) information from PJS, 
i.e. the full electronic clinical records of SLAM. As of 2014, approximately 230,000 
cases are represented on the system. CRIS was approved as a data resource for 
secondary analysis by the Oxfordshire Research Ethics Committee (reference 
08/H0606/71+5). As CRIS is an anonymised database there was no requirement for 
individual participant consent for studies using CRIS, including the studies reported 
in this thesis. 
 
The CRIS system allows researchers to search both structured and free-text fields in 
the clinical records, and searches can be tailored precisely to the research question. 
Natural language programming (NLP) applications have been designed to identify 
specific terminology of interest, making it possible to extract increasing volumes of 
supplementary information from free-text content in the clinical records. NLP 
applications go beyond a basic keyword search to take into account the context of 
terms of interest (such as negation and tense) making it possible to conduct large 
scale automated extraction and coding of free-text information, with a high degree of 
precision compared to human coders. 
  
1.8.2 South East London Community Health Study (SELCOH) 
The South East London Community Health (SELCOH) study is a community 
psychiatric and physical morbidity survey of adults in the general population. The 
original aim of the study was to generate epidemiological evidence of the mental and 
physical health needs in the local population of South East London -- an ethnically 
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and socioeconomically diverse, geographically defined, inner city community. The 
study was developed by and in partnership with the clinicians serving the local 
population. 
 
Wave 1 of the survey was carried out in 2008-2010. Trained interviewers conducted 
face-to-face computer assisted interviews with 1698 adults aged 16 years and over, 
from 1076 randomly selected private households located within Southwark and 
Lambeth, two South East London boroughs.  
 
The interview survey questionnaire collected information on a number of topics, 
including: socio-demographics; socioeconomic status; migration; social support; 
neighbourhood characteristics; social adversity; health behaviours; physical and 
mental health symptoms; and treatment and health service use. Translators were used 
in interviews with non-English speaking adults. Participants received £15 for a 
completed interview. The study received approval from the King's College London 
Research Ethics Committee, with reference CREC/07/08-152. 
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1.9 My contribution 
I was first author on all four of the published papers in this thesis, and was jointly 
responsible (along with my supervisors) for the conceptualisation and design of the 
studies.  I was responsible for all data extraction and cleaning, with help from 
informaticians in my department. I conducted all the data analyses, with support 
from my supervisors. I undertook report writing in collaboration with my supervisors 
and other co-authors.  
 
1.9.1  Studies using CRIS 
In order to extract the data needed for my studies, I collaborated with clinical 
informaticians of the CRIS team, by providing the detailed instructions on the data to 
be extracted. The informaticians extracted the data according to those instructions. I 
was responsible for checking the quality of the data and data cleaning, and also 
received help from the informaticians in the process.  
 
1.9.1.1 Validation of personality disorder diagnoses 
I undertook a formal validation of the NLP application developed for identifying 
diagnoses on CRIS, specifically of personality disorder diagnoses in my cohort of 
interest. Fifty cases with or without a personality disorder diagnosis were randomly 
selected from a cohort of patients with severe mental illness and/or personality 
disorder. Case note documents for the 50 individuals were then independently 
processed to mask all diagnosis information.  As a trained psychiatrist, I 
subsequently rated these 50 cases for the presence or absence of personality disorder, 
whilst blind to the original diagnostic information. The kappa coefficient for level of 
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agreement between the case register diagnosis and blind clinical rating of the case 
records was 0.72 (p<0.001).  
 
1.9.2  Study using SELCOH 
For the study using SELCOH, I had access to the full set of data collected from 
Wave 1 of SELCOH, and used this dataset selectively for the purpose of my study, 
i.e investigating the association between personality disorder and general health. I 
was responsible for all data analyses, with advice on analytic strategy from my 
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Objective: It is well established that serious mental illness is associated with raised mortality, yet few studies
have looked at the life expectancy of people with personality disorder (PD). This study aims to examine the
life expectancy and relative mortality in people with PD within secondary mental health care.
Methods:We set out to examine this using a large psychiatric case register in southeast London, UK. Mortality
was obtained through national mortality tracing procedures. In a cohort of patients with a primary diagnosis
of PD (n=1836), standardised mortality ratios (SMRs) and life expectancies at birth were calculated, using
general population mortality statistics as the comparator.
Results: Life expectancy at birth was 63.3 years for women and 59.1 years for men with PD—18.7 years and
17.7 years shorter than females and males respectively in the general population in England and Wales.
The SMR was 4.2 (95% CI: 3.03–5.64) overall; 5.0 (95% CI: 3.15–7.45) for females and 3.5 (95% CI: 2.17–
5.47) for males. The highest SMRs were found in the younger age groups for both genders.
Conclusion: People with PD using mental health services have a substantially reduced life expectancy,
highlighting the signiﬁcant public health burden of the disorder.
© 2012 Elsevier Inc. All rights reserved.
Introduction
Mental disorder is an established risk factor for increased mortality
[1,2]. People with mental disorders die prematurely for a variety of
reasons, including poor physical health [3–5], adverse physiological
consequences of long termpsychotropicmedication, unhealthy lifestyle
[5], as well as increased death rates as a result of suicide, accidents and
homicide [6–8]. The risk of increased mortality has been shown to vary
according to type of mental disorder, with substance use disorders
conferring a particularly high risk of early death [1,9,10]. Personality
disorder is a global health problem [11]. It is one of the hardest psychi-
atric conditions to treat and has a considerable economic impact on
general medical and mental health services. People with personality
disorder (PD) are known to be at particularly high risk of increased
mortality as a result of both natural and unnatural causes [12–16].
However, no study has comprehensively examined life expectancy at
birth of the full range of secondary care service users with PD. Life
expectancy is a vital public health statistic which serves as a readily
identiﬁable indicator of general mortality in a speciﬁed population
followed up for a certain period of time.
Methods
In the current study, we used a large psychiatric case register to
conduct a retrospective cohort study, the purpose of which was to
ascertain life expectancy at birth and age- and gender-standardised
mortality of personality-disordered patients compared to the general
England and Wales population. We also calculated standardised
mortality ratios stratiﬁed by gender and age group, in order to investigate
differences among subgroups.
Setting and participants
Our sample was drawn from the electronic case register of the
South London and Maudsley NHS Foundation Trust (SLAM), Europe's
largest secondary mental health care provider serving an aggregate pop-
ulation of 1.2 million people living in four London boroughs (Lambeth,
Southwark, Lewisham and Croydon). The SLAM Biomedical Research
Centre (BRC) Case Register provides anonymised in-depth information
derived from an electronic clinical record system. The development and
protocol of this case register has been described in detail in a previous
open access publication [17]. SLAM incorporates inpatient and outpatient
care, and a broad array of community care teams, as well as psychiatric
liaison services to general hospitals, and forensic, old age, child and
adolescent, and learning disability mental health teams.
Electronic clinical records have been used comprehensively across all
SLAM services since 2006 and the BRC Case Register Interactive Search
(CRIS) system was developed in 2008 to allow searching and retrieval
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of anonymised information from full clinical records with over 182,000
cases currently represented on the system. CRIS was approved as a data
resource for secondary analysis by the Oxfordshire Research Ethics
Committee (reference 08/H0606/71).
All caseswithin the case register that had been given a primary PDdi-
agnosis by International Classiﬁcation of Diseases, 10th Edition (ICD-10)
within the four-year period from 1 January 2007 to 31 December 2010,
and were over 15 years of age, were recruited into the study as a cohort
(n=1836). All-cause mortality in patients with PD over this four-year
period was used for analyses. The beginning of 2007 was chosen as a
starting point for the observation because this corresponded to the
most complete recording of clinical data on the Case Register.
Measures
Death identiﬁcation
NHS number is a\ unique identiﬁer for UK NHS records. All death
certiﬁcations are linked to this identiﬁer at national level, and health
service providers are required by law to keep records up to date with
respect to this. Every death in the UK, after the issuing of a formal
death certiﬁcate, must be reported to the Ofﬁce for National Statistics
General Records Ofﬁce and conveyed to the NHS Care Records Service,
which holds these death notiﬁcations and makes them available to all
NHS organisations. In accordance, on a weekly basis, SLAM downloads
a list of deceased patients from the NHS Care Records Service and
updates their dates of death onto the patients' records, whether that
person is active to services or has been discharged. In the present
study, deaths determined by a date of death within the 4-year period
were enrolled for analyses.
Personality disorder
This was based on the patient's primary ICD-10 diagnosis of PD
(categories F60 and F61) dated from 1 January 2007 to 31 December
2010 in the Case Register.
Demographics
Date of birth, gender, ethnicity and marital status of all patients
are routinely recorded on the Case Register. Age was calculated at
the date of primary diagnosis of PD that occurred in the observation
period. All those who were under the age of 15 at this date were
excluded from the analyses.
Statistical analysis
Life expectancy at birth
Life expectancy at birth is an index derived from age-speciﬁc
mortality that highlights the impact of mortality in younger age groups.
A life table is constructedusing the age-speciﬁcmortality of an observed
population over a given period of time; life expectancy at birth is calcu-
lated from the accumulated total person-years contributed by the
entire concurrent cohort divided by the size of the population at the
beginning of follow up.We used Chiang's method of abridged life tables
with ﬁve-year age bands to calculate life expectancy [18]. For each indi-
vidual, the period of time from the date of PD diagnosis until death or
the end of the observation period (whichever occurred ﬁrst), was
taken as the ‘at-risk period’. In each 5-year age band, the total person-
years at risk is the sum of all the at-risk periods of the individuals in
the age band. The number of people who had a recorded death during
this periodwas used as the numerator to calculate the annual mortality
rate for the age band. In some instances, individuals moved from one
age band to the next during the four-year observation period. In such
cases, the speciﬁc time at risk contributed by those individuals to each
age band was then assigned to the respective age bands. Given that
those below the age of 15 years were excluded from our cohort, we
ﬁlled in the three cells in the life table corresponding to death rates
for 0–5 years, 5–10 years and 10–15 years of age with the respective
comparative death rates for these age groups in the England and
Wales general population in 2008 [19]. These tables were inserted into
a Microsoft Excel spreadsheet and values for gender-speciﬁc life expec-
tancywere calculatedwith 95% conﬁdence intervals. These life expectan-
cy estimateswere comparedwith gender-speciﬁc life expectancy at birth
for the England and Wales population in 2006–2008 [20], and the
arithmetic differences between the two were then calculated.
Standardised mortality ratios
The estimation of all SMRs was carried out using Stata version 10
[21]. As with life expectancy, the at-risk period was deﬁned as the
period of time from the date of PD diagnosis in the observation period
until date of death or the end of the observation period (whichever
occurred ﬁrst). SMRs were calculated for the four-year follow-up
period, using the number of deaths observed in the cohort in these four
years as the numerator. SMRs were gender- and age-standardised using
ﬁve-year age bands (i.e., 15–19, 20–24, 25–29, …, 85–89, 90 or over).
The denominator was derived by calculating the total person-years at
risk in each age group of the sample, then multiplying this by the
corresponding age- and gender-speciﬁc mortality rate in the England
and Wales population [19]. The time period at risk contributed by
individuals who moved from one age band to the next during the obser-
vation period was assigned to the respective age bands.
Results
A total of 1836 cases formed the analysed cohort. The characteristics of the cases
are displayed in Table 1. In summary, the majority were female (60%), 73% were
white British and 74% were in the 15–44 years age group. Regarding marital status,
66% were single, 10% were either married, cohabiting or in a civil partnership, and
12% were divorced, separated or widowed.
Estimates of life expectancy at birth of people with PD, stratiﬁed by gender, are
displayed in Table 2 alongwith the differences compared to general population estimates.
Compared to the England and Wales general population, the life expectancy of men and
women with PD in this sample was lower by 17.7 and 18.7 years respectively.
Table 3 displays age- and gender-standardised SMRs for the entire cohort and then
stratiﬁed by gender and age groups. The SMR for all patients with PD in this cohort was
4.2 (95% CI: 3.03–5.64) and the SMRs for male and female personality-disordered
patients were of a similar magnitude. Stratiﬁcation by age bands revealed that the
youngest age group (15–44 years old) carried the highest excess mortality, compared
to the general population, and that the youngest age group had higher excess mortality
compared to the oldest age group.
Table 1
Characteristics and 4-year mortality of patients with personality disorder
Characteristics Number of PD cases
(number of deaths, %)





White British 1340 (39)
Mixed 29 (0)
Asian or Asian British 41 (3)
Black or Black British 226 (1)
Other 84 (0)
Not stated/unknown 116 (0)
Age group
15–44 years 1354 (20)
45–64 years 419 (11)
65+years 63 (12)
Personality disorder
Any personality disorder (F60–F61) 1836 (43)
Cluster A (F60.0, F60.1) 109 (2)
Cluster B (F60.2, F60.3, F60.31, F60.4) 924 (18)
Cluster C (F60.5, F60.6, F60.7) 62 (1)
Other 741 (22)
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Discussion
Main ﬁndings
Our study highlights the substantial public health burden of
personality disorder in terms of elevated mortality, especially for
younger age groups. We found that patients with personality disorder
can expect, on average, considerably shortened lives compared to
their counterparts in the general population, with men losing
17.7 years of life and women losing 18.7 years. Their mortality was
four times that of the comparative general population. Furthermore,
a 10-fold increased mortality risk was found for younger people
with personality disorder. These ﬁndings critically underscore the
vulnerable nature of people with PD and the urgent need for develop-
ing feasible strategies to prevent premature mortality in this group of
patients.
A number of studies have previously found an association be-
tween PD and raised mortality [12–16]. However, to our knowledge,
our study is the ﬁrst to comprehensively examine the life expectancy
of secondary care service users with PD. Only one other study has
attempted to describe life expectancy for people with PD. Hannerz
et al. [22] used a Swedish nationwide hospital discharge registry to
estimate life expectancies in different diagnostic groups for individuals
treated as inpatients. Both men and women with personality disorder
had a lower “expectation of remaining life” at all ages, compared to
peoplewith schizophrenia and affective psychosis aswell as the general
population. However, the restriction of that analysis to hospitalised
patients and the use of ICD-8 diagnoses limit the application of the
ﬁndings to present-day secondary care settings. Approximate estimates
of life expectancy at birth can be calculated using SMRs from published
studies [23]; however doing this from the few existing studies would
only generate a very rough estimate for people with PD, and one
which would be less accurate than the method used in our study.
Strengths and limitations
Our study has a number of strengths. We analysed a large sample of
cases covering a broad age range. We included everyone with PD who
had contact with services over a 4-year period, whether this was in the
context of inpatient admission, community care or one-off emergency
presentation. We therefore captured a wide range of patients with PD
adding to the generalisability of our ﬁndings to other secondary care
settings. TheNHS settingwith relatively comprehensive coverage provid-
ed to speciﬁc geographic catchments was also an advantageous setting
regarding generalisability to other secondary care settings. In terms of
diagnosis, although research diagnostic criteria may be preferable, our
use of clinicians' case record ICD-10 diagnoses favours generalisability
to real clinical practice. The mortality data were derived from a robust
source and under-ascertainment of deaths is likely to have been very
low. Furthermore, any possible failures in the reporting of deaths would
only have led to an underestimation of the detected associations.
The ﬁndings need to be considered in the light of certain limitations.
First, standardised mortality ratios only provide a coarse picture of
deaths in a speciﬁed study population without the consideration of
confounders other than age and gender. Potentially important con-
founders which are unmeasured in this study include socio-economic
status, comorbid psychiatric and physical conditions and substance
misuse. Second, we were only able to report on all-cause mortality;
against this, our aim was to clarify excess mortality and reduced life
expectancy rather than investigate underlying causes of death. Third,
our statistical power to examine associations between PD clusters and
mortality was not sufﬁcient to detect signiﬁcant differences. Fourth,
we used national data as a comparison, whichmight not be representa-
tive of the local population in southeast London. To address this, we
carried out a sensitivity analysis, standardising with mortality statistics
for London alone (data not shown); in the sensitivity analysis, the point
estimates for SMRs were not substantially different compared to those
displayed in Table 3. Fifth, the observed age-related decline in SMRs
may be due to survival effects i.e., that people with PDs surviving to
older age may have other protective factors conferring this survival.
Finally, we acknowledge that a large number of people with PD do not
present themselves to mental health services and are either managed
in primary care or within general medical services. Our ﬁndings there-
fore only apply to secondary mental health service users.
Possible mechanisms
A number of mechanisms are likely to underlie the detected associ-
ation between PD and reduced life expectancy. First, the rate of death
from unnatural causes, including suicide and homicide, is elevated
in PD [6] and this is likely to have contributed to the reduced life expec-
tancy detected in this study. Second, considering deaths due to natural
causes, personality disorder is associated with poorer general health.
For example, Borderline PD has been found to be associatedwith higher
numbers of medical problems and one recent epidemiological study
found that most PD groups were associatedwith cardiovascular disease
[24].More generally,mental disorders are linked to poor health through
unhealthy lifestyle [25,26], physical consequences of psychotropic
medication [3], and problems accessing medical care [27]; some or all
of these factors may account for reduced survival in people with PD.
Substance use disorders are a major cause of death and disability [1,9]
and frequently co-occur with PD, particularly in young people with
Cluster B PD [28], and elevated mortality in this particular group
may reﬂect unhealthy lifestyles characterised by heavy substance use
and smoking. Patients with PD are often prescribed excessive doses of
psychotropic and non-psychotropicmedications [29]which themselves
may potentially lead to unwanted physical consequences. Finally,
people with PD often struggle to obtain adequate health care and
have greater unmet treatment needs [30].
We conclude that people with PD have a signiﬁcantly reduced life
expectancy at birth compared to the general population. This fact
alone highlights the importance of routinely assessing personality
Table 2
Estimated life expectancy at birth of patients with personality disorder in southeast London
Female Male
Life expectancy




(95% CI, number of deaths)
Difference from male
general population*
All personality disorders 62.9 (61.5–64.3, n=23) –18.7 years 59.7 (57.9–61.5, n=20) −17.7 years
*Life expectancy at birth 2006–2008 in England and Wales: Female=81.6 years; Male=77.4 years [21].
Table 3
Age- and gender-standardised mortality ratios (SMRs) for personality disorder,
stratiﬁed by gender and age groups in 2007–2010
Number of cases Standardised mortality ratio
(95% CI, number of deaths)
Total PD group 1836 4.2 (3.03–5.64, n=43 )
Females 1103 5.0 (3.15–7.45, n=23)
Males 733 3.5 (2.17–5.47, n=20)
Age 15–44 years 1354 10.3 (6.29–15.91, n=20)
45–64 years 419 3.6 (1.78–6.37, n=11)
65 and over 63 2.5 (1.31–4.43, n=12)
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status in psychiatric patients. It also highlights the need for clinicians
to pay greater attention to the physical health status and lifestyles of
patients with PD, in addition to the standard practice of assessing
their suicide risk. Further research is urgently required to determine
the mechanisms underlying the reduced life expectancy of people
with PD.
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Abstract
Background: People with personality disorder have reduced life expectancy, yet, within this population, little is known
about the clinical predictors of natural and unnatural deaths. We set out to investigate this, using a large cohort of
secondary mental health patients with personality disorder.
Methods: We identified patients with an ICD-10 diagnosis of personality disorder, aged $15 years in a large secondary
mental healthcare case register. The case register was linked to national mortality tracing. Using Cox regression, we
modelled the effect of a number of pre-specified clinical variables on all-cause, natural cause and unnatural cause mortality.
Findings: 2,440 patients were identified. Eighty-five deaths (3.5% of cohort) occurred over a 5-year observation period, of
which over 50% were from natural causes. All-cause mortality was associated with alcohol or drug use (adjusted Hazard
Ratio [aHR] 2.3; 95% CI 1.3–4.1), physical illness (aHR 1.9; 95% CI 1.0–3.6), and functional impairment (aHR 1.9; 95% CI 1.0–
3.6). Natural cause mortality was associated with mild problems of alcohol or drug use (aHR 3.4; 95% CI 1.5–7.4), and
physical illness (aHR 2.4; 95% CI 1.0–5.6). Unnatural cause mortality was associated only with severe alcohol or drug use (aHR
3.1; 95% CI 1.3–7.3).
Interpretation: Alcohol and drug use, physical illness, and functional impairment are predictors of mortality in individuals
with personality disorder. Clinicians should be aware of the existence of problems in these domains, even at mild levels,
when assessing the needs of patients with personality disorder.
Citation: Fok ML-Y, Stewart R, Hayes RD, Moran P (2014) Predictors of Natural and Unnatural Mortality among Patients with Personality Disorder: Evidence from a
Large UK Case Register. PLoS ONE 9(7): e100979. doi:10.1371/journal.pone.0100979
Editor: Stephen D. Ginsberg, Nathan Kline Institute and New York University School of Medicine, United States of America
Received April 8, 2014; Accepted June 1, 2014; Published July 7, 2014
Copyright: ! 2014 Fok et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that, for approved reasons, some access restrictions apply to the data underlying the findings. The dataset is comprised
of original patient-level data and it cannot be deposited in a publicly accessible format. The data is available on request and requests may be sent to the Clinical
Records Interactive Search (CRIS) system administrator (contact details below), to request the data for this study. CRIS Administrator, PO 92, Institute of Psychiatry,
De Crespigny Park, London SE5 8AF or email: cris.administrator@kcl.ac.uk.
Funding: This study was supported by the Clinical Records Interactive Search (CRIS) system funded and developed by the National Institute for Health Research
(NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London and a joint infrastructure
grant from Guy’s and St Thomas’ Charity and the Maudsley Charity. The authors appreciated the technical support from informatics personnel in the Biomedical
Research Centre. RH is funded by a Medical Research Council (MRC) Population Health Scientist Fellowship. The views expressed are those of the author(s) and
not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish,
or preparation of the manuscript.
Competing Interests: One of the co-authors, RS, is an academic editor for PLOS ONE. This does not alter the authors’ adherence to PLOS ONE policies on
sharing data and materials.
* Email: marcella.fok@kcl.ac.uk
" RDH and PM are joint senior authors on this work.
Introduction
Personality disorders (PD) present a considerable health
problem globally. They are highly prevalent mental disorders,
affecting up to 10% of community samples [1]. People with PD are
at increased risk of co-morbid health problems, substance misuse
[2] and cardiovascular disease [3]. It is now well established that
serious mental disorder is associated with early mortality [4].
However, only very recently has it emerged that individuals with a
PD diagnosis also have substantially reduced life expectancy [5,6],
with increased mortality from both natural and unnatural causes
[6,7,8]. The excess mortality risks are particularly high for younger
people with personality disorder [5]. Yet, within the population of
individuals with PD, little is known about the clinical predictors of
natural and unnatural mortality. Premature death in people with
PD may arise as a result of a number of mechanisms. For example,
people with PD often have difficulty with emotional regulation,
which they may try to manage with behaviours carrying significant
health risks, such as self-harm, and alcohol and substance abuse.
These same behaviours also carry a risk of accidental death.
Comorbid axis-I psychopathology [9,10], tendency to hostility and
aggression [11], and poor psychosocial functioning are common
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features among individuals with PD and may partially account for
the excess mortality, along with recognised associations between
PD and poor health [3,12]. However, these are speculative
mechanisms with little empirical data to support or refute them.
No previous study has examined the independence of clinical
risk factors for mortality among patients with PD. This is an
important gap in the literature, as effective interventions to reduce
mortality must be based on a thorough knowledge of the specific
risk factors predicting mortality in the population in question.
With this in mind, we set out to investigate the independence of a
set of a priori clinical predictors for all-cause, natural and unnatural




Our sample was drawn from the electronic clinical records of
the South London and Maudsley NHS Foundation Trust (SLAM).
SLAM is a secondary mental health care provider that serves an
aggregate population of 1.2 million people living in four London
boroughs (Lambeth, Southwark, Lewisham and Croydon). Elec-
tronic clinical records have been used comprehensively across all
SLAM services since 2006 and the SLAM Biomedical Research
Centre (BRC) Clinical Record Interactive Search (CRIS) system
was developed in 2008 to allow searching and retrieval of
anonymised information from full clinical records with approxi-
mately 230,000 cases currently represented on the system. The
development and protocol of CRIS has been described in detail
[13], as has the process for case note anonymisation [14]. CRIS
was approved as a data resource for secondary analysis by the
Oxfordshire Research Ethics Committee (reference 08/H0606/
71+5). As CRIS is an anonymised and de-identified database there
is no requirement for individual participant consent for this study.
Inclusion Criteria
The analysed cohort was extracted from the CRIS system and
comprised all individuals meeting all of the following criteria:
N Age greater than 15 years;
N Primary International Classification of Diseases, 10th Edition
(ICD-10) [15] diagnosis of PD (categories F60 and F61) on
case record within the period from 1 January 2007 to 31
December 2011;
N Assessed by a clinician using the Health of the Nations
Outcome Scale (HoNOS) at least once during this same
period.
The face validity of PD diagnoses on the CRIS system has been
examined against blinded clinician rating of case note document,
with a kappa coefficient of 0.72 (p,0.001) for level of agreement
[16].
Main outcome measures
We defined three five-year outcomes: all-cause mortality,
natural and unnatural mortality. The beginning of 2007 was
chosen as a starting point for the observation because this
corresponded to the most complete recording of clinical data on
the CRIS system.
Death identification. All death certifications are linked to
NHS numbers. Every death in the UK, after the issuing of a
formal death certificate, must be reported to the Office for
National Statistics General Records Office and conveyed to the
NHS Care Records Service, which holds these death notifications
and makes them available to all NHS organisations. Accordingly,
on a weekly basis, SLAM downloads a list of deceased patients
from the NHS Care Records Service and updates their dates of
death onto the patients’ records, whether that person is active to
services or has been discharged. In the present study, deaths
determined by a date of death within the 5-year period were
enrolled for analyses.
Cause of Death. Death certification data on all deaths in
CRIS cases up to the end of 2011 was obtained from the Health &
Social Care Information Centre (HSCIC). Cause of death data, in
the form of ICD-10 codes, were matched to deceased cases in the
study cohort using individual NHS number. Natural causes of
death were defined as those with ICD-10 codes A00-R99 (major
diagnostic categories), while unnatural causes were identified by
ICD-10 codes V01-Y89, U509 (accidental, intentional, and
undetermined).
In the case of a deceased individual not having corresponding
cause of death data identified by this method, anonymised records
were extracted using CRIS and manually scrutinised by a clinician
(MF) for information pertaining to natural/unnatural cause of
death.
Explanatory variables
Demographic and socioeconomic factors. Date of birth,
gender, and ethnicity were defined from routinely completed fields
on the source records. Age was calculated from the patient’s PD
diagnosis date. Ethnicity classifications were: ‘‘White British or
other white background’’, ‘‘East Asian’’, ‘‘South Asian’’, ‘‘African,
Caribbean or other black background’’, and ‘‘Mixed, unknown,
and others’’.
The index of multiple deprivation is an area-level measure of
socioeconomic status, calculated at the level of lower super output
area for the residence (LSOA) – a UK address-grouping construct
which contains a minimum of 1000 residents and 400 households,
and an average of 1,500 residents. The index of multiple
deprivation is derived from multiple domains including: employ-
ment, income, education, health, barriers to housing and services,
crime and the living environment. Each domain is given a specific
weighting to reflect its overall importance in the calculation of this
index. Moreover, each domain is made up of a number of specific
indicators that reflect different aspects of the deprivation they are
intended to measure. Full details of each domain, the indicators
they contain and the domain weightings that were used to derive
the index of multiple deprivation are reported elsewhere [17]. In
this study, a patient’s residential postcode in England that was
recorded closest in time to the beginning of the observation period
was used to obtain an index of multiple deprivation score, which
was used in the analysis as a proxy for socioeconomic status.
Increasing scores in the index of multiple deprivation are
indicative of more severe deprivation. In the analysis, deprivation
scores were divided into tertiles. A separate category was given for
homelessness.
Clinical variables. We rated the presence and severity of key
clinical problems using the Health of the Nation Outcome Scale
(HoNOS), a widely used and validated, 12-item, clinician-
administered measure [18,19,20]; a review of the psychometric
properties of the HoNOS by Pirkis et al found that the instrument
had good validity and adequate reliability overall [19]. We selected
the following 8 HoNOS items for investigation as potential risk
factors for mortality, on a priori grounds: (1) overactive or
aggression; (2) non-accidental self-injury; (3) problem-drinking or
drug-taking; (5) physical illness or disability problems; (6) problems
associated with hallucinations and delusions; (7) problems with
depressed mood; (9) problems with social relationships; and (10)
Predictors of Natural and Unnatural Mortality in Personality Disorder
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Table 1. Cohort characteristics and crude hazard ratios for association with all-cause mortality.
Variables Number of individuals (Number of deaths) % deaths Crude Hazard Ratio (95% CI)
Total 2440 (85)
Gender
Female 1372 (42) 3.1 Referent
Male 1068 (43) 4.0 1.3 (0.8–1.9)
Age group
15–29 years 763 (13) 1.7 Referent
30–44 976 (22) 2.3 1.1 (0.6–2.3)
45–64 610 (34) 5.6 3.0 (1.6–5.7)**
65+ 91 (16) 17.6 12.0 (5.8–24.9)***
Ethnicity
White British or other white 1764 (73) 4.1 Referent
East Asian 38 (3) 7.9 2.0 (0.6–6.5)
South Asian 35 (0) 0.0 –
African, Caribbean or other black 388 (7) 1.8 0.4 (0.2–0.9)*
Mixed/unknown 215 (2) 0.9 0.3 (0.1–1.1)
Deprivation in area of residence
Low 741 (22) 3.0 Referent
Medium 749 (28) 3.7 1.3 (0.7–2.2)
High 749 (30) 4.0 1.4 (0.8–2.4)
Homeless/Missing/unknown 201 (5) 2.5 0.8 (0.3–2.0)
Non-accidental self injury
Not a problem 1404 (51) 3.6 Referent
Subclinical, minor problem 389 (9) 2.3 0.7 (0.3–1.3)
Mild problem 311 (11) 3.5 1.1 (0.6–2.0)
Severe/very severe problem 325 (14) 4.3 1.4 (0.7–2.4)
Missing 11 (0) 0.0
Overactivity and aggression
Not a problem 1123 (30) 2.7 Referent
Subclinical, minor problem 659 (30) 4.6 1.7 (1.0–2.9)*
Mild problem 379 (15) 4.0 1.6 (0.8–2.9)
Severe/very severe problem 270 (10) 3.7 1.5 (0.7–3.0)
Missing 9(0) 0.0
Depressed mood
Not a problem 522 (18) 3.5 Referent
Subclinical, minor problem 638 (24) 3.8 1.1 (0.6–2.0)
Mild problem 785 (26) 3.3 1.0 (0.5–1.8)
Severe/very severe problem 484 (17) 3.5 1.1 (0.6–2.1)
Missing 11 (0) 0.0
Hallucinations and delusions
Not a problem 1674 (56) 3.4 Referent
Subclinical, minor problem 310 (7) 2.3 0.6 (0.3–1.4)
Mild problem 250 (10) 4.0 1.2 (0.6–2.3)
Severe/very severe problem 193 (12) 6.2 1.7 (0.9–3.2)
Missing 13 (0) 0.0
Drinking or drug use
Not a problem 1447 (44) 3.0 Referent
Subclinical, minor problem 305 (5) 1.6 0.6 (0.2–1.4)
Mild problem 298 (15) 5.0 1.7 (0.9–3.0)
Severe/very severe problem 363 (21) 5.8 1.9 (1.1–3.2)*
Missing 27 (0) 0.0
Predictors of Natural and Unnatural Mortality in Personality Disorder
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problems with activities of daily living (ADL) – the latter refers to
problems with basic activities of self-care (e.g. eating, washing,
dressing, toilet) as well as more complex skills such as budgeting,
shopping, and use of transport. The eight exposures were chosen
in order to represent a range of non-demographic variables
(behavioural, co-morbid symptoms, health status and functioning
status) that have been associated with adverse outcomes including
mortality in previous studies investigating personality disorder or
other mental disorders [21,22,23,24,25].
The HoNOS items have operationalized response options that
follow the format of: 0 ‘‘not a problem’’; 1 ‘‘subclinical, minor
problem requiring no action’’, 2 ‘‘mild problem but definitely
present’’, 3 ‘‘ moderately severe problem’’, and 4 ‘‘severe to very
severe problem’’ [26]. In this analysis, we used items from the first
HoNOS questionnaire that was completed during the observation
period as measures of baseline level of clinical severity in each
patient. Due to small numbers in some categories, for the purposes
of data analysis, all items were collapsed into four categories: 0) not
a problem; 1) subclinical problem; 2) mild problem, and 3–4)
severe or very severe problem.
Statistical analysis
We used Cox proportional hazards regression to model the
effect of the above risk factors on 1) all-cause mortality, 2) natural
cause mortality and 3) unnatural cause mortality, respectively. For
each patient the ‘at-risk’ period commenced from the date of the
PD diagnosis. The censoring date was the end of the observation
period (31st December 2011) for those who survived until the end
of the observation period, and the event date was the date of death
if this occurred during the observation period. Crude and adjusted
associations between all-cause, natural cause and unnatural cause
mortality and the principal exposures of interest (HoNOS subscale
scores) or potential confounders were examined. HoNOS
subscales that are associated with increased mortality risk were
included in subsequent adjusted analyses. In the adjusted analyses,
three levels of adjustment were used: the first model included only
age and gender; the second model also included ethnicity and
deprivation in area of residence (i.e. all demographic variables).
The third and final model included all variables in the second
model plus all HoNOS subscale ratings.
Results
We identified 4296 cases of PD, of whom 2440 (56.8%) had at
least one HoNOS rating in the observation period. Having at least
one HoNOS was not associated with death within the observation
period or with gender, but it was associated with older age [mean
age (standard deviation) 38.2 (13.0) vs. 36.0 (12.9); p,0.001].
Therefore a total of 2,440 cases with PD formed the analysed
cohort, of whom 85 (3.4%) died within the 5-year observation
period. The mean follow-up period was 985.5 (SD 550.6) days. Of
the 85 deaths, 16 required scrutiny of free-text data in order to
classify natural or unnatural cause of death, which remained
unknown in 6 cases. Of the 79 deaths with known cause, 49 (62%)
were from natural causes and 30 (38%) were from unnatural
causes. Table 1 displays number of cases and deaths from all
causes by cohort characteristics, and unadjusted hazard ratios.
Older age was associated with increased mortality risk, and
African, Caribbean or other black ethnic group was associated
with decreased risk. HoNOS subscales associated with increased
mortality risk were overactivity / aggression, drinking / drug use,
physical illness / disability, and problems with ADL. HoNOS
subscales that were not associated with mortality risk were omitted
from the subsequent adjusted models (Tables 2–4), with the
exception of non-accidental injury, because self-injury is a
Table 1. Cont.
Variables Number of individuals (Number of deaths) % deaths Crude Hazard Ratio (95% CI)
Physical illness or disability
Not a problem 1484 (29) 2.0 Referent
Subclinical, minor problem 363 (14) 3.9 2.0 (1.0–3.7)*
Mild problem 322 (15) 4.7 2.2 (1.2–4.1)*
Severe/very severe problem 253 (27) 10.7 5.5 (3.3–9.4)**
Missing 18 (0) 0.0
Relationships
Not a problem 563 (19) 3.4 Referent
Subclinical, minor problem 531 (18) 3.4 1.0 (0.5–1.9)
Mild problem 731 (21) 2.9 0.9 (0.5–1.6)
Severe/very severe problem 594 (26) 4.4 1.4 (0.8–2.6)
Missing 21 (1) 4.8
Activities of daily living
Not a problem 1179 (29) 2.5 Referent
Subclinical, minor problem 584 (16) 2.7 1.0 (0.6–1.9)
Mild problem 453 (20) 4.4 1.7 (1.0–3.0)
Severe/very severe problem 200 (20) 10.0 4.2 (2.4–7.4)***
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prevalent problem in people with PD and is also a well-established
predictor of mortality in previous studies [22,27].
All-cause mortality – adjusted models
Tests of the proportional hazards assumption indicated there
was no violation and thus it was appropriate to proceed with Cox
regression modelling. Table 2 displays Cox regression analyses of
associations between clinical variables and all-cause mortality at
three levels of adjustment – 1) adjusted for age and gender; 2)
adjusted for age, gender, ethnicity and deprivation in area of
residence (i.e. all demographics); and 3) adjusted for all demo-
graphics and all HoNOS subscales other than the exposure in
question. Age was entered as a continuous variable in the models.
All-cause mortality was associated with drinking / drug use,
physical illness / disability, and problems with ADL at the first two
levels of adjustment. All these associations were attenuated in the
fully adjusted model, but they remained statistically significant. An
association between the non-accidental injury subscale and all-
cause mortality was observed after the first level of adjustment (age
and gender); however at subsequent levels of adjustment it was no
longer significant. An association between overactivity / aggres-
sion and all-cause mortality was observed in the first two models,
but was no longer significant after adjusting for other HoNOS
subscales.
Natural cause mortality – adjusted models
Table 3 summarises Cox regression models of factors associated
with natural cause mortality. As in Table 2, three levels of
adjustment are shown. The non-accidental injury and overactivity
/ aggression HoNOS subscales were not associated with natural
cause mortality. Mild and severe drinking / drug use were both
associated with natural cause mortality across the first two adjusted
models; however in the fully adjusted model only mild drinking /
drug use remained significant. Severe physical illness / disability
was associated with natural cause mortality across all three models.
Severe problems with ADL was associated with natural cause
mortality in the first two models, but was not significant in the final
model.
Table 2. Cox regression analyses of factors associated with all-cause mortality amongst individuals with personality disorder.
Risk Factors Hazard Ratio (95% CI)
Adjusted for age{ and gender Adjusted for all demographica factors Fully adjustedb
Non-accidental self injury
Not a problem Referent Referent Referent
Subclinical, minor problem 0.8 (0.4–1.7) 0.8 (0.4–1.6) 0.7 (0.3–1.4)
Mild problem 1.5 (0.8–3.0) 1.5 (0.7–2.8) 1.0 (0.5–1.9)
Severe/very severe problem 2.1 (1.1–3.8)* 2.0 (1.1–3.8)* 1.3 (0.7–2.5)
Overactivity and aggression
Not a problem Referent Referent Referent
Subclinical, minor problem 1.7 (1.0–2.8)* 1.6 (1.0–2.7) 1.6 (1.0–2.7)
Mild problem 1.4 (0.7–2.5) 1.4 (0.7–2.5) 1.1 (0.6–2.1)
Severe/very severe problem 1.5 (0.7–3.0) 1.6 (0.8–3.2) 1.0 (0.5–2.1)
Drinking or drug use
Not a problem Referent Referent Referent
Subclinical, minor problem 0.7 (0.3–1.7) 0.7 (0.3–1.7) 0.6 (0.3–1.6)
Mild problem 2.4 (1.3–4.3)** 2.3 (1.3–4.2)** 2.1 (1.1–3.9)*
Severe/very severe problem 2.7 (1.6–4.6)*** 2.8 (1.6–4.7)*** 2.3 (1.3–4.1)**
Physical illness or disability
Not a problem Referent Referent Referent
Subclinical, minor problem 1.4 (0.7–2.7) 1.4 (0.7–2.6) 1.3 (0.7–2.5)
Mild problem 1.4 (0.7–2.6) 1.3 (0.7–2.5) 1.2 (0.6–2.3)
Severe/very severe problem 3.0 (1.7–5.3)*** 2.8 (1.6–5.0)*** 1.9 (1.0–3.6)*
Activities of daily living
Not a problem Referent Referent Referent
Subclinical, minor problem 0.9 (0.5–1.7) 0.9 (0.5–1.7) 0.9 (0.5–1.6)
Mild problem 1.5 (0.8–2.6) 1.5 (0.9–2.7) 1.2 (0.7–2.1)
Severe/very severe problem 2.7 (1.5–4.8)** 2.8 (1.5–5.0)** 1.9 (1.0–3.6)*
{Entered as a continuous variable in all models.
aDemographic factors = age, gender, ethnicity, deprivation.
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Unnatural cause mortality – adjusted models
Table 4 displays Cox regression models examining factors
associated with unnatural cause mortality. Only severe drinking /
drug use was associated with this outcome, an association which
was significant across all three models.
Discussion
In this large clinical cohort of people with a diagnosis of
personality disorder, monitored over a 5-year period, more than
fifty percent of deaths were accounted for by natural causes.
Alcohol or drug use, physical illness, and impairment in ADL were
all independently associated with all-cause mortality. Mortality
from natural causes was independently associated with mild
problems in alcohol or drug use, and severe physical illness, while
unnatural cause mortality was predicted only by severe alcohol or
drug use. Against our expectations, we did not find an association
between the HoNOS subscale assessing non-accidental self-injury
and any mortality outcome.
No previous research has investigated clinical predictors of
either all-cause or cause-specific mortality in individuals with PD.
Mortality studies in PD have instead almost exclusively investi-
gated deaths from unnatural causes, particularly within borderline
PD [28,29]. In borderline PD, depression, substance use disorder
and antisocial PD (or traits) are associated with higher risk of
completed suicide [28,29]. However, despite the increased
recognition of natural causes underlying excess mortality in people
with mental disorders [30,31,32], no previous study has investi-
gated deaths from natural causes among people with PD.
The recent Nordic psychiatric case register study by Nordentoft
et al found that, in a cohort of over 270,000 patients with
diagnoses of schizophrenia spectrum disorders, affective disorders,
substance abuse or personality disorder, those with substance
abuse or personality disorder had the most reduced life expectancy
compared to the general population [6]. This chimes with the
findings of previous mortality studies in psychiatric populations
[7,8,33,34]. Both substance abuse and PD are associated with
deaths from diseases and medical conditions (i.e. natural causes)
Table 3. Cox regression analyses of factors associated with natural cause mortality amongst individuals with personality disorder.
Risk Factors
Number of individuals (Number of




demographica factors Fully adjustedb
Non-accidental self injury
Not a problem 1404 (33) Referent Referent Referent
Subclinical, minor problem 389 (4) 0.7 (0.2–1.9) 0.7 (0.2–1.9) 0.7 (0.2–2.1)
Mild problem 311 (8) 2.2 (1.0–4.9) 2.2 (1.0–5.0) 1.4 (0.6–3.3)
Severe/very severe problem 325 (4) 1.2 (0.4–3.4) 1.2 (0.4–3.6) 0.7 (0.2–2.3)
Overactivity and aggression
Not a problem 1123 (18) Referent Referent Referent
Subclinical, minor problem 659 (14) 1.3 (0.7–2.7) 1.3 (0.6–2.5) 1.2 (0.6–2.4)
Mild problem 379 (11) 1.3 (0.6–2.9) 1.3 (0.6–2.9) 0.9 (0.4–2.0)
Severe/very severe problem 270 (6) 1.4 (0.6–3.6) 1.6 (0.6–4.1) 1.0 (0.4–2.7)
Drinking or drug use
Not a problem 1447 (26) Referent Referent Referent
Subclinical, minor problem 305 (4) 1.1 (0.4–3.1) 1.0 (0.4–3.0) 1.0 (0.3–3.0)
Mild problem 298 (10) 3.8 (1.8–8.3)** 3.8 (1.7–8.4)** 3.4 (1.5–7.4)**
Severe/very severe problem 363 (9) 2.9 (1.3–6.4)* 2.9 (1.3–6.7)* 2.4 (1.0–5.8)
Physical illness or disability
Not a problem 1484 (12) Referent Referent Referent
Subclinical, minor problem 363 (10) 1.8 (0.8–4.3) 1.8 (0.7–4.3) 1.8 (0.8–4.4)
Mild problem 322 (6) 0.9 (0.3–2.6) 0.8 (0.3–2.3) 0.8 (0.3–2.2)
Severe/very severe problem 253 (21) 3.7 (1.7–8.0)** 3.5 (1.6–7.7)** 2.4 (1.0–5.6)*
Activities of daily living
Not a problem 1179 (15) Referent Referent Referent
Subclinical, minor problem 584 (7) 0.7 (0.3–1.8) 0.7 (0.3–1.7) 0.7 (0.3–1.6)
Mild problem 453 (11) 1.4 (0.6–3.1) 1.4 (0.7–3.2) 1.1 (0.5–2.4)
Severe/very severe problem 200 (16) 3.0 (1.4–6.3)** 3.2 (1.5–6.8)** 2.2 (0.9–4.9)
{Entered as a continuous variable in all models.
aDemographic factors = age, gender, ethnicity, deprivation.
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and with deaths from suicides, accidents and homicides (i.e.
unnatural causes) [6,33]. In our cohort of patients with PD, we
found that higher scores on the HoNOS subscale assessing alcohol
or drug use was associated with a two- to three-fold increased risk
of death (both natural and unnatural). Deaths from accidents,
homicides and suicides (i.e. unnatural causes) in patients abusing
alcohol and/or illicit drugs might be explained by greater
impulsivity, their involvement in a violent subculture or other risk
behaviours. Considering natural causes of death, alcoholism is
strongly linked with gastrointestinal disease, chiefly cirrhosis and
peptic ulceration, whilst drug abuse is associated with viral
infections, particularly hepatitis and HIV. It is noteworthy,
however, that mild rather than severe alcohol or drug use
predicted death from natural causes. One possible explanation for
this finding is that substance use rated as mild in severity is more
likely to go untreated. Similar mechanisms may help to explain an
association between subclinical depression and mortality in
patients with serious mental illness [35]. Another possibility is
that those people with PD and severe alcohol or drug use who
present to clinical services represent relatively healthy survivors,
which would obscure any association with later mortality risk.
The detected association between all-cause and natural cause
mortality with physical illness is unsurprising. PD is associated with
poor health [12], and physical ill-health from unhealthy lifestyles,
undertreated medical conditions and harmful side effects of
medications are known to reduce life expectancy in people with
mental disorders [36,37]. Previous studies have reported substan-
tially reduced life expectancy among individuals who self-harm
[27], and frequency of self-harm is associated with increased risk of
suicide [22]. In contrast, our study found no independent
association between the HoNOS subscale on self-harm and
mortality. Similarly, although high rates of violent behaviour in
individuals with PD are a focus for clinical and public concern [1]
and associations have been reported between hostility and
mortality in cardiovascular disease [11], we found no association
between overactivity and aggression, and mortality. On the other
Table 4. Cox regression analyses of factors associated with unnatural cause mortality amongst individuals with personality
disorder.
Risk Factors
Number of individuals (Number of








Not a problem 1404 (15) Referent Referent Referent
Subclinical, minor problem 389 (5) 1.3 (0.5–3.5) 1.2 (0.4–3.3) 1.0 (0.3–2.8)
Mild problem 311 (3) 1.0 (0.3–3.6) 0.9 (0.3–3.2) 0.7 (0.2–2.7)
Severe/very severe problem 325 (7) 2.5 (1.0–6.2) 2.3 (0.9–5.8) 1.5 (0.6–4.1)
Overactivity and aggression
Not a problem 1123 (11) Referent Referent Referent
Subclinical, minor problem 659 (12) 1.9 (0.8–4.2) 1.9 (0.8–4.3) 1.8 (0.8–4.1)
Mild problem 379 (3) 0.8 (0.2–3.0) 0.9 (0.2–3.2) 0.8 (0.2–3.0)
Severe/very severe problem 270 (4) 1.6 (0.5–5.0) 1.5 (0.5–4.8) 1.0 (0.3–3.5)
Drinking or drug use
Not a problem 1447 (14) Referent Referent Referent
Subclinical, minor problem 305 (1) 0.4 (0.0–2.7) 0.3 (0.0–2.5) 0.3 (0.0–2.5)
Mild problem 298 (4) 1.4 (0.5–4.4) 1.3 (0.4–4.0) 1.3 (0.4–4.1)
Severe/very severe problem 363 (11) 3.2 (1.4–7.1)** 3.2 (1.4–7.1)** 3.1 (1.3–7.3)*
Physical illness or disability
Not a problem 1484 (15) Referent Referent Referent
Subclinical, minor problem 363 (3) 0.8 (0.2–2.9) 0.8 (0.2–2.8) 0.7 (0.2–2.5)
Mild problem 322 (8) 2.4 (1.0–5.9) 2.4 (1.0–2.8) 2.1 (0.9–5.3)
Severe/very severe problem 253 (4) 1.7 (0.5–5.2) 1.5 (0.5–4.7) 1.1 (0.3–3.7)
Activities of daily living
Not a problem 1179 (12) Referent Referent Referent
Subclinical, minor problem 584 (8) 1.3 (0.5–3.1) 1.3 (0.5–3.2) 1.2 (0.5–3.1)
Mild problem 453 (7) 1.5 (0.6–3.7) 1.5 (0.6–3.8) 1.2 (0.5–3.2)
Severe/very severe problem 200 (3) 1.5 (0.4–5.4) 1.5 (0.4–5.3) 1.2 (0.3–4.5)
{Entered as a continuous variable in all models.
aDemographic factors = age, gender, ethnicity, deprivation.
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hand, difficulties with ADL independently predicted all-cause
mortality. Together with the null findings with respect to self-harm
and aggression, this is consistent with research showing that, in
some cohorts, self-neglect may be a stronger predictor of mortality
than more obvious risk factors such as suicide or violence [38]. It is
also consistent with other research showing that ADL impairment
is independently predictive of all-cause mortality among individ-
uals with severe mental illness [24]. ADL impairment is therefore a
potentially important marker of vulnerability in individuals with
PD and further investigation is needed into the extent to which this
is accounted for by poor psychosocial functioning and consequent
chronic social disadvantage through social isolation and unem-
ployment.
To our knowledge, this is the first study to investigate clinical
predictors of all-cause and cause-specific mortality in individuals
with personality disorder. A key strength of the study was the use
of a large, representative clinical cohort, covering a broad age
range and patients accessing various points of secondary care
(inpatient admission, community care or one-off emergency
presentation), increasing generalisability to other secondary care
settings. We examined a wide range of clinical variables as
exposures of interest, and included important potential demo-
graphic and socioeconomic confounders. The mortality data were
drawn from death certification which is a legal requirement across
the UK; under-ascertainment of deaths is therefore likely to be
very low and only deaths occurring outside the UK are likely to be
missed. However, the findings need to be considered in the light of
certain limitations. Some measurement error is possible among
demographic, socioeconomic as well as clinical variables (i.e.
HoNOS items) when using routinely collected case record data;
however, we would expect that any measurement error would be
essentially random, so unlikely to introduce bias. Although we
accounted for a wide range of clinical and socio-demographic
variables, there may be residual confounding. In particular, we did
not include frequency/intensity of service contact or account for
possible effects of pharmacological or psychosocial interventions.
Level of service contact and interventions may have a bearing on
symptoms and health [39], either positively or negatively, which
can contribute to mortality risk. Duration of illness and smoking
are further variables that were not accounted for. A further
limitation is the lack of power for examining more specific causes
of death. Finally, we acknowledge that a large number of people
with PD do not present to mental health services and are either
managed in primary care or within general medical services. Our
findings therefore only apply to secondary mental health service
users.
Our findings are important and have clear implications for
clinical practice. People with personality disorder are acknowl-
edged to have reduced life expectancy [5], and this study has
identified that the most risky subset of patients are those with
alcohol and drug problems, poor physical health, and severe
functional impairment. Each of these risk factors now demands
attention.
The physical health status of patients with personality disorder
should be regularly reviewed. We do not think that such a basic
principle can be overstated, because we know that compared with
members of the general population, people with mental health
problems receive poorer physical healthcare [40]. Moreover, this
problem is likely to be particularly pertinent to service users with a
personality disorder, because they are often perceived to be
‘difficult’ [41] and not deserving of care [42]. Functional
impairment is an enduring feature of most forms of personality
disorder [43] and should therefore be a central component of the
clinical assessment of people with suspected personality disorder.
Finally, apparently mild problems with drugs and alcohol was the
strongest predictor of mortality to emerge from our study,
confirming the importance of taking an alcohol and drug history
from personality-disordered patients, including those without
conspicuous alcohol- and drug-related problems [35,38].
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Abstract
Purpose To examine the impact of co-morbid personality
disorder (PD), on inpatient and community-based service
use and risk of involuntary hospitalization, amongst
patients with severe mental illness (SMI).
Methods We identified SMI cases (schizophrenia, schiz-
oaffective and bipolar disorder) with and without co-mor-
bid PD, and PD cases, aged C18 years, in a large
secondary mental healthcare case register. Using multi-
variable logistic regression, we examined the association
between co-morbid PD and high level of inpatient and
community-based service use (defined as the top decile of
service use), and involuntary hospitalization, respectively,
adjusting for socio-demographics, clinical symptoms and
social functioning.
Results Severe mental illness patients with co-morbid PD
(SMI-PD) (n = 961) had more severe symptoms and social
functioning problems compared to SMI patients without
PD (n = 10,963) and patients who had PD but no con-
current SMI (n = 2,309). A greater proportion of SMI-PD
patients were high inpatient service users (22.4 vs. 10.1 %).
This association was attenuated but remained significant,
after adjustment (fully adjusted odds ratio, OR 2.31, 95 %
CI 1.88–2.84). The association between SMI-PD and high
community-based service use was confounded by
symptoms and social functioning. Compared to patients
with SMI, SMI-PD patients were significantly more likely
to experience involuntary hospitalization (fully adjusted
OR 1.56, 95 % CI 1.31–1.85).
Conclusions In SMI patients, co-morbidity with PD is
robustly associated with both high use of inpatient psychiatric
services and an increased likelihood of involuntary hospital-
ization. Patients with SMI and co-morbid PD are likely to
require tailored interventions that target both the underlying
personality pathology as well as the Axis I disorder.
Keywords Personality disorders ! Severe mental illness !
Co-morbidity ! Health services ! Involuntary
hospitalization
Introduction
Personality disorder (PD) is prevalent among patients with
severe mental illness (SMI) [1] where it has been shown to
be independently associated with both suicidal [2] and
violent behaviour [3]. Moreover people with PD are more
likely to report poor physical health [4] and are at sub-
stantially increased risk of mortality compared to the
general population [5]. From a service perspective, studies
of cohorts of patients with SMI have found that those with
co-morbid PD spend more time in hospital [6, 7]. However,
the full impact of co-morbid PD on community and hos-
pital-based service utilization by patients with SMI has not
been described. Moreover, the factors underlying an asso-
ciation between co-morbid PD and increased service use in
patients with SMI are not well understood. Apart from
diagnosis [8], heavy service use amongst people with
mental disorder is associated with alcohol and drug use,
non-adherence with medication [9], homelessness and
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other socio-demographic variables [10], as well as violence
[11]. Some or all of these variables may confound or
mediate an association between co-morbid PD and heavy
service use in SMI, but no study has examined the impact
of controlling for these covariates.
In this study we used a large historic cohort to examine the
impact of co-morbid PD on the use of psychiatric services
among patients with SMI. For comprehensiveness, we mea-
sured both inpatient and community-based service use, and
took into account a range of socio-demographic, clinical and
social functioning variables. SMI predominates amongst
patients who are involuntarily hospitalized [12]. Given that
involuntary hospitalization is associated with level of inpa-
tient service use and has an important bearing on clinical
outcomes [13], a further objective of this study was to
determine whether co-morbid PD is associatedwith increased
involuntary hospitalization amongst patients with SMI—an
association which has also not previously been examined.
Methods
Setting
The study was based in South London and Maudsley NHS
Foundation Trust (SLaM), a state-funded, secondary
mental healthcare provider with close to 100 % monopoly
in serving an aggregate population of 1.2 million people
living in four London boroughs (Lambeth, Southwark,
Lewisham and Croydon). SLaM services include inpatient
and community-based care, as well as psychiatric liaison
services to general hospitals, and forensic, old age, child
and adolescent, addictions, and learning disability mental
health teams. The SLaM Biomedical Research Centre
(BRC) Case Register provides anonymised in-depth
information derived from SLaM’s electronic clinical record
system. The development and protocol of this case register
has been described in detail in a previous open access
publication [14], and the case register has been used
extensively in previous research [15, 16]. Electronic clin-
ical records have been used comprehensively across all
SLaM services since 2006 and the BRC Clinical Record
Interactive Search (CRIS) system was developed in 2008 to
allow searching and retrieval of anonymised information
from full clinical records with over 200,000 cases currently
represented on the system. CRIS was approved as a data
resource for secondary analysis by the Oxfordshire
Research Ethics Committee (reference 08/H0606/71).
Sample
The cohort assembled for this study consisted of individ-
uals from three mutually exclusive diagnostic groups—(1)
SMI; (2) PD; and (3) SMI co-morbid with PD (SMI-PD).
Diagnoses were based on the 10th edition of the World
Health Organisation International Classification of Dis-
eases (ICD-10) [17]. Patients were considered to have SMI
if they had been given a lifetime diagnosis of schizophrenia
(ICD-10 code: F20), schizoaffective disorder (F25) or
bipolar affective disorder (F31) at any time before the end
of the study period. Patients with PD had a lifetime diag-
nosis of any of the ICD-10 categories of PD diagnosis
(F60.0–F61.0). Individuals were classified as having SMI
and PD co-morbidly if they had been given both an SMI
diagnosis and a PD diagnosis during the study period.
Diagnoses were taken from a structured field in the Case
Register and supplemented by the appearance of diagnoses
in free text, extracted using Generalised Architecture for
Text Engineering (GATE) software [18].
All individuals aged 18 or over within the case register that
had been given diagnoses falling in any of these groups, and
had received SLaM services within the five-year study period
from 1 January 2007 to 31 December 2011, were included.
The beginning of 2007 was chosen as a starting point for the
study because this corresponded to the most complete
recording of clinical data on the Case Register. Individuals
diagnosed with an organic disorder or with mental retarda-
tion, within the observation period, were excluded from the
study. We also excluded from the SMI-PD group any indi-
viduals with paranoid or schizoid PD (n = 74), as these
diagnoses should not be made in the presence of a primary
psychotic diagnosis such as schizophrenia.
In order to examine the validity of the PD diagnoses in the
Case Register, 50 cases with or without a PD diagnosis were
randomly selected from our cohort. Case note documents for
the 50 individuals were then independently processed tomask
all diagnosis information. These 50 cases were subsequently
rated by a trained psychiatrist (MF; who was blind to the
original diagnostic information) for the presence or absence
of PD. The kappa coefficient for level of agreement between
the case register diagnosis and blind clinical rating of the case
records was 0.72 (p\ 0.001).
Main outcome measures
Measures of each individual’s mental health service use
with respect to hospitalization, community-based contact,
and involuntary hospitalization were determined by selec-
tive and systematic data extraction from the case register.
For each patient, the observation period began on the 1st
January 2007 or the dates of their first recorded event on
the case register from that day onwards, whichever was
later. Observation ended on 31st December 2011 or the
date of death, whichever was earlier.
Inpatient service use The time in days that each indi-
vidual had spent hospitalized as an inpatient was
1632 Soc Psychiatry Psychiatr Epidemiol (2014) 49:1631–1640
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calculated, as a proportion of the duration of his/her
observation period. Patients ranking in the top decile on
this measure were considered to be high users of inpatient
services.
Community-based service use Community-based contact
was defined as a clinical event in which the patient had
face-to-face contact with a healthcare worker in any SLaM
service other than inpatient units. The time in days in
which each individual had community-based contact (i.e.
count of each day in which there was contact) was calcu-
lated, as a proportion of the duration of his/her observation
period. Patients ranking in the top decile on this measure
were considered to be high users of community-based
services.
Involuntary hospitalization The Mental Health Act
provides the legislative framework by which people in
England and Wales diagnosed with mental disorder can be
detained in hospital or police custody and be assessed and
treated with respect to their disorder, against their wishes.
Use of the Mental Health Act is routinely recorded on the
case register. Thus, for each patient in the cohort we were
able to ascertain whether he/she had been involuntarily
hospitalized at any point within the observation period.
This was used as a dichotomous outcome (detained vs. not
detained) in the analysis.
Explanatory variables
Demographic and socioeconomic factors
Date of birth, gender, ethnicity, relationship status, and
employment status were defined from routinely completed
fields on the source records. Age was calculated from the
beginning of the patient’s observation period. Ethnicity
classifications were: ‘‘White British or other white back-
ground’’, ‘‘East Asian’’, ‘‘South Asian’’, ‘‘African, Carib-
bean or other black background’’, and ‘‘Mixed, unknown,
and others’’. Relationship status was classified as being in a
current relationship (cohabiting, married or civil partner) or
no current relationship (divorced, civil partnership dis-
solved, separated, single, widow/surviving civil partner or
unknown). Employment status was classified as being in
paid employment (part-time or full-time paid employment,
self employed), or not in paid employment (unemployed,
registered disabled, retired, full-time student including
tertiary or school age, government training scheme, vol-
unteer, not known, other).
We used an area-level index of multiple deprivation to
measure socioeconomic status, calculated at the level of
lower super output area for the residence (LSOA)—a UK
address-grouping construct which contains an average of
1,500 residents. The patient’s address in England that was
recorded closest in time to the beginning of the observation
period was used to obtain deprivation scores. The index of
multiple deprivation is derived from a range of domains
applied to the area including: employment, income, edu-
cation, health, barriers to housing and services, crime and
the living environment. Each domain is given a specific
weighting to reflect its overall importance in the calculation
of this index. Moreover, each domain is made up of a
number of specific indicators that reflect different aspects
of the deprivation they are intended to measure. Increasing
scores in the index of multiple deprivation are indicative of
more severe deprivation. In this analysis, deprivation
scores were divided into tertiles. A separate category was
given for homelessness.
Symptoms and social functioning
We rated for the presence and severity of symptoms, as well
as social functioning problems using the Health of the
NationsOutcome Scale (HoNOS), awell-validated, 12-item,
clinician-administered measure [19–21]. Eight of the 12
items assess clinical symptoms—(1) overactive, aggressive,
disruptive or agitated behaviour; (2) non-accidental self-
injury; (3) problem-drinking or drug-taking; (4) cognitive
problems; (5) physical illness or disability problems; (6)
problems associated with hallucinations and delusions; (7)
problems with depressed mood; (8) other mental and
behavioural problems. The remaining four items cover social
functioning—(9) problemswith relationships; (10) problems
with activities of daily living; (11) problems with living
conditions; (12) problems with occupation and activities.
The 12 items have operationalized response options that
follow the format of 0 ‘‘not a problem’’; 1 ‘‘subclinical,
minor problem requiring no action’’, 2 ‘‘mild problem but
definitely present’’, 3 ‘‘moderately severe problem’’, and 4
‘‘severe to very severe problem’’ [22]. In this analysis we
used items from the first HoNOS questionnaire that was
completed during the observation period as measures of
baseline level of symptoms and social functioning in each
patient. Due to small numbers in some categories, for the
purposes of data analysis, all HoNOS items were collapsed
into two categories: (0–2) not a problem, subclinical, or mild
problem, and (3–4) severe or very severe problem. Overall,
79.7 % of patients in the study received at least one HoNOS
assessment during the observation period. Due to incomplete
data for some covariates, the final fully-adjusted models had
analytic samples that were reduced compared to the crude
models. However, incomplete data were evenly distributed
between the exposure groups.
Statistical analysis
All analyses were undertaken using STATA 11 [23]. We
used multivariate logistic regression to model the effect of
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different diagnosis categories on the three outcomes
(inpatient service use, community-based service use, and
involuntary hospitalization), adjusting for possible
explanatory variables. We present crude and adjusted odds
ratios with 95 % confidence intervals derived from logistic
regression models. In all three cases, the first logistic
regression model included only diagnosis as an explanatory
variable. The second model also included demographic
factors (age, gender, ethnicity, relationship status) and
socioeconomic factors (deprivation in area of residence and
employment) were subsequently added to the model. In the
third and final model of predictors of service use, we added
symptoms and social functioning as covariates to the
model. In modelling predictors of involuntary hospitaliza-
tion, we also adjusted for length of observation period.
We conducted two sets of sensitivity analyses. The first
set involved using 5 and 15 % as alternative definitions to
the original top 10 % cut-off for defining high inpatient and
community-based service use. The second set of sensitivity
analyses used inpatient and community-based service use
as continuous variables, and modelled these using linear
regressions. The service use data were highly skewed and,
therefore, we log-transformed these data (resulting in the
data approximating a normal distribution) before develop-
ing the two linear regression models.
Results
A total of 14,233 individuals were identified by CRIS, using
our criteria for inclusion into the study. The cohort was
54.3 % male and had a mean age of 41.9 years (standard
deviation 14.7 years). In terms of ethnic background,
53.8 % were white, 30.4 % were African, Caribbean or
other black background, 2.9 % were East Asian, 2.6 % were
South Asian, and 10.3 % were mixed or unknown. Twelve
percent of the cohort had a cohabiting, married or in a civil
partnership relationship status and 2.4 % of the cohort was
classified as homeless. Only 4.2 % of the cohort were in
paid employment; 5.9 % of the cohort died before the end
of the study observation period (31st December 2011).
Of the 14,233 individuals, 10,963 were in the SMI
group, 2,309 in the PD group, and 961 in the SMI-PD
group. Table 1 provides the demographic and socioeco-
nomic characteristics of the patients included in the study,
according to the three diagnosis groups. Compared to the
SMI group, a larger proportion of the SMI-PD group was
younger, from a white ethnic background and was home-
less and a smaller proportion was in a relationship.
Differences were noted in the HoNOS sub-scale profiles
between the SMI and SMI-PD groups. Compared to the
SMI group, the SMI-PD group had a higher proportion of
individuals with severe or very severe problems in five of
eight symptom domains—overactivity and aggression (13.5
vs. 6.8 %; p\ 0.001); non-accidental injury (8.3 vs. 1.7 %;
p\ 0.001); depressed mood (13.7 vs. 6.5 %; p\ 0.001);
problem drinking or drug-taking (16.3 vs. 6.2 %;
p\ 0.001); other mental health problem (23.7 vs. 14.3 %;
p\ 0.001). They also had a greater proportion of individ-
uals with severe problems compared to the SMI group, in
three of four social functioning domains—occupational
(14.2 vs. 9.3 %; p\ 0.001); living conditions (11.5 vs.
6.9 %; p\ 0.001); and relationship problem (19.7 vs.
10.3 %; p\ 0.001). In the remaining three clinical domains
(hallucinations and delusions, cognitive problems, physical
illness or disability) and one social functioning domain
(activities of daily living) the two groups were comparable.
Table 2 shows the measures of psychiatric service use
amongst the three diagnosis groups. Five thousand six
hundred and eight individuals (39.4 % of total cohort) had
at least one inpatient admission during the study period.
The PD group had proportionately fewer patients (26.9 %),
and the SMI-PD group had proportionately more patients
(63.1 %) admitted as an inpatient, compared to the SMI
group (40.0 %). Those in the top 10 % of inpatient service
use (as a proportion of length of observation period) spent
an average of 136.4 days per year in hospital. Amongst the
three diagnosis groups, the SMI-PD group had the highest
proportions of high users of inpatient services (22.4 %) and
high users of community-based services (13.6 %), respec-
tively. This group also had the highest prevalence of
individuals experiencing involuntary hospitalization
(41.8 %). In contrast, the PD group had the lowest pro-
portions of high users of both inpatient (4.5 %) and com-
munity-based (5.4 %) services, as well as involuntary
hospitalization (10.7 %).
Table 3 displays the results of multivariate logistic
regression for high inpatient service use. Individuals with
SMI and co-morbid PD were twice as likely to be high
users of inpatient services compared to individuals with
SMI without co-morbid PD (crude odds ratio 2.57, 95 %
confidence interval 2.18–3.03, p value \0.001). Adjust-
ment for demographic and socioeconomic factors did not
attenuate the association and addition of baseline severity
of symptoms and social functioning problems to the model
had little impact on the strength of the association (fully
adjusted odds ratio 2.31, 95 % confidence interval
1.88–2.84, p value\0.001).
The equivalent regression model for high community-
based service use is shown in Table 4. Co-morbid PD
conferred a small but significant increase in the odds of
high service use (crude odds ratio 1.32, 95 % confidence
interval 1.09–1.61, p value\0.05). This association was
not attenuated by adjustment for demographic and socio-
economic factors. However, the addition of clinical and
social functioning problems to the model rendered the odds
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ratio non significant (fully adjusted odds ratio 1.11, 95 %
confidence interval 0.89–1.39).
Sensitivity analysis using the top 5 % as cut-off for high
service use yielded similar results (adjusted odds ratio
(AOR) for inpatient service use associated with co-morbid
PD: 2.75, 95 % confidence interval 2.11–3.58; AOR for
community-based service use: 0.96, 95 % confidence
interval 0.75–1.21); likewise, when using 15 % as alter-
native cut-off (AOR for inpatient service use: 1.98, 95 %
confidence interval 1.64–2.38; AOR for community-based
service use 1.08, 95 % confidence interval 0.89–1.30).
When we re-ran the analyses using linear regression, the
independent effect of co-morbid PD on the inpatient ser-
vice use of SMI patients was retained (fully adjusted b
coefficient 0.28, 95 % confidence interval 0.14–0.41,
p value\0.001). The sensitivity analysis for community-
based service use showed a smaller but independent effect
of co-morbid PD (fully adjusted b coefficient 0.16, 95 %
confidence interval 0.07–0.26, p value\0.01).
Table 5 shows the multivariate regression for involun-
tary hospitalization. SMI patients with co-morbid PD were
almost twice as likely to be involuntarily hospitalized
compared to SMI patients without co-morbid PD (crude
odds ratio 1.83, 95 % confidence interval 1.60–2.09,
p value\0.001). Adjustment for demographic and socio-
economic factors, symptoms and social functioning, and
length of observation period in the study, did not attenuate
this association (fully adjusted odds ratio 1.56, 95 % con-
fidence interval 1.31–1.85, p value\0.001).
Discussion
Main findings
In this cohort of patients accessing secondary mental health
services, SMI patients who had co-morbid PD were sig-
nificantly more likely to be high users of inpatient services,
Table 1 Demographic and
socioeconomic characteristics
of patients with severe mental
illness (SMI), personality
disorder (PD), and SMI co-
morbid with PD (SMI-PD)—
groups are mutually exclusive
Severe mental illness includes
schizophrenia, schizoaffective
disorder and bipolar affective
disorder
Characteristics SMI (n = 10,963) PD (n = 2,309) SMI-PD (n = 961)
n % (95 % CI) n % (95 % CI) n % (95 % CI)
Age
15–29 2,225 20.3 (19.5–21.0) 792 34.3 (32.4–36.2) 342 35.6 (32.6–38.6)
30–44 4,363 39.8 (38.9–40.7) 965 41.8 (39.8–43.8) 417 43.4 (40.3–46.5)
45–64 3,280 29.9 (29.1–30.8) 480 20.8 (19.1–22.4) 187 19.5 (17.0–22.0)
65? 1,095 10.0 (9.4–10.5) 72 3.1 (2.4–3.8) 15 1.6 (0.8–2.3)
Gender
Female 4,770 43.5 (42.6–44.4) 1,291 55.9 (53.9–57.9) 445 46.3 (43.2–49.5)
Male 6,193 56.5 (55.6–57.4) 1,018 44.1 (42.1–46.1) 516 53.7 (50.5–56.8)
Ethnicity
White British or other
white
5,314 48.5 (47.5–49.4) 1,704 73.8 (72.0–75.6) 641 66.7 (63.7–69.7)
East Asian 355 3.2 (2.9–3.6) 41 1.8 (1.2–2.3) 14 1.5 (0.7–2.2)
South Asian 323 2.9 (2.6–3.3) 35 1.5 (1.0–2.0) 7 0.7 (0.2-1.3)
African, Caribbean or
other black
3,883 35.4 (34.5–36.3) 221 9.6 (8.4–10.8) 225 23.4 (20.7–26.1)
Mixed/unknown 1,088 9.9 (9.4–10.5) 308 13.3 (12.0–14.7) 74 7.7 (6.0–9.4)
Married/cohabiting
No 9,520 86.8 (86.2–87.5) 2,063 89.3 (88.1–90.6) 882 91.8 (90.0–93.5)
Yes 1,443 13.2 (12.5–13.8) 246 10.7 (9.4–11.9) 79 8.2 (6.5–10.0)
Deprivation in area of residence (in tertiles)
Low deprivation 3,154 28.8 (27.9–29.6) 710 30.7 (28.9–32.6) 257 26.7 (23.9–29.5)
Medium deprivation 3,349 30.5 (29.7–31.4) 697 30.2 (28.3–32.1) 299 31.1 (28.2–34.0)
High deprivation 3,513 32.0 (31.2–32.9) 672 29.1 (27.3–31.0) 269 28.0 (25.2–30.8)
Homeless 229 2.1 (1.8–2.4) 68 2.9 (2.3–3.6) 49 5.1 (3.7–6.5)
Missing/unknown 718 6.5 (6.1–7.0) 162 7.0 (6.0–8.1) 87 9.1 (7.2–10.9)
Employment status
Not in paid employment
or student
10,513 95.9 (95.5–96.3) 2,201 95.3 (94.5–96.2) 928 96.6 (95.4–97.7)
In paid employment 450 4.1 (3.7–4.5) 108 4.7 (3.8–5.5) 33 3.4 (2.3–4.6)
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compared to SMI patients without co-morbid PD. This
association remained significant after adjustment for socio-
demographic factors and a wide range of clinical and social
functioning variables. The presence of co-morbid PD also
significantly increased the likelihood of involuntary hos-
pitalization among SMI patients, an association which was
not explained by the measured potential confounding
variables.
Previous work and possible mechanisms
To the best of our knowledge this is the first study to
examine the impact of co-morbid PD on both inpatient
and community-based service use of adult patients with
SMI. Tyrer and Simmonds [7] reviewed the outcome of
three randomised controlled trials that investigated dif-
ferent models of care in SMI, and found in post hoc
analyses that patients with co-morbid PD spent more time
in hospital compared to those without co-morbid PD,
regardless of the model of care. Keown and others
investigated psychiatric bed use amongst SMI patients
seen in a UK community mental health team, and found
that the concurrent presence of PD and also severity of PD
were associated with increased psychiatric bed use
amongst SMI patients [6, 7]. Our finding that co-morbid
PD increases inpatient service use in SMI patients is
consistent with existing evidence that co-morbid person-
ality pathology worsens outcomes in SMI [2, 3, 24–27].
The SMI-PD patient group in our study was characterised
by a number of factors known to contribute to increased
psychiatric service use—more severe psychopathology
[25], higher levels of aggression [11] and self-injury [28],
greater problems with alcohol and drug use [29, 30],
greater problems with housing [11] and occupation, and
less stable relationships [31, 32], compared to the SMI
group. However, adjustment for these potential con-
founders had little effect on the strength of the association
with inpatient service use.
Table 2 Indicators of
psychiatric service use among
patients with severe mental
illness (SMI), personality
disorder (PD), and SMI co-
morbid with PD (SMI-PD)—




a Mean = 136.4 days per year;
SD ±87.2; range 52.2–365
b Mean = 51.5 days per year;
SD ±43.1; range 29.6–365
Service use SMI (n = 10,963) PD (n = 2,309) SMI-PD (n = 961)
n % (95 % CI) n % (95 % CI) n % (95 % CI)
Inpatient admission
No 6,583 60.0 (59.1–61.0) 1,687 73.1 (71.3–74.9) 355 36.9 (33.9–40.0)
Yes 4,380 40.0 (39.0–40.9) 622 26.9 (25.1–28.7) 606 63.1 (60.0–66.1)
High inpatient service
use (top 10 % of
sample)a
1,104 10.1 (9.5–10.6) 104 4.5 (3.7–5.4) 215 22.4 (19.7–25.0)
High community-based
service use (top 10 %
of sample)b
1,167 10.6 (10.1–11.2) 125 5.4 (4.5–6.3) 131 13.6 (11.5–15.8)
Involuntary hospitalization
No 7,865 71.7 (70.9–72.6) 2,061 89.3 (88.0–90.5) 559 58.2 (55.0–61.3)
Yes 3,098 28.3 (27.4–29.1) 248 10.7 (9.5–12.0) 402 41.8 (38.7–45.0)
Table 3 Multivariate logistic regression analyses for having high level of inpatient service use—severe mental illness (SMI), personality
disorder (PD), and SMI co-morbid with PD (SMI-PD)







symptoms and social functioningc
SMI Referent Referent Referent Referent
PD 0.42 (0.34–0.52)* 0.41 (0.33–0.51)* 0.52 (0.42–0.65)* 0.41 (0.30–0.55)*
SMI-PD 2.57 (2.18–3.03)* 2.43 (2.06–2.88)* 2.62 (2.19–3.14)* 2.31 (1.88–2.84)*
* p\ 0.001
a Demographic factors = age, gender, ethnicity, relationship status
b Socioeconomic factors = deprivation in area of residence, employment
c Symptoms and social functioning variables include = overactivity and aggression, non-accidental self-injury, hallucinations and delusions,
depressed mood, cognitive problem, problem-drinking or drug taking, physical illness or disability, other mental health problem, problem with
activities of daily living, social relationships, standard of living conditions, occupational and recreational activities
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Based on previous work on patients with PD and co-
morbid PD [33, 34], one may have expected a similar
pattern with regard to community-based services. How-
ever, we did not detect an association between co-morbid
PD and community-based service use. While we would not
expect high inpatient use to exclude high community ser-
vice use, it may be that some patients had their clinical
needs met as an inpatient rather than in the community [35,
36]. Indeed, some individuals in the top decile of inpatient
service use spent a great majority of the year in hospital,
consequently reducing the amount of time that they could
have received community services. Although we know of
no other study that has examined both inpatient and com-
munity-based service use in adults with a dual diagnosis of
SMI and PD, a recent study in adolescents with Axis I
psychiatric disorders [36] found that those with co-morbid
PD used more inpatient and emergency, but comparable
outpatient psychiatric services, compared to those without
co-morbid PD.
No study has previously examined the impact of co-
morbidity with PD on the risk of involuntary hospitaliza-
tion in patients with SMI. The combination of personality
disorder in the presence of SMI independently increased
the risk of involuntary hospitalization. Compared to the
SMI group, the SMI-PD group had a higher proportion of
individuals with severe clinical problems in five of eight
clinical domains, including aggression [37] and non-acci-
dental injury. Levels of social dysfunction were also higher
among the SMI-PD group compared to the SMI group.
Thus factors associated with increased risk to self and/or
others (a criterion for involuntary detention under the
English Mental Health Act) were more prevalent in the
SMI-PD group compared to those with SMI alone. These
factors are very likely to be on the causal pathway to
involuntary hospitalization for those with co-morbid PD
and the attenuation in the size of the odds ratio which
occurred when these covariates were added to the model
provides some support for this argument. A diagnosis of
personality disorder alone was associated with a lower
likelihood of detention in hospital. This is consistent with
recommended clinical practice [38], as there is no evidence
base to suggest that compulsory treatment in hospital for
people with PD improves clinical outcomes.
Strengths and limitations
The study used a large cohort derived from a secondary
mental health setting which included the full range of
inpatient and community-based services and to our
knowledge is the first study of its kind. We accounted for a
wide range of covariates, including demographic, socio-
economic, clinical and social functioning variables.
Examining both inpatient admission and all community-
based service use in the cohort, as well as involuntary
hospitalization, offered a fuller and more comprehensive
picture of the impact of co-morbid PD in patients with SMI
and this adds to the novelty of the findings.
The findings need to be considered in the light of
certain limitations. We relied on ICD-10 diagnoses as
opposed to standardised assessments, but the use of rou-
tinely-collected clinical data allowed us to obtain data on
a very large sample size, thus optimising the precision of
our findings. Moreover, our use of routine clinical diag-
noses in a very large population favours generalisability to
real clinical practice. In addition, we established an
acceptable level of reliability between the case register
diagnoses of personality disorder and blind clinical rat-
ings. Although there were incomplete data in some mod-
els, it is unlikely to explain the observed associations, as
there was little variation in results across the regression
models. In addition, incomplete data were not unevenly
distributed among the exposure groups of interest (SMI
Table 4 Multivariate logistic regression analyses for high level of community-based service use—severe mental illness (SMI), personality
disorder (PD), and SMI co-morbid with PD






Adjusted for demographica ?
socioeconomicb factors and
symptoms and social functioningc
SMI Referent Referent Referent Referent
PD 0.48 (0.40–0.58)** 0.46 (0.38–0.56)** 0.50 (0.41–0.61)** 0.56 (0.44–0.70)**
SMI-PD 1.32 (1.09–1.61)* 1.27 (1.04–1.54)* 1.30 (1.06–1.60)* 1.11 (0.89–1.39)
** p\ 0.001, * p\ 0.05
a Demographic factors = age, gender, ethnicity, relationship status
b Socioeconomic factors = deprivation in area of residence, employment
c Symptoms and social functioning variables include = overactivity and aggression, non-accidental self-injury, hallucinations and delusions,
depressed mood, cognitive problem, problem-drinking or drug taking, physical illness or disability, other mental health problem, problem with
activities of daily living, social relationships, standard of living conditions, occupational and recreational activities
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and SMI-PD). Misclassification of area deprivation level
may have occurred for any cohort members who moved
during the course of the study. There was a wide distri-
bution of the time from start of observation to first Ho-
NOS rating in the cohort (median 116 days, interquartile
range 18–357 days) and this may have influenced the
results. The relatively low prevalence of co-morbid PD in
the SMI cohort (8.1 %), stands in contrast with prevalence
rates reported in other studies [39–42] and indicates that
there was under-detection of PD in our sample [24, 43].
On the other hand, it is possible that some cases of PD
were misclassified and that the probability of this occur-
ring was dependent upon service use (i.e. that heavy users
of services were more likely to attract a diagnosis of PD).
If this is the case, then it is possible that we have over-
estimated the strength of association between co-morbid
PD and heavy service use. The historical cohort design
means that in some cases, the diagnosis of co-existing PD
was made during the course of or in some cases, towards
the end of the individual’s observation period. This,
together with our cross-sectional analysis, limits our
ability to make causal inferences.
We conclude that amongst patients with SMI, the co-
existence of PD is independently associated with both high
use of inpatient psychiatric services and an increased
likelihood of involuntary hospitalization. Co-morbid PD is
often unrecognised yet, as shown by our data, it is an
important prognostic variable. This highlights the impor-
tance of routinely assessing personality status in individu-
als presenting to secondary mental health services [44]
with Axis 1 disorders. Patients with SMI and co-morbid PD
are likely to require tailored interventions that target both
the underlying personality pathology as well as the Axis I
disorder. In this respect, better treatment models are
required to help to reduce admissions and involuntary
hospitalization for patients with SMI and co-morbid Axis II
pathology [7, 42, 45].
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Little is known about the impact of personality disorder (PD) on the health 
of people living in the community. The authors set out to examine the 
association between PD and general health, using a cross-sectional survey 
of a representative community sample in London, UK. A total of 1,698 
adults aged 16 years or over from 1,075 randomly selected households 
were recruited and interviewed face-to-face by trained interviewers. Using 
multivariable logistic regression, the authors examined the cross-sectional 
association between PD screen status, as assessed by the Standardised As-
sessment of Personality–Abbreviated Scale (SAPAS), and self-rated health, 
adjusting for demographic and health covariates. Of the participants, 
14.5% screened positively for PD. A greater proportion of those scoring 
positively for PD reported poor self-rated health, compared to screen nega-
tive participants (41.3% versus 15.0%). This association was reduced, but 
remained significant, after adjustment for potential confounders (unad-
justed odds ratio (OR) = 3.99, 95% CI [2.93, 5.42]; fully adjusted OR = 
1.53, 95% CI [1.02, 2.29]. Of note, subthreshold symptoms of PD were 
significantly associated with poor self-rated health (unadjusted OR per unit 
SAPAS score increment = 1.53, 95% CI [1.40, 1.67]; fully adjusted OR = 
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1.19, 95% CI [1.07, 1.33]. Furthermore, people screening positive for PD 
were more likely to report multiple (three or more) long-standing illnesses. 
The authors conclude that in the general population, individuals who are at 
high risk for PD are independently at increased risk of poor general health.
The relationship between mental and physical ill health is one that is both 
intuitive and borne out by empirical research. Poor physical health increases 
the risk of mental disorder (Braam et al., 2005; Buist-Bouwman, de Graaf, 
Vollebergh, & Ormel, 2005; Ostergaard & Foldager, 2011), and a number of 
prospective studies have demonstrated the existence of a longitudinal associ-
ation between mental disorder and later physical disorders, including cancer 
and stroke (Glymour et al., 2012; Oerlemans, van den Akker, Schuurman, 
Kellen, & Buntinx, 2007). It is now also widely acknowledged that people 
with mental disorders suffer a disproportionate burden of physical health 
problems and are at increased risk of early mortality (Chang et al., 2010; 
Chwastiak, Rosenheck, Desia, & Kazis, 2010; Fok et al., 2012; Grigoletti et 
al., 2009; Henderson, Hotopf, Shah, Hayes, & Kuh, 2011; von Hausswolff-
Juhlin, Bjartveit, Lindstrom, & Jones, 2009). The factors mediating this re-
lationship are thought to be wide ranging and include poor lifestyle, social 
disadvantage, and unequal access to physical health care. 
Individuals with PD are more likely to experience comorbid health prob-
lems (Frankenburg & Zanarini, 2006; Moran et al., 2007). However, rela-
tively little is known about the relationship between PD and general health 
in community populations. Most studies on the impact of PD are limited by 
their reliance on clinical or help-seeking samples (Frankenburg & Zanarini, 
2004; Skodol, Pagano, et al., 2005), their focus on subtypes of PD (El-Gab-
alawy, Katz, & Sareen, 2010), or their focus on discrete medical conditions 
as outcomes (Moran et al., 2007). This study sought to investigate the as-




Participants were community residents in randomly selected households lo-
cated within the boroughs of Southwark and Lambeth in South East Lon-
don, all of whom were recruited for the South East London Community 
Health study (SELCOH), a community survey of psychiatric and physical 
morbidity of adults in the general population. A detailed description of the 
aims, design, and methods of the SELCOH is available in an open access 
publication by Hatch et al. (2011). See Figure 1 for a flow diagram of partici-
pant selection. Trained interviewers conducted face-to-face interviews with 
participants, using a computer-assisted survey questionnaire. 
MEASURES
Outcome of Interest—Self-Rated Health. Self-rated health is a measure of 
subjective health status and an important indicator of general health (Singh-
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Manoux et al., 2006). Prospective community-based studies across the world 
have shown a strong association between self-rated health and mortality 
even after adjustment for key covariates such as functional status, depres-
sion, and comorbidity (DeSalvo, Bloser, Reynolds, He, & Muntner, 2006). In 
this study, self-rated health was assessed in interview by the question: “How 
is your health in general? Would you say your health is Excellent, Very good, 
Good, Fair, or Poor?” For this analysis, self-rated health data were coded 
into a binary outcome variable with two levels: (1) excellent/very good/good 
and (2) fair/poor. For ease of reading, these are hereafter referred to in this 
paper as “good” and “poor” self-rated health, respectively. 
Exposure of Interest—Personality Disorder Screen Status. The Standardised 
Assessment of Personality–Abbreviated Scale (SAPAS) is a rapid screen for 
FIGURE 1. Flow diagram of the recruitment of participants for the 
study.
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PD, which demonstrates good psychometric properties (Moran et al., 2003) 
and excellent clinical utility (Bukh, Bock, Vinberg, Gether, & Kessing, 2010; 
Germans, Van Heck, & Hodiamont, 2012; Gorwood et al., 2010). The SA-
PAS consists of eight questions, corresponding to a descriptive statement 
about the person. The full text of the questions can be found in the original 
SAPAS validation study by Moran et al. (2003). Each question on the SAPAS 
is scored 0 (No) or 1 (Yes), and the scores on the eight items are added to-
gether to produce a total score. In clinical populations, a score of 3 or more 
has a positive predictive value of .89 at identifying the presence of PD, with 
a sensitivity of 0.94 and a specificity of 0.85 (Moran et al., 2003). To deter-
mine those at high risk for PD in this study, we used a cut-point of 4, which 
has a slightly better positive predictive value where the prevalence in the 
population is assumed to be lower, an assumption that befits a community 
population.
Sociodemographic Variables. Age was recoded into a categorical variable as 
follows: 16 to 24 years, 25 to 34 years, 35 to 44 years, 45 to 54 years, 55 to 
64 years, and 65 years and over. Occupational class was measured by current 
occupation categorized according to the Registrar General’s classification 
(Office of Population Censuses and Surveys, 1980) into six categories: pro-
fessional (I), managerial/technical (II), skilled nonmanual (III-NM), skilled 
manual (III-M), semiskilled (IV) and unskilled (V). For this analysis, occupa-
tional class was collapsed into three categories: (a) nonmanual, (b) manual, 
and (c) no current occupation. The latter category was added to represent 
those without a current occupation needed to categorize participants in a 
social class group (approximately 44% of the sample). Self-reported ethnic-
ity was indicated as one of the following groups: White British, Black Carib-
bean, Black African, Indian, Pakistani, Bangladeshi, or Other. South Asian 
(i.e., Indian, Pakistani, and Bangladeshi) and Other ethnic groups were col-
lapsed to improve distribution.
Body Mass Index (BMI). Participants had their height and body weight mea-
sured at the time of the interview, and these anthropometric measures were 
used to calculate their BMI. BMI is defined as the individual’s body weight in 
kilograms divided by the square of his or her height in meters. BMI data were 
recoded into four categories: underweight (BMI < 18.5), normal (18.5 ≤ BMI 
≤ 24.9), overweight (25.0 ≤ BMI ≤ 29.9), and obese (BMI ≥ 30).
Exercise. Participants were dichotomized with regard to exercise behavior 
according to their “yes” or “no” response to the following question: “In 
the last four weeks, outside of work, have you taken part in any sports or 
vigorous activities or done any exercises, things like jogging, bike riding, 
brisk walking, swimming, gym work-out, football, yoga, dancing, climbing 
or other?”
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Alcohol Use. Hazardous alcohol use was measured with the Alcohol Use 
Disorders Identification Test (AUDIT; Babor, Higgins-Biddle, Saunders, & 
Monteiro, 2001) developed by the World Health Organization (WHO). The 
measure comprises 10 questions relating to alcohol consumption, symptoms 
of alcohol dependence, and problems related to alcohol abuse within the 
past 12 months. Each item is scored 0–4 with a summed overall score rang-
ing from 0–40. An AUDIT score of 8 or more was used to define hazardous 
alcohol use (Reinert & Allen, 2002). 
Smoking. Smoking behavior was assessed by asking participants whether 
they had ever smoked, how old they were when they started to smoke regu-
larly, and whether they were a current smoker. Based on their responses, in-
dividuals were placed in one of the following four categories—never smoked, 
ex-smoker, current smoker, or sporadic smoker (for those who report they 
had never smoked regularly).
Drug Use. Illicit drug use in the past year was included in the analysis as 
a dichotomous variable, based on participants’ “yes” or “no” response to 
questions asking whether they had taken the following substances in the 
previous year: cannabis, amphetamines, cocaine, ecstasy, LSD, tranquilizers, 
crack, and heroin.
Common Mental Disorder. Common mental disorder was assessed with the 
Revised Clinical Interview Schedule (CIS-R), a structured interview that asks 
about the following 14 symptom domains (using skips to allow asymptomat-
ic individuals to answer a minimum of 28 questions): fatigue, sleep problems, 
irritability, worry, depression, depressive ideas, anxiety, obsessions, subjec-
tive memory and concentration, somatic symptoms, compulsions, phobias, 
physical health worries, and panic. The total scores on the CIS-R were di-
chotomized so that scores ≥12 delineated a mixed depression-anxiety state at 
a lower threshold than syndromes of major depression and anxiety disorder, 
but where clinical intervention would be appropriate (Lewis, Pelosi, Araya, 
& Dunn, 1992). 
Long-Standing Illness. Participants were asked the following question: “Do 
you have any long-standing illness, disability or infirmity—meaning anything 
that has troubled you over a period of time or that is likely to affect you over 
a period of time?” Further to this question, participants were asked to spec-
ify their long-standing illness or illnesses, as many as they deemed relevant, 
within a given list of conditions—asthma, chronic bronchitis, other chest 
trouble, depression, diabetes, stomach or digestive problems, liver problems, 
rheumatic disorder of arthritis, heart trouble, depression or other nervous ill-
ness, high blood pressure, stroke, migraine, back trouble, epilepsy or fits, gy-
necological problem, irritable bowel syndrome, cancer, and “other”(illness 
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or condition). This information was used to give further description to the 
illnesses experienced by participants, but was not included in our regression 
model.
STATISTICAL ANALYSIS
All analyses were completed in STATA 11 (Stata Corporation, 2008). For 
the multivariable analyses, we only included data from participants who had 
complete data on both SAPAS and self-rated health status (n = 1,662). We 
used survey commands (svy) for estimates of prevalence and associations 
where appropriate to generate robust standard errors. The reader should 
refer to Hatch et al. (2011) for further details of the weighting procedure. 
We calculated the numbers of subjects overall in the good self-rated 
health sample and the poor self-rated health sample, respectively, as well 
as the unweighted frequencies and weighted percentages (within these two 
groups) with 95% confidence intervals across each of the other measured 
variables. 
We carried out a multivariable logistic regression to estimate odds ratios 
for the association between self-rated health status and PD screen status, 
adjusting for potential confounding/explanatory variables. We present crude 
and adjusted odds ratios with 95% confidence intervals derived from logistic 
regression models. The first logistic regression model included only PD screen 
status as an explanatory variable and health status as the outcome variable. 
All subsequent models included sociodemographic variables. Variables that 
are considered to be associated with health status on a priori grounds (smok-
ing, BMI and exercise status, hazardous to dependent drinking, drug use, 
common mental disorder, and long-standing illness) were entered sequen-
tially into a series of regression models in order to examine independence 
of associations. The final model included all the covariates. We carried out 
two sensitivity analyses to examine the effect of a unit increase in SAPAS 
score on the odds of reporting poor health: (a) by replacing the dichotomous 
exposure (PD screen positive vs. PD screen negative status) in the regression 
model with SAPAS score, and (b) by excluding data from those screening 
positively for PD and repeating the regression using SAPAS score.
Finally, we calculated unweighted frequencies and weighted percentages 
(with 95% confidence intervals) of specific long-standing illnesses reported 
in our sample, stratified by SAPAS PD screen status.
RESULTS
SAMPLE
In the SELCOH study, from 2008 to 2010, contact was established with 2,070 
households out of 3,600 selected addresses. The remaining 1,530 households 
consisted of 359 unusable (i.e., not residential, not private households, or 
vacant) addresses, 957 addresses that were approached but no contact was 
made with household members, 31 duplicates, 16 households already used 
in a pilot study, and 76 addresses where contact was made with a household 
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TABLE 1. Sociodemographic and Health Characteristics of Study Sample,  
Stratified by SAPAS PD Screen Status
SAPAS PD screen negative sample 
(n = 1,421)
SAPAS PD screen positive sample 
(n = 241)
Characteristics n Weighted % [95% CI] n Weighted % [95% CI]
Age group
16–24 299 18.2 [16.0, 20.6] 56 20.8 [16.1, 26.4]
25–34 351 20.2 [18.0, 22.5] 49 16.1 [12.1, 21.0]
35–44 292 19.4 [17.2, 21.8] 42 15.8 [11.9, 21.0]
45–54 212 14.4 [12.6, 16.4] 41 15.9 [11.9, 21.0]
55–64 128 12.4 [10.4, 14.7] 25 14.8 [10.2, 21.0]
65+ 139 15.4 [12.9, 18.3] 28 16.6 [11.7, 23.0]
Gender
Female 787 65.9 [63.7, 68.0] 155 72.9 [67.4, 77.8]
Male 634 34.1 [32.1, 36.3] 86 27.1 [22.2, 32.6]
Occupational class
Nonmanual 635 41.5 [38.6, 44.4] 60 22.4 [17.6, 28.2]
Manual 206 14.1 [12.2, 16.2] 33 12.7 [9.0, 17.6]
Not working 552 42.3 [39.3, 45.3] 141 62.2 [55.7, 68.3]
Missing 28 2.2 [1.5, 3.2] 7 2.7 [1.3, 5.6]
Ethnicity
White 892 64.4 [61.1, 67.6] 142 60.4 [53.5, 66.9]
Black Caribbean 110 7.9 [6.3, 9.9] 30 12.6 [8.7, 18.1]
Black African 208 13.9 [11.7, 16.5] 19 7.5 [4.5, 12.3]
Asian 53 3.5 [2.4, 5.0] 9 4.0 [2.1, 7.6]
Other 157 10.2 [8.5, 12.2] 40 15.1 [11.0, 20.3]
Missing 1 0.1 [0.0, 0.6] 1 0.4 [0.1, 2.9]
BMI 
Underweight 34 2.4 [1.6, 3.4] 5 1.9 [0.8, 4.6]
Normal weight 622 41.2 [38.5, 44.0] 96 37.9 [31.6, 44.5]
Overweight 436 30.0 [27.6, 32.5] 72 28.9 [23.3, 35.2]
Obese 282 22.4 [20.0, 25.1] 53 23.8 [18.5, 30.1]
Missing 47 4.0 [2.9, 5.5] 15 7.6 [4.5, 12.5]
Exercise in last month
No 583 44.3 [41.3, 47.3] 133 58.0 [51.3, 64.4]
Yes 831 55.0 [52.0, 58.0] 105 40.3 [34.0, 47.0]
Missing 7 0.7 [0.3, 1.6] 3 1.7 [0.5, 5.5]
Long-standing illness
No 908 59.2 [56.3, 61.9] 99 35.4 [29.5, 41.8]
Yes 512 40.8 [38.0, 43.6] 142 64.6 [58.2, 70.5]
Missing 1 0.1 [0.0, 0.4] 0 0.0
CIS-R common mental 
disorder
Fewer than 12 1170 81.8 [79.5, 83.9] 100 40.9 [34.7, 47.5]
12 and above 247 17.9 [15.8, 20.2] 139 58.1 [51.5, 64.5]
Missing 4 0.3 [0.1, 0.7] 2 0.9 [0.2, 4.2]
Drug use in past year
No 1125 82.5 [80.2, 84.6] 177 76.9 [71.4, 81.7]
Yes 296 17.5 [15.4, 19.8] 64 23.1 [18.3, 28.6]
Alcohol use
Nonhazardous use 1129 82.5 [80.2, 84.5] 189 79.9 [74.2, 84.6]
Hazardous use 290 17.4 [15.4, 19.6] 51 19.4 [14.8, 24.9]
Missing 2 0.1 [0.0, 0.5] 1 0.8 [0.1, 5.2]
Smoking
Never smoked 444 32.0 [29.2, 34.9] 62 26.2 [20.7, 32.6]
Current smoker 330 21.7 [19.4, 24.2] 85 33.6 [27.8, 39.9]
Ex-smoker 378 28.6 [26.0, 31.4] 66 28.6 [23.0, 35.0]
Sporadic smoker 269 17.8 [15.8, 19.9] 28 11.6 [7.9, 16.7]
Self-rated health
Excellent/very good/good 1226 85.0 [82.8, 87.0] 148 58.7 [52.0, 65.1]
Fair/poor 195 15.0 [13.0, 17.2] 93 41.3 [34.9, 48.0]
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member but no follow-up contact could be made. Therefore, contact was 
established with 2,070 private households, of which 1,075 households had 
at least one member interviewed, representing a 51.9% household participa-
tion rate. Of 2,359 people eligible (all adults aged 16 and over) within the 
participating households, 1,698 (71.9%) participated (mean participants per 
household = 2.7; SD = 1.2). Thirty-six of 1,698 interviewees had missing re-
sponses to one or more items of the SAPAS questionnaire and were excluded 
from our analysis. Of the 1,662 remaining, all had answered the self-rated 
health question. The sample was similar to the most recent UK Census infor-
mation in 2001 with regard to demographic and socioeconomic indicators 
for the catchment area (Hatch et al., 2011). Thus, in our sample of 1,662 
participants, 56.7% were female, 45.4% were aged under 35, and those 
in nonmanual, manual, and not working occupational categories made up 
41.8%, 14.4%, and 41.7%, respectively. In terms of ethnicity, 62.2% were 
White, 8.4% were Black Caribbean, 13.7% were Black African, 3.7% were 
Asian, and 11.9% were of “other” ethnic background.
PERSONALITY DISORDER SCREEN STATUS
A total of 241 participants (14.5%) screened positively for PD, at a cut-
point score of 4 or more on the SAPAS. Table 1 shows the demographic and 
health characteristics of the sample by PD screen status. PD screen negative 
and screen positive groups were broadly similar in age and sex distribu-
tions, as well as ethnicity. A greater proportion of those in the PD screen 
positive group were not working (62.2% vs. 42.3% of the screen positive 
group). Fewer people in the screen positive group (40.3%) had exercised in 
the last month compared to those in the screen negative sample (55.0%), 
and a greater proportion of the PD screen positive group were current smok-
ers (33.6% vs. 21.7%). PD screen status was not related to BMI or alcohol 
status. However, a greater proportion of those screening positively for PD 
had a long-standing illness or disability (64.6% vs. 40.8%), and also com-
mon mental disorder (58.1% vs. 17.9%). In terms of self-rated health, a 
TABLE 2. Weighted Logistic Regression of Association Between Positive SAPAS PD Screen Status 
(Score ≥ 4) and Poor Self-Rated Health1
Odds ratio [95% C]
Crude 3.99 [2.93, 5.42]**
Adjusted for sociodemographic factors 3.44 [2.45, 4.83]**
Adjusted for sociodemographics, BMI, and exercise 3.30 [2.32, 4.70]**
Adjusted for sociodemographics and smoking 3.28 [2.33, 4.64]**
Adjusted for sociodemographics and drug and alcohol use 3.31 [2.34, 4.66]**
Adjusted for sociodemographics and long-standing illness 2.72 [1.91, 3.88]**
Adjusted for sociodemographics and common mental disorder 1.91 [1.31, 2.77]**
Adjusted for sociodemographics and all of the above 1.53 [1.02, 2.29]*
Note. 1Sociodemographic factors include age, gender, occupational class, and ethnicity. **p < .001; *p < .05.
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greater proportion of PD screen positive participants rated their health as 
poor (41.3%), compared to those in the screen negative group (15.0%)
SELF-RATED HEALTH
A total of 1,374 respondents (82.7%) rated their health in general to be good 
(i.e., excellent, very good, or good), and 288 (17.3%) reported this to be 
poor (i.e., fair or poor). Participants reporting poor health were older than 
those reporting good health (61.5% aged 45 years or older, vs. 38.8%). A 
greater proportion of those reporting poor health were not working (66.9% 
vs. 40.3%), were obese (38.6% vs. 18.9%) and had not exercised in the last 
month (28.6% vs. 58.4%). Those reporting poor health were more likely to 
be current smokers (34.3% vs. 21.0%), although there were no major group 
differences in terms of hazardous alcohol use and drug use in the past year 
(drug use: 18.0% of poor health group vs. 18.4% of good health group; haz-
ardous alcohol use: 15.3% vs. 16.0%). Unsurprisingly, a greater proportion 
of those reporting poor health also reported having a long-standing illness 
(79.2% vs. 36.3%). Of note, more people within the poor health group met 
threshold for the presence of common mental disorder (55.4% in the poor 
health group vs. 16.7% in the good health group). A greater proportion of 
those reporting poor health screened positively for PD on the SAPAS (33.1% 
vs. 11.1%).
MULTIVARIABLE ANALYSIS
Table 2 displays the crude and adjusted odds ratios, 95% confidence inter-
vals (CI), and p values for SAPAS PD screen status and all the explanatory/
confounding variables included in the multiple logistic regression with poor 
self-rated health as outcome. Participants screening positive for PD were just 
under four times more likely to report poor health, compared to those screen-
ing negative (crude odds ratio 3.99, 95% CI [2.93, 5.42], p < .001). Adjust-
ment for age, sex, occupational class, and ethnicity (i.e., sociodemographic 
factors) did not attenuate this association. The addition of common mental 
TABLE 3. Weighted Logistic Regression of Association Between SAPAS Score (Per Unit Increment) 
and Poor Self-Rated Health1
Odds Ratio [95% CI]
Crude 1.53 [1.40, 1.67]**
Adjusted for sociodemographic factors 1.48 [1.35, 1.62]**
Adjusted for sociodemographics, BMI, and exercise 1.47 [1.34, 1.62]**
Adjusted for sociodemographics and smoking 1.46 [1.33, 1.60]**
Adjusted for sociodemographics and drug and alcohol use 1.47 [1.33, 1.61]**
Adjusted for sociodemographics and long-standing illness 1.23 [1.11, 1.37]**
Adjusted for sociodemographics and common mental disorder 1.39 [1.27, 1.53]**
Adjusted for sociodemographics and all of the above 1.19 [1.07, 1.33]*
Note. 1Sociodemographic factors include age, gender, occupational class, and ethnicity. **p < .001; *p < .005.
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disorder to the model considerably attenuated the association (1.91; 95% 
CI [1.31, 2.77]), although the association remained statistically significant. 
The addition of long-standing illness as a covariate had a similar (though 
smaller) attenuating effect, resulting in an adjusted odds ratio of 2.72 (95% 
CI [1.91, 3.88]). Adjusting for other variables, namely BMI, smoking, drug 
use, hazardous alcohol use, and exercise, resulted in only small attenuations 
in the odds ratio. When all covariates were included in the model, the fully 
adjusted odds ratio remained statistically significant (OR = 1.53, 95% CI 
[1.02, 2.29], p = .039).
The first sensitivity analysis, which looked at the effect of unit increment 
in SAPAS score, yielded similar results (crude OR per SAPAS score unit incre-
ment = 1.53, 95% CI [1.40, 1.67], p < .001; fully adjusted OR = 1.19, 95% 
CI [1.07, 1.33], p = .002) (Table 3). The second sensitivity analysis, which 
looked only at the effect of unit increment in SAPAS score in the PD screen 
negative sample (n = 1421), also produced comparable results (crude OR 
per SAPAS score unit increment = 1.48, 95% CI [1.25, 1.75], p < .001; fully 
adjusted OR = 1.33, 95% CI [1.09, 1.63], p = .006) (data not shown).
TABLE 4. Unweighted Frequencies and Weighted Percentages (of Total Population Sample) of Specific 
Long-standing Illnesses Among SAPAS PD Screen Negative (Score Lower Than 4) Sample and SAPAS 
PD Screen Positive (Score 4 or Greater) Sample
SAPAS PD screen negative sample 
(n = 1,421)







Depression 56 4.7 [3.6, 6.2] 45 19.5 [14.7, 25.4]
Asthma 104 7.6 [6.3, 9.3] 31 14.7 [10.4, 20.3]
Chronic bronchitis 5 0.4 [0.2, 0.9] 3 1.6 [0.5, 4.8] 
Other chest problems 13 1.1 [0.6, 2.1] 9 4.6 [2.4, 8.8]
Diabetes 59 5.4 [4.2, 6.9] 14 7.2 [4.2, 12.0]
Stomach/digestive problems 45 3.7 [2.7, 5.0] 15 6.7 [4.0, 10.9]
Liver problems 10 0.7 [0.4, 1.4] 5 2.6 [1.0, 6.3]
Rheumatism/arthritis 95 9.1 [7.4, 11.2] 30 16.7 [11.9, 23.0]
Heart problems 38 3.7 [2.6, 5.1] 13 7.4 [4.3, 12.4]
High blood pressure 120 11.2 [9.3, 13.3] 29 14.9 [10.5, 20.9]
Stroke 8 0.7 [0.4, 1.5] 5 3.1 [1.3, 7.3]
Migraines 33 2.4 [1.7, 3.5] 17 8.1 [5.0, 12.8]
Back problems 80 6.2 [5.0, 7.7] 32 14.5 [10.3, 19.9]
Seizures 6 0.5 [0.2, 1.1] 6 2.5 [1.1, 5.9]
Gynecological problems 24 1.9 [1.3, 2.9] 9 3.7 [1.9, 7.0]
Irritable bowel syndrome 30 2.4 [1.6, 3.4] 4 1.5 [0.6, 4.1]
Cancer 18 1.7 [1.1, 2.7] 5 2.8 [1.1, 6.8]
Other illness 228 18.3 [16.2, 20.7] 73 31.9 [25.9, 38.5]
Reports 3 or more illnesses (excluding 
depression)
96 8.9 [7.3, 10.7] 40 19.9 [14.8, 26.1]
Reports 3 or more illnesses (including 
depression)
109 9.9 [8.2, 11.9] 48 22.9 [17.6, 29.2]
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PERSONALITY DISORDER SCREEN STATUS AND  
LONG-STANDING ILLNESS 
Table 4 presents unweighted frequencies and weighted percentages (with 
95% confidence intervals) of specific long-standing illnesses reported by 
study participants, stratified by their PD screen status. A greater propor-
tion of people in the screen positive sample reported the following specific 
illnesses: depression (19.5% vs. 4.7%), asthma (14.7% vs. 7.6%), other 
chest problems (4.6% vs. 1.1%), rheumatism/arthritis (16.7% vs. 9.1%), 
migraines (8.1% vs. 2.4%), back problems (14.5% vs. 6.2%), and “other 
illness” (31.9% vs. 18.3%). Moreover, a greater proportion of people in the 
screen positive sample reported three or more illnesses; this was the case both 
when depression was excluded (19.9% vs. 8.9%) and when depression was 
included (22.9% vs. 9.9%). 
DISCUSSION
MAIN FINDINGS
In this representative sample of 1,662 randomly selected London residents, 
approximately one in seven participants screened positively for PD. Those 
screening positively for PD were significantly more likely to report poor gen-
eral health, compared to those screening negatively for PD. This association 
remained significant after adjustment for a range of covariates and was also 
observed for those with subthreshold levels of PD symptoms. A greater pro-
portion of those screening positively for PD reported the following specific 
longstanding illnesses: depression, asthma, other chest problems, rheuma-
tism or arthritis, migraines, back problems, and “other illnesses.” We also 
found that a greater proportion of this sample reported three or more ill-
nesses. For some illnesses, such as chronic bronchitis, liver problems, stroke, 
and seizures, the number of reporting participants was too small to allow 
meaningful comparison between the two groups.
STRENGTHS AND LIMITATIONS
The study used a large, representative sample drawn from an urban com-
munity setting and took into account a wide range of covariates, including 
sociodemographic variables, lifestyle and health behavior factors, and pres-
ence of common mental disorder and physical conditions. In addition, the 
sensitivity analyses revealed the significant effect of minor degrees of person-
ality dysfunction on health.
The findings need to be considered in the light of certain limitations. 
First, the 51.9% household participation rate in the SELCOH study means 
there is likely to be participation bias, so prevalence estimates need to be in-
terpreted with caution, particularly because those with the most severe men-
tal disorders are least likely to participate in community studies (Knudsen, 
Hotopf, Skogen, Øverland, & Mykletun, 2010). Despite this, the household 
participation rate and the 71.9% participation rate among eligible house-
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hold members, taken together, were relatively high given the level of depriva-
tion in the area.
Second, we used a brief screen for PD and arguably a more detailed as-
sessment of personality would have allowed us to examine the association 
more carefully. Against this, the brevity of the screen considerably reduced 
respondent burden and thus helped to ensure completeness of personality 
data (obtained on 98% of participants).
Third, we acknowledge the potential for overreporting bias of person-
ality dysfunction among those with active psychiatric illness (Zimmerman, 
1994), although self-reports are considered by some authors as concurrently 
reliable and valid during acute psychiatric illness (Costa, Bagby, Herbst, & 
McCrae, 2005). 
Fourth, the study was carried out in two neighboring boroughs in South 
East London, and the generalizability of our findings to other communities 
is uncertain. Finally, the cross-sectional study design limits our ability to 
make causal inferences or go beyond a theoretical discussion about PD as a 
determinant of health. 
PREVIOUS WORK
To our knowledge, ours is the first study to examine the association between 
PD and general health in a representative community sample. A number of 
studies have previously demonstrated a link between PD and various specific 
health conditions; however, these studies have been limited by their use of 
clinical or age-specific samples (thus limiting generalizability of findings), or 
only looked at one health condition. In the Collaborative Longitudinal Per-
sonality Disorders Study (CLPS), patients with major depressive disorder and 
co-occurring PD had significantly more impairment in emotional role limita-
tions, social functioning, and general health perceptions than patients with 
major depressive disorder and no PD (Skodol, Grilo, et al., 2005). In a study 
of middle-aged residents in St. Louis, disordered personality predicted worse 
physical functioning, role limitations, fatigue and pain, even when current 
health problems and the presence of depression were controlled (Powers & 
Oltmanns, 2012). In a study of more than 8,000 community-dwelling adults 
in Great Britain, Moran et al. (2007) found that those at risk for PD were 
at greater risk for cardiovascular disease, even after adjusting for smoking, 
alcohol, and other potential confounders (Moran et al., 2007). However, this 
study did not examine general health and neither did it examine the impact 
of subthreshold symptoms of PD.
Of note, we found that subthreshold personality disturbance has an im-
portant bearing on health—a finding that agrees with other work showing 
that subthreshold personality disturbance (measured as one criterion less 
than the DSM-IV threshold for personality disorders) is associated with sig-
nificant handicap (Yang, Coid, & Tyrer, 2010). In a similar vein, Zimmer-
man, Chelminski, Young, Dalrymple, and Martinez (2012) have reported 
that among psychiatric outpatients, the presence of one feature of borderline 
PD alone predicts greater comorbidity, functional impairment, and service 
use. 
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POSSIBLE MECHANISMS
A number of mechanisms are likely to underlie the detected association be-
tween PD screen status and poor self-reported health. First, personality dys-
function often co-occurs with mental illness such as depression, which in 
turn predicts poor health (Reiner, 2002). It is therefore possible that the 
relationship between PD and poor health is mediated by concurrent mental 
illness. The attenuation of the size of the odds ratio when common mental 
disorder was added to the regression model provides some support for this 
explanation.
Second, our findings indicate that people with personality dysfunction 
are also more likely to have a number of long-standing conditions, ranging 
from depression to back problems (Table 4). Third, the presence of PD may 
affect the treatment and prognosis of concurrent medical illness (Franken-
burg & Zanarini, 2006). For example, patients with PD and a chronic condi-
tion such as diabetes mellitus or end-stage renal disease have been found to 
behave in a more disordered manner in relation to their illness and may have 
greater difficulty complying with treatment (Pollock-BarZiv & Davis, 2005; 
Wuerth, Finkelstein, & Finkelstein, 2005). 
Fourth, personality dysfunction may predispose to a poorer relation-
ship with health care services and this in turn may lead to adverse health 
outcomes. In primary care, PD is associated with frequent and unplanned 
attendance to general practice, but with fewer referrals to secondary care 
(Moran, Jenkins, Tylee, Blizard, & Mann, 2000; Moran, Rendu, Jenkins, Ty-
lee, & Mann, 2001). In mental health settings, patients with PD, compared 
to those without PD, receive greater polypharmacy, which is itself associated 
with inherent health risks (Bender et al., 2001; Crawford et al., 2011). Fifth, 
the perception of health may be influenced by personality factors, regard-
less of the presence of medical problems (Barsky, Cleary, & Klerman, 1992; 
Goodwin & Engstrom, 2002). Finally, given the cross-sectional nature of 
these data, it is possible that the direction of causality is reversed and that 
poor health leads to personality dysfunction. 
IMPLICATIONS
We conclude that in the general population, people at risk for PD are at 
significantly increased risk for poor general health. At a population level, 
this finding highlights the public health impact of PD, as well as the impor-
tance of assessing personality dysfunction at all points of health care service 
delivery. For mental health practitioners, our findings further emphasize the 
importance of assessing general health in addition to mental health in those 
presenting to services. Future research needs to tease out the mechanism 
underlying the association between PD and health status. Elucidating this 
mechanism will help us to better understand the dramatically reduced life 
expectancy of individuals with PD (Fok et al., 2012). 
14 FOK ET AL.
REFERENCES
Babor T. R., Higgind-Biddle, J. C., Saunders, J. 
B., & Monteiro, M. G. (Eds.). (2001). The 
Alcohol Use Disorders Identification Test: 
Guidelines for use in primary care. (2nd 
ed.). Geneva, Switzerland: Department of 
Mental Health and Substance Dependence, 
World Health Organization.
Barsky, A. J., Cleary, P. D., & Klerman, G. L. 
(1992). Determinants of perceived health 
status of medical outpatients. Social Science 
and Medicine, 34(10), 1147–1154.
Bender, D. S., Dolan, R. T., Skodol, A. E., San-
islow, C. A., Dyck, I. R., McGlashan, T. H., 
et al. (2001). Treatment utilization by pa-
tients with personality disorders. American 
Journal of Psychiatry, 158(2), 295–302.
Braam, A. W., Prince, M. J., Beekman, A. T., De-
lespaul, P., Dewey, M. E., Geerlings, S. W., 
et al. (2005). Physical health and depressive 
symptoms in older Europeans: Results from 
EURODEP. British Journal of Psychiatry, 
187, 35–42.
Buist-Bouwman, M. A., de Graaf, R., Vollebergh, 
W. A., & Ormel, J. (2005). Comorbidity of 
physical and mental disorders and the effect 
on work-loss days. Acta Psychiatrica Scan-
dinavica, 111(6), 436–443.
Bukh, J. D., Bock, C., Vinberg, M., Gether, U., 
& Kessing, L. V. (2010). Clinical utility of 
Standardised Assessment of Personality–
Abbreviated Scale (SAPAS) among patients 
with first episode depression. Journal of Af-
fective Disorders, 127(1–3), 199–202.
Chang, C.-K., Hayes, R., Broadbent, M., Fer-
nandes, A., Lee, W., Hotopf, M., et al. 
(2010). All-cause mortality among people 
with serious mental illness (SMI), substance 
use disorders, and depressive disorders in 
southeast London: A cohort study. BMC 
Psychiatry, 10(1), 77. doi:10.1186/1471-
244X-10-77
Chwastiak, L. A., Rosenheck, R. A., Desai, R., & 
Kazis, L. E. (2010). Association of psychi-
atric illness and all-cause mortality in the 
National Department of Veterans Affairs 
Health Care System. Psychosomatic Medi-
cine, 72(8), 817–822.
Costa, P. T., Jr., Bagby, R. M., Herbst, J. H., & Mc-
Crae, R. R. (2005). Personality self-reports 
are concurrently reliable and valid during 
acute depressive episodes. Journal of Affec-
tive Disorders, 89(1–3), 45–55.
Crawford, M. J., Kakad, S., Rendel, C., Mansour, 
N. A., Crugel, M., Liu, K. W., et al. (2011). 
Medication prescribed to people with per-
sonality disorder: The influence of patient 
factors and treatment setting. Acta Psychi-
atrica Scandinavica, 124(5), 396–402.
DeSalvo, K. B., Bloser, N., Reynolds, K., He, J., 
& Muntner, P. (2006). Mortality prediction 
with a single general self-rated health ques-
tion. Journal of General Internal Medicine, 
21(3), 267–275.
El-Gabalawy, R., Katz, L. Y., & Sareen, J. (2010). 
Comorbidity and associated severity of 
borderline personality disorder and physi-
cal health conditions in a nationally repre-
sentative sample. Psychosomatic Medicine, 
72(7), 641–647.
Fok, M. L., Hayes, R. D., Chang, C. K., Stewart, 
R., Callard, F. J., & Moran, P. (2012). Life 
expectancy at birth and all-cause mortality 
among people with personality disorder. 
Journal of Psychosomatic Research, 73(2), 
104–107.
Frankenburg, F. R., & Zanarini, M. C. (2004). The 
association between borderline personality 
disorder and chronic medical illnesses, poor 
health-related lifestyle choices, and costly 
forms of health care utilization. Journal of 
Clinical Psychiatry, 65(12), 1660–1665.
Frankenburg, F. R., & Zanarini, M. C. (2006). 
Personality disorders and medical comor-
bidity. Current Opinion in Psychiatry, 
19(4), 428–431.
Germans, S., Van Heck, G. L., & Hodiamont, P. P. 
(2012). Results of the search for personality 
disorder screening tools: Clinical implica-
tions. Journal of Clinical Psychiatry, 73(2), 
165–173.
Glymour, M. M., Yen, J. J., Kosheleva, A., Moon, 
J. R., Capistrant, B. D., & Patton, K. K. 
(2012). Elevated depressive symptoms and 
incident stroke in Hispanic, African-Ameri-
can, and White older Americans. Journal of 
Behavioral Medicine, 35(2), 211–220.
Goodwin, R., & Engstrom, G. (2002). Personality 
and the perception of health in the general 
population. Psychological Medicine, 32(2), 
325–332.
Gorwood, P., Rouillon, F., Even, C., Falissard, B., 
Corruble, E., & Moran, P. (2010). Treat-
ment response in major depression: Effects 
of personality dysfunction and prior depres-
sion. British Journal of Psychiatry, 196(2), 
139–142.
Grigoletti, L., Perini, G., Rossi, A., Biggeri, A., 
Barbui, C., Tansella, M., et al. (2009). Mor-
tality and cause of death among psychiatric 
patients: A 20-year case-register study in 
an area with a community-based system 
of care. Psychological Medicine, 39(11), 
1875–1884.
Hatch, S. L., Frissa, S., Verdecchia, M., Stew-
art, R., Fear, N. T., Reichenberg, A., et al. 
(2011). Identifying socio-demographic and 
socioeconomic determinants of health in-
PERSONALITY DISORDER AND SELF-RATED HEALTH 15
equalities in a diverse London community: 
The South East London Community Health 
(SELCoH) study. BMC Public Health, 
11(1), 861.
Henderson, M., Hotopf, M., Shah, I., Hayes, R. 
D., & Kuh, D. (2011). Psychiatric disorder 
in early adulthood and risk of premature 
mortality in the 1946 British Birth Cohort. 
BMC Psychiatry, 11, 37.
Knudsen, A. K., Hotopf, M., Skogen, J. C., Øver-
land, S., & Mykletun, A. (2010). The health 
status of nonparticipants in a population-
based health study. American Journal of 
Epidemiology, 172(11), 1306–1314.
Lewis, G., Pelosi, A. J., Araya, R., & Dunn, G. 
(1992). Measuring psychiatric disorder in 
the community: A standardized assessment 
for use by lay interviewers. Psychological 
Medicine, 22(2), 465–486.
Moran, P., Jenkins, R., Tylee, A., Blizard, R., & 
Mann, A. (2000). The prevalence of per-
sonality disorder among UK primary care 
attenders. Acta Psychiatrica Scandinavica, 
102(1), 52–57.
Moran, P., Leese, M., Lee, T., Walters, P., Thorni-
croft, G., & Mann, A. (2003). Standardised 
Assessment of Personality–Abbreviated 
Scale (SAPAS): Preliminary validation of a 
brief screen for personality disorder. British 
Journal of Psychiatry, 183, 228–232.
Moran, P., Rendu, A., Jenkins, R., Tylee, A., & 
Mann, A. (2001). The impact of personal-
ity disorder in UK primary care: A 1-year 
follow-up of attenders. Psychological Medi-
cine, 31(8), 1447–1454.
Moran, P., Stewart, R., Brugha, T., Bebbington, 
P., Bhugra, D., Jenkins, R., et al. (2007). 
Personality disorder and cardiovascular 
disease: Results from a national house-
hold survey. Journal of Clinical Psychiatry, 
68(1), 69–74.
Oerlemans, M. E., van den Akker, M., Schuurman, 
A. G., Kellen, E., & Buntinx, F. (2007). A 
meta-analysis on depression and subse-
quent cancer risk. Clinical Practice and Epi-
demiology in Mental Health, 3, 29.
Office of Population Censuses and Surveys. (1980). 
Classifications of occupations 1980. Lon-
don: Her Majesty’s Stationary Office.
Ostergaard, S. D., & Foldager, L. (2011). The as-
sociation between physical illness and ma-
jor depressive episode in general practice. 
Acta Psychiatrica Scandinavica, 123(4), 
290–296.
Pollock-BarZiv, S. M., & Davis, C. (2005). Person-
ality factors and disordered eating in young 
women with type 1 diabetes mellitus. Psy-
chosomatics, 46(1), 11–18.
Powers, A. D., & Oltmanns, T. F. (2012). Personal-
ity disorders and physical health: A longitu-
dinal examination of physical functioning, 
healthcare utilization, and health-related 
behaviors in middle-aged adults. Journal of 
Personality Disorders, 26(4), 524–538.
Reiner, R. (2002). Depression as a predictor for 
coronary heart disease: A review and meta-
analysis. American Journal of Preventive 
Medicine, 23(1), 51–61.
Reinert, D. F., & Allen, J. P. (2002). The Alcohol 
Use Disorders Identification Test (AUDIT): 
A review of recent research. Alcoholism: 
Clinical and Experimental Research, 26(2), 
272–279.
Singh-Manoux, A., Martikainen, P., Ferrie, J., 
Zins, M., Marmot, M., & Goldberg, M. 
(2006). What does self rated health mea-
sure? Results from the British Whitehall II 
and French Gazel cohort studies. Journal 
of Epidemiology and Community Health, 
60(4), 364–372.
Skodol, A. E., Grilo, C. M., Pagano, M. E., Bender, 
D. S., Gunderson, J. G., Shea, M. T., et al. 
(2005). Effects of personality disorders on 
functioning and well-being in major depres-
sive disorder. Journal of Psychiatric Prac-
tice, 11(6), 363–368.
Skodol, A. E., Pagano, M. E., Bender, D. S., Shea, 
M. T., Gunderson, J. G., Yen, S., et al. 
(2005). Stability of functional impairment 
in patients with schizotypal, borderline, 
avoidant, or obsessive-compulsive person-
ality disorder over two years. Psychological 
Medicine, 35(3), 443–451.
Stata Corporation. (2008). Stata statistical soft-
ware, release 10.1. College Station, TX: 
Author.
von Hausswolff-Juhlin, Y., Bjartveit, M., Lind-
strom, E., & Jones, P. (2009). Schizophre-
nia and physical health problems. Acta 
Psychiatrica Scandinavica, Supplementum, 
438, 15–21.
Wuerth, D., Finkelstein, S. H., & Finkelstein, F. O. 
(2005). The identification and treatment of 
depression in patients maintained on dialy-
sis. Seminars in Dialysis, 18(2), 142–146.
Yang, M., Coid, J., & Tyrer, P. (2010). Personal-
ity pathology recorded by severity: Na-
tional survey. British Journal of Psychiatry, 
197(3), 193–199.
Zimmerman, M. (1994). Diagnosing personality 
disorders. A review of issues and research 
methods. Archives of General Psychiatry, 
51(3), 225–245.
Zimmerman, M., Chelminski, I., Young, D., Dal-
rymple, K., & Martinez, J. (2012). Does the 
presence of one feature of borderline per-
sonality disorder have clinical significance? 
Implications for dimensional ratings of per-





For ease of reading, the studies in chapters 2, 3, 4 and 5 will henceforth be referred 
to by abbreviated names, as follows: 
• The study in Chapter 2, entitled “Life expectancy at birth and all-cause 
mortality among people with personality disorder”, will be referred to as the 
Life Expectancy Study. 
• The study in Chapter 3, entitled “Predictors of natural and unnatural 
mortality among patients with personality disorder: evidence from a large 
UK case register”, will be referred to as the Predictors of Mortality Study. 
• The study in Chapter 4, entitled “The impact of co-morbid personality 
disorder on use of psychiatric services and involuntary hospitalization in 
people with severe mental illness”, will be referred to as the Service Use 
Study. 
• The study in Chapter 5, entitled “Personality disorder and self-rated health:  a 
population-based cross-sectional survey”, will be referred to as the Health 
Study. 
 
6.1 Summary of findings 
The studies in this thesis highlight the public health burden of personality disorder, 
with respect to health status, mortality and service use. The findings critically 
underscore the specific vulnerability conferred by an individual’s personality 
dysfunction, both in the community and also in secondary care settings.  
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Personality disorder is associated with poor physical health. The Health Study 
showed that the association between personality and poor health operates not just in 
clinical settings as has been previously reported, but also within the community 
population. Among the community sample, individuals at high risk of personality 
disorder were significantly more likely to be unemployed, have poorer health-related 
behaviours, multiple longstanding illnesses, and common mental disorders. 
However, personality dysfunction appeared to have an independent relationship with 
poor general self-rated health, over and above these factors. This applied to clinically 
significant levels of personality dysfunction as well as subthreshold personality 
dysfunction. 
 
Poor health potentially implicates elevated mortality. The Life Expectancy Study 
found that people diagnosed with personality disorder in secondary mental 
healthcare experienced a dramatic reduction in life expectancy – by 18 and 19 years 
-- compared to men and women in the general population, and the overall mortality 
was four times that of the general population. Young people with personality 
disorder bore the highest risk – a 10-fold increase in expected mortality, although 
personality disorder at all ages was associated with increased mortality.  
 
The Predictors of Mortality Study gave evidence that this burden of excess mortality 
is strongly linked to physical causes. In this study, the majority of early deaths in 
people with personality disorder were deaths from natural causes. The strongest 
clinical predicting factors of natural deaths were physical illness, and substance and 
alcohol problems. Specifically, substance and alcohol use problems of a mild degree 
was significantly associated with natural death. Deaths from unnatural causes were 
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similarly predicted by substance and alcohol problems, but at levels deemed to be 
severe. Problems with daily functioning were also significantly associated with 
mortality from all causes.  
 
Severe mental illness (SMI) typically accounts for a substantial proportion of 
secondary mental health service use. The Service Use Study investigated the added 
burden of comorbid personality disorder on service use for SMI patients. The study 
found that SMI patients who had co-morbid personality disorder were significantly 
more likely to be high users of inpatient services, and were more likely to experience 
involuntary hospitalization, compared to SMI patients without co-morbid personality 
disorder. This association was not accounted for by socio-demographic factors and 





6.2 Personality disorder and mortality 
Only five previous studies have examined the relationship between personality 
disorder and mortality [84-88]. The Life Expectancy Study supports this body of 
literature, and further provides the first comprehensive examination of the life 
expectancy of secondary mental health service users with personality disorder. Prior 
to this, a study by Hannerz et al [92] used a Swedish nationwide hospital discharge 
registry to estimate life expectancies in different diagnostic groups for individuals 
treated as inpatients. Both men and women with personality disorder had a lower 
“expectation of remaining life” at all ages, compared to people with schizophrenia 
and affective psychosis as well as the general population. However, the restriction of 
that analysis to hospitalised patients and the use of ICD-8 diagnoses limit the 
application of the findings to present-day secondary care settings. The data from the 
Life Expectancy Study contributes to the literature generally as well as providing UK 
specific data on life expectancy.  
 
Support for these life expectancy findings emerge in a study published after the work 
described in this thesis, in 2013, by Nordentoft et al, using data derived from a 
cohort of 270,770 recent-onset mentally ill patients in Denmark, Finland and Sweden 
[111].  Life expectancy amongst men with personality disorder was found to be 
between 13 and 22 years lower than that of men in the general population, and that 
amongst women with personality disorder to be between 15 and 20 years lower than 
that of women in the general population. These estimates are consistent with those 
found in the Life Expectancy Study.  
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No previous research has investigated clinical predictors of either all-cause or cause-
specific mortality in individuals with personality disorder. Mortality studies in 
personality disorder have instead almost exclusively investigated deaths from 
unnatural causes, particularly within borderline personality disorder [94, 95]. In 
borderline personality disorder, depression, substance use disorder and antisocial 
personality disorder (or traits) are associated with higher risk of completed suicide 
[94, 95]. However, despite the increased recognition of natural causes underlying 
excess mortality in people with mental disorders [96-98], no previous study has 
investigated deaths from natural causes among people with personality disorder. 
 
The aforementioned Nordic psychiatric case register study by Nordentoft et al found 
that, amongst patients with diagnoses of schizophrenia spectrum disorders, affective 
disorders, substance abuse or personality disorder, those with substance abuse or 
personality disorder had the greatest reduction in life expectancy compared to the 
general population [111]. This chimes with the findings of previous mortality studies 
in psychiatric populations [80, 82-84]. Both substance abuse and personality disorder 
are associated with deaths from diseases and medical conditions (i.e. natural causes) 
and with deaths from suicides, accidents and homicides (i.e. unnatural causes) [84, 
111]. In the Predictors of Mortality Study, amongst our cohort of patients with 
personality disorder, we found that a higher score on the HoNOS subscale assessing 
alcohol or drug use was associated with a two- to three-fold increased risk of death 
(both natural and unnatural).  
 
Interestingly, further evidence that substance use and personality disorder are a 
particularly detrimental combination emerges from a study by Bogdanowicz et al 
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[112] (published after the work described in this thesis) which examined the 
influence of psychiatric comorbidity on excess mortality amongst opioid misusers. 
This study found that comorbid personality disorder was associated with a two-fold 
increased risk of all-cause mortality, and almost four-fold risk of death from hepatic 
disease, compared to opioid misusers without personality disorder. No such 
association was found with comorbid SMI in this population. 
 
Let us consider the potential mechanism underpinning the association between each 
of the three identified predicting factors (substance and alcohol use, physical illness, 
functional impairment) and mortality in personality disorder. Deaths from accidents, 
homicides and suicides (i.e. unnatural causes) in patients with personality disorder 
who abuse alcohol and/or illicit drugs might be explained by the acute effects of 
intoxication leading to greater impulsivity and associated risk-taking behaviour, 
resulting in fatal accidents or suicide.  Similarly, an increased risk of death by 
violence may also reflect the increased likelihood for involvement in a violent drug-
related subculture. Considering natural causes of death, alcoholism is strongly linked 
with gastrointestinal disease, chiefly cirrhosis and peptic ulceration, whilst drug 
abuse is associated with viral infections, particularly hepatitis and HIV. It is 
noteworthy, however, that mild rather than severe alcohol or drug use predicted 
death from natural causes.  One possible explanation for this finding is that 
substance use rated as mild in severity is more likely to go undetected and untreated.  
Similar mechanisms may help to explain an association between subclinical 
depression and mortality in patients with serious mental illness [113]. Another 
possibility is that those with personality disorder and severe alcohol or drug use who 
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present to clinical services, represent relatively healthy survivors, which would 
obscure any association with later mortality risk.  
 
The detected association between all-cause and natural cause mortality with physical 
illness is unsurprising. Personality disorder is associated with poor health [114], and 
physical ill-health from unhealthy lifestyles. In addition, undertreated medical 
conditions, and the harmful side effects of medications -- which are often extensively 
used by people with personality disorder [115] -- are known to reduce life 
expectancy in people with mental disorders [116, 117]. Previous studies have 
reported substantially reduced life expectancy among individuals who self-harm 
[118], and frequency of self-harm is associated with increased risk of suicide [119]. 
In contrast, our study found no independent association between the HoNOS 
subscale on self-harm and mortality. Similarly, although high rates of violent 
behaviour in individuals with personality disorder are a focus for clinical and public 
concern [28] and associations have been reported between hostility and mortality in 
cardiovascular disease [120], we found no association between overactivity and 
aggression, and mortality. On the other hand, difficulties with activities of daily 
living (ADL) independently predicted all-cause mortality. Together with the null 
findings with respect to self-harm and aggression, this is consistent with research 
showing that self-neglect may be a stronger predictor of mortality than the more 
obvious risk factors of self-harm or violence [121]. It is also consistent with other 
research showing that ADL impairment is independently predictive of all-cause 
mortality among individuals with severe mental illness [122]. ADL impairment is 
therefore a potentially important marker of vulnerability in individuals with 
personality disorder. Further investigation is needed to examine the causal pathway 
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between ADL impairment and mortality in this patient group; potential mediators of 
this relationship may include chronic social disadvantage, social isolation and 
poverty (all of which might conceivably result from the reduced opportunities to 
work and socialise that occur in the presence of ADL impairment).  
 
6.3 Comorbid personality disorder and secondary mental health 
service use 
The Service Use Study was the first study to examine the impact of co-morbid 
personality disorder on both inpatient and community-based mental health service 
use of adult patients with SMI. Tyrer and Simmonds [62] reviewed the outcome of 
three randomised controlled trials that investigated different models of care in SMI 
and found, in post-hoc analyses, that patients with co-morbid personality disorder 
spent more time in hospital compared to those without co-morbid personality 
disorder, regardless of the model of care. Keown and others investigated psychiatric 
bed use amongst SMI patients seen in a UK community mental health team, and 
found that the concurrent presence of personality disorder and also severity of 
personality disorder were associated with increased psychiatric bed use amongst 
SMI patients [61, 62]. My finding in this study that co-morbid personality disorder 
increases inpatient service use in SMI patients is consistent with these studies, and 
chimes with existing evidence that co-morbid personality pathology worsens 
outcomes in SMI [24, 56, 57, 59, 60, 123]. The SMI-PD (i.e. SMI with comorbid 
personality disorder) patient group was characterised by a number of factors known 
to contribute to increased psychiatric service use, i.e more severe psychopathology 
[59], higher levels of aggression [124] and self-injury [125], greater problems with 
alcohol and drug use [126, 127], greater problems with housing [124] and 
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occupation, and less stable relationships [128, 129], compared to the SMI group. 
However, adjustment for these potential confounders had little effect on the strength 
of the association with inpatient service use.  
 
Based on previous work on patients with personality disorder and co-morbid 
personality disorder [105, 109], one may have expected a similar pattern with regard 
to community-based services.  In this respect, however, the findings of the Service 
Use Study were inconclusive. Although no other study has examined both inpatient 
and community-based service use in adults with a dual diagnosis of SMI and 
personality disorder, a recent study in adolescents with Axis I psychiatric disorders 
[110] found that those with co-morbid personality disorder used more inpatient and 
emergency, but comparable outpatient, psychiatric services, compared to those 
without co-morbid personality disorder.  
 
6.4 Comorbid personality disorder and involuntary hospitalization 
No study has previously examined the impact of co-morbid personality disorder on 
the risk of involuntary hospitalization in patients with SMI. In the Service Use Study, 
the combination of personality disorder in the presence of SMI independently 
increased the risk of involuntary hospitalization.  Compared to the SMI group, the 
SMI-PD group had a higher proportion of individuals with severe clinical problems 
in five of eight clinical domains, including aggression [130] and non-accidental 
injury.  Levels of social dysfunction were also higher among the SMI-PD group 
compared to the SMI group. Thus factors associated with increased risk to self 
and/or others (a criterion for involuntary detention under the English Mental Health 
Act) were more prevalent in the SMI-PD group compared to those with SMI alone.  
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These factors are very likely to be on the causal pathway to involuntary 
hospitalization for those with co-morbid personality disorder. The attenuation in the 
size of the odds ratio, which occurred when these covariates were added to the 
model, provides some support for this argument.  A diagnosis of personality disorder 
alone was associated with a lower likelihood of detention in hospital. This is 
consistent with recommended clinical practice [131], as there is no evidence base to 
suggest that compulsory treatment in hospital for people with personality disorder 
improves clinical outcomes.   
 
6.5 Personality disorder and health in the general population 
The Health Study is the first study to examine the association between personality 
disorder and general health in a representative community sample. A number of 
studies have previously demonstrated a link between personality disorder and 
various specific health conditions; however, these studies have been limited by their 
use of clinical or age-specific samples (thus limiting generalizability of findings), or 
by the fact that they have only looked at one health condition.  
 
Of note, the Health Study found that subthreshold personality disturbance has an 
important bearing on health – a finding which chimes with other work showing that 
subthreshold personality disturbance (measured as one criterion less than the DSM-
IV threshold for personality disorders) is associated with significant handicap [51]. 
In a similar vein, Zimmerman et al have reported that amongst psychiatric 
outpatients the presence of one feature of borderline personality disorder alone 
predicts greater comorbidity, functional impairment and service use [132].  
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A number of mechanisms are likely to underlie the detected association between 
personality disorder screen status and poor self-reported health. Personality 
dysfunction often co-occurs with mental illness such as depression, which in turn 
predicts poor health [133]. It is therefore possible that the relation between 
personality disorder and poor health is mediated by concurrent mental illness. The 
attenuation of the size of the odds ratio when common mental disorder was added to 
the regression model provides some support for this explanation.   
 
The findings from the Health Study indicate that people with personality dysfunction 
are also more likely to have a number of longstanding conditions, ranging from 
depression to back problems. Related to this, the presence of personality disorder 
may affect the treatment and prognosis of concurrent medical illness [25]. For 
example, patients with personality disorder and a chronic condition such as diabetes 
mellitus or end-stage renal disease have been found to behave in a more disordered 
manner in relation to their illness and may have greater difficulty complying with 
treatment [134, 135].  
 
Furthermore, an underlying psychological characteristic in people with personality 
disorder may render them more vulnerable to physical illness such as cardiovascular 
disease [69]; possible candidates for this underlying characteristic include negative 
affectivity [136], affective instability [137], and hostility [138]. Personality 
dysfunction may predispose to a poorer relationship with healthcare services and this 
in turn may lead to adverse health outcomes. In primary care, personality disorder is 
associated with frequent and unplanned attendance to general practice, yet fewer 
referrals to secondary care [33, 103].  In mental health settings, compared to those 
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without personality disorder, patients with personality disorder receive greater 
polypharmacy, which is itself associated with inherent health risks [105, 115].  The 
perception of health may be influenced by personality factors, regardless of the 
presence of medical problems [72, 139]. Finally, given the cross-sectional nature of 
these data, it is possible that the direction of causality is reversed and that poor 
health leads to dysfunctional personality change, or alternatively, that poor health 
colours the self-description of personality (i.e. reporting bias), leading to a greater 




6.6 Methodological considerations  
There are a number of methodological considerations that need to be considered in 
the interpretation of the findings in all four studies. 
 
6.6.1 Studies using CRIS 
The Life Expectancy Study, Predictors of Mortality Study and Service Use Study 
were all historical cohort studies that used a routine clinical database. The main 
advantage of this design is access to a large clinical cohort derived from a secondary 
mental health setting which included the full range of inpatient and community-
based services, as well as a wide range of clinically important outcome and covariate 
data.  However, certain limitations inherent in the use of such a database need to be 
recognised. 
 
First, all three studies relied on ICD-10 diagnoses as opposed to standardised 
assessments. Against this, the use of routinely-collected clinical data allowed me to 
obtain data on a very large sample size, thus optimising the precision of my findings.  
Moreover, the use of routine clinical diagnoses in a very large population favours 
generalisability to real clinical practice. In addition, I established an acceptable level 
of reliability between the case register diagnoses of personality disorder and blind 
clinical ratings, obtaining kappa of 0.72 (p <0.001). 
 
Second, routinely collected clinical data may contain measurement error, which 
applies to demographic and socioeconomic variables as well as clinical variables 
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such as HoNOS items. However, we would expect that any measurement error 
would be essentially random, so unlikely to introduce systematic bias. 
 
Finally, it is known that a large number of people with personality disorder do not 
present to mental health services and are either managed in primary care or within 
general medical services. Findings from the Life Expectancy Study, Predictors of 
Mortality Study, and Service User Study therefore are principally generalizable to 
secondary mental health service users. 
 
6.6.2 The mortality studies 
The two mortality studies both had potentially important unmeasured confounders. 
In the Life Expectancy Study these included socio-economic status, comorbid 
psychiatric and physical conditions and substance misuse. In the Predictors of 
Mortality Study, frequency and intensity of service contact, and possible effects of 
pharmacological or psychosocial interventions were not considered. Level of service 
contact and interventions may have a bearing on symptoms and health [140], either 
positively or negatively, which can contribute to mortality risk. Other variables that 
were unaccounted for were duration of illness and smoking status. 
 
Despite having good sample sizes, both mortality studies had insufficient statistical 
power to examine more fine-grain associations, such as that between personality 
disorder clusters and mortality, and that between clinical variables and more specific 
causes of death. 
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The Life Expectancy Study used national data as a comparison, which might not be 
representative of the local population in South East London. To address this, I 
carried out a sensitivity analysis, standardising with mortality statistics for London 
alone. The point estimates for SMRs obtained in this sensitivity analysis were not 
substantially different from those obtained with national data. 
 
6.6.3 The Service Use Study 
In the Service Use Study, the historical cohort design meant that in some cases, the 
diagnosis of co-existing personality disorder was made during the course of, or in 
some cases, towards the end of the individual’s observation period. This, together 
with my cross-sectional analysis, limits my ability to make causal inferences 
(between comorbid personality disorder and high service use).  
 
Furthermore, the relatively low prevalence of co-morbid personality disorder in the 
SMI cohort (8.1%), stands in contrast with prevalence rates reported in other studies 
[18, 35, 141, 142] and indicates that there was under-detection of personality 
disorder in the sample [123, 143]. On the other hand, it is possible that some cases of 
personality disorder were misclassified and that the probability of this occurring was 
dependent upon service use (i.e. that heavy users of services were more likely to 
attract a diagnosis of personality disorder). If this is the case, then it is possible that 
the strength of association between co-morbid personality disorder and heavy service 
use was over-estimated.   
 
Although there was incomplete data in some models in this study, it is unlikely to 
explain the observed associations, as there was little variation in results across the 
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regression models. In addition, incomplete data was not unevenly distributed among 
the exposure groups of interest (SMI and SMI-PD).  
 
6.6.4 The Health Study 
The Health Study used a large, representative sample drawn from an urban 
community setting, and took into account a wide range of covariates, including 
sociodemographic variables, lifestyle and health behaviour factors, as well as 
presence of common mental disorder and physical conditions.  However, this study 
also had its limitations.  First, the 51.9% household participation rate in the 
SELCOH study means that participation bias was likely present, so prevalence 
estimates need to be interpreted with caution, particularly because those with the 
most severe mental disorders are least likely to participate in community studies 
[144]. Despite this, the household participation rate and the 71.9% participation rate 
among eligible household members, taken together, were relatively high. Second, a 
brief screen was used for personality disorder and arguably a more detailed 
assessment of personality would have allowed me to examine the association more 
carefully. Against this, the brevity of the screen considerably reduced respondent 
burden and thus helped to ensure completeness of personality data (obtained on 98% 
of participants).   Third, as acknowledged above, poor health may colour the self-
description of personality (i.e. reporting bias), leading to over-reporting of 
personality disorder traits [8]. Notwithstanding, self-reports of personality are 
generally considered to be concurrently reliable and valid during acute psychiatric 
and medical illness [145]. Fourth, the study was carried out in two neighbouring 
boroughs in South East London, and the generalizability of the findings to other 
communities is uncertain. Finally, the cross-sectional study design limits my ability 
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to make causal inferences or go beyond a theoretical discussion about personality 
disorder as a determinant of health. 
 
6.6.5 Personality disorder exposures across the studies 
Lastly, it is important to note that different approaches were used to capture 
personality status across the studies. Whilst the CRIS studies (i.e. the Life 
Expectancy Study, the Predictors of Mortality Study and the Service Use Study) used 
routine clinical diagnosis to identify people with personality disorder in a clinical 
population, the Health Study made use of a standardized, structured instrument to 
assess personality dysfunction in a community sample. Thus the reader is advised 
not to interpret the personality disorder exposures between these studies as entirely 




6.7 Implications for clinical practice and future research 
The findings in this thesis contribute substantially to knowledge about the burden of 
personality disorder in secondary mental health services and also in the general 
population. The findings highlight the public health impact of personality disorder, 
and point to the critical importance of routinely assessing personality status at all 
points of healthcare service delivery. The finding that even subthreshold personality 
dysfunction can have implications for health, should encourage clinicians across all 
sectors (including primary care, emergency services, and secondary services) to 
always consider personality factors when meeting the needs of help-seeking 
individuals. For mental health practitioners, the findings regarding personality 
disorder and health emphasize the importance of assessing general health in addition 
to mental health in those presenting to services. Future research needs to tease out 
the mechanism underlying the association between personality disorder and health 
status. 
 
The identification of specific risk factors with respect to mortality in personality 
disorder has clear implications for clinical practice. The physical health status of 
patients with personality disorder should be regularly reviewed. Such a basic 
principle of medical care cannot be overstated.  Compared with members of the 
general population, people with mental health problems receive poorer physical 
healthcare [146] and within this population, individuals with personality disorder are 
among the most poorly served, in part because they are often perceived to be 
‘difficult’ [147] and thus not deserving of care [148].  
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Functional impairment is an enduring feature of most forms of personality disorder 
[49] and, given the evidence from this thesis of its association with early mortality, 
should be a central component of the clinical assessment of people with suspected 
personality disorder. Furthermore, apparently mild problems with drugs and alcohol 
was the strongest predictor of mortality to emerge from the Predictors of Mortality 
Study, confirming the importance of taking a careful alcohol and drug history from 
all personality-disordered patients, including those without conspicuous alcohol- and 
drug-related problems [113, 121].   In summary, clinicians need to pay greater 
attention to the physical health status, drug and alcohol use, and functional status of 
their patients with personality disorder.   
 
Amongst patients with SMI, the co-existence of personality disorder was found to be 
independently associated with both high use of inpatient psychiatric services and an 
increased likelihood of involuntary hospitalization. This fact, together with the 
tendency for under-diagnosis of co-morbid personality disorder, again highlights the 
importance of routinely assessing personality status in all individuals presenting to 
secondary mental health services, with or without Axis I disorders. Patients with 
SMI and co-morbid personality disorder are likely to require tailored interventions 
that target both the underlying personality pathology as well as the Axis I disorder. 
In this respect, the use of crisis plans and assertive outreach models may help to 
reduce admissions and involuntary hospitalization for patients with SMI and co-




In conclusion, the findings of this thesis provide evidence of the burden of 
personality disorder in secondary mental health services and in the general 
population. In particular, personality disorder or personality dysfunction is 
independently associated with poor health, increased mortality and significantly 
reduced life expectancy. Amongst people with personality disorder, the most risky 
subset with respect to mortality, are those with alcohol and drug problems, poor 
physical health, and severe functional impairment. Co-morbid personality disorder in 
severe mental illness, which often goes undiagnosed, is independently associated 
with both high use of inpatient psychiatric services and an increased likelihood of 
involuntary hospitalization. These findings provide a strong rationale for routinely 
assessing personality status in individuals presenting to general health services and 
mental health services. The findings also indicate that clinicians and services should 
pay greater attention to the areas of physical health, drug and alcohol use, and 
functional impairment among people with personality disorder. To not do so, runs 
the risk of missing valuable opportunities for intervening with this evidently 
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